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Monocytes are haematopoietic stem cell-derived, immune effector cells. In mice, 
monocytes consist of two principal subsets: the classical Ly6C-expressing subset and 
the patrolling Ly6Clow subset. The origin and fate of Ly6Clow monocytes remains a topic 
of debate, as does their interrelationship with Ly6C+ monocytes. The current model of 
Ly6Clow monocyte development suggests that Ly6C+ monocytes are the obligate, steady 
state precursors of the Ly6Clow subset, undergoing conversion or maturation within the 
blood. However, several studies have reported differing genetic dependencies of 
monocyte subsets that are in conflict with this model of Ly6Clow monocyte 
development.  
To re-investigate monocyte precursor-product relationships, this project combined 
genetic, kinetic and adoptive transfer studies to probe the interrelationships between 
bone marrow precursors, blood monocytes and tissue macrophages. This study firstly 
confirms the existence of a third, minor monocyte subset that expresses MHC II and 
varying levels of Ly6C and is found in the blood, spleen and bone marrow monocyte 
compartments. Secondly, this study establishes that all three monocyte subsets arise in 
the bone marrow from a proliferating common pro-monocyte via two genetically 
distinct lineages. This study demonstrates that Ly6Clow MHC II- monocytes arise from a 
novel Nr4a1-dependent, Irf8-independent intermediate population in the bone marrow 
compartment under steady state conditions, whereas. Thirdly, Nr4a1-dependent 
monocytes have a long half-life and circulate within the systemic and splenic 
vasculature, contributing minimally to tissue macrophage populations under steady state 
conditions. The findings in this thesis clarify and extend our understanding of monocyte 
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 Historical perspectives of monocyte biology 1.1
Almost all metazoan organisms present some form of defence against invading 
pathogens. Versions of the innate immune system can be seen in invertebrates, such as 
Drosophila melanogaster, and vertebrates including mice and humans. The innate 
immune system consists of both humoral agents, such as antimicrobial peptides, 
complement proteins and opsonins, and cellular mechanisms to fight invading 
pathogens, such as bacteria, fungi and parasites. The cellular arm of the innate immune 
system consists mainly of specialised cells known as phagocytes. Russian zoologist, 
Elie Metchnikoff, was the first person to combine the observation of phagocytosis with 
a detailed hypotheses of the protective role this process could have (Gordon, 2008).  
Phagocytes can be found across animal phyla and appear, in evolutionary terms, before 
the development of the vascular system. Interestingly, specialised phagocytic cells 
capable of detoxification and immune-like functions can be found in colonies of the 
social amoeba Dictyostelium discoideum (Chen et al., 2007). This indicates 
phagocytosis is an ancient and conserved scavenging mechanism that has been adapted 
for protective functions prior to the expansion of animal phyla. 
The highly conserved nature of phagocytes allowed Metchnikoff to utilise transparent 
cells, in particular of starfish larvae and water fleas, as models for early intravital 
microscopy. During these experiments, he noted that if he pierced the larvae with a 
foreign object, he could observe the recruitment of amoeboid cells around the foreign 
object (Gordon, 2008; Metchnikoff, 1891; Metchnikoff, 1892, 1893). Metchnikoff 
continued to use simple, transparent organisms and directly observed under the 
microscope the engulfment of particulate matter. The term phagocyte was eventually 
coined by Professor Carl Friedrich Wilhelm Claus, with whom Metchnikoff discussed 






Figure 1-1 Metchnikoff's drawing of phagocytes during inflammation 
Reproduced from (Metchnikoff, 1968).  
 
In addition to noting their role as defence against microbial pathogens, Metchnikoff was 
also the first person to postulate, using Echinoderm larvae, the contribution of 
phagocytes to the maintenance and renewal of tissues (Metchnikoff, 1884b; 
Metchnikoff, 1968). These observations led Metchnikoff to suggest that phagocytes 
seen outside of the vascular system participated in the remodelling of tissue and in 
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recruiting leucocytes to the point of tissue injury (Metchnikoff, 1884a, b; Metchnikoff, 
1892, 1893). 
Metchnikoff defined two types of phagocyte, the smaller polymorphonuclear (PMN) 
leukocyte that he named a “microphage” and the larger mononuclear leukocyte he 
termed “macrophage” (Gordon, 2008; Metchnikoff, 1968; Yona and Gordon, 2015).  
The incredible diversity in anatomical location and functionality is part of what makes 
macrophages so fascinating, has led to great confusion in the classification of these cells 
and their interrelationships (Yona and Gordon, 2015). Ehrlich, an early advocate of 
humoral immunology who was awarded the Nobel Prize jointly with Metchnikoff, 
pioneered the classification of blood cells based on their nuclear morphology stained 
with dyes (Ehrlich, 1956; Silverstein, 2009). The pathologist Ludwig Aschoff built 
upon the early work by Ehrlich by the systematic cellular classification that he termed 
the “reticuloendothelial system” (RES) (Halpern, 1959). This classification unified 
phagocytes from diverse tissues into a single system (Halpern, 1959). Aschoff 
hypothesised that phagocytes belonged in a single system on the basis that these cells 
had the shared ability to ingest and accumulate particulate matter (Halpern, 1959). 
Furthermore, he divided cells of the RES into “sessile” and “wandering” and suggested 
that the cells of the RES derived from their anatomical location (Halpern, 1959). 
However mounting evidence accumulated, from the use of experimental inflammation 
models both in vitro (Carrel and Ebeling, 1926; Lewis, 1925) and in vivo (Ebert and 
Florey, 1939; Marchesi and Florey, 1960) that demonstrated monocytes giving rise to 
macrophages. These observations led to the development of a new framework 
postulating that macrophages belonged to the haematopoietic system and that they arose 
from blood monocytes. Consequently, the RES model seemed inaccurate and out-dated 
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and was eventually replaced by the concept of the mononuclear phagocyte system 
(MPS).  
The MPS, is a model established by van Furth and Cohn (van Furth and Cohn, 1968; 
van Furth et al., 1972) which hierarchically organised macrophages, monocytes and, 
after their discovery in 1975, dendritic cells (Steinman et al., 1975) in a single system. 
This system regarded monocytes as the circulating precursors to tissue resident 
macrophages, providing an intermediate between cycling bone marrow (BM) 
progenitors and effector macrophages in tissues. Thus, the MPS outlined a linear model 
of macrophage development (van Furth, 1970, 1980; van Furth et al., 1972) that has 
proved to be highly effective and persistent. However, the majority of the experiments 
that led to the establishment of the MPS relied upon investigating monocytes and 
macrophages under inflammatory conditions and not in steady state. In addition, many 
studies have published observations that are at odds with the linear concept of the MPS. 
For example, during embryogenesis, macrophages can be seen before the emergence of 
HSCs at embryonic day 10.5 (E10.5) (Boisset et al., 2010; Sorokin et al., 1992) and 
tissue resident macrophage populations are unaffected by in monocytopenic mice 
(Yamada et al., 1990). Consequently, yolk sac origins of tissue resident macrophages in 
steady state has begun to be realised (see section 1.5) and the effector functions of 





Figure 1-2 A schematic illustrating different models of monocyte and macrophage 
ontogeny 
 
As can be seen in Figure 1-2, recent advances in our understanding of monocyte and 
macrophage ontogeny and functionality do not invalidate the model of the mononuclear 
phagocyte system, rather adds an additional layer of complexity. 
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 Blood monocytes 1.2
1.2.1 Monocyte subsets 
Monocytes belong to the myeloid arm of the immune system. They develop normally in 
lymphoid deficient mice harbouring combined mutations in recombinase activating 
gene-2 (Rag2-/-) and common cytokine receptor γ chain (Il2rg-/- or γc) (Auffray et al., 
2007; Mazurier et al., 1999).  
Amongst blood cells, monocytes can be defined by high expression of CSF1R 
(CD115+) and the integrin CD11b (CD11b+) (MacDonald et al., 2005; Sasmono et al., 
2003), and do not express CD3, CD19, Ly6G and NK cell markers. Morphologically, 
monocytes can be identified by their high cytoplasm-to-nucleus ratio and their 
distinctive bean shaped nuclei (Auffray et al., 2009b) (Figure 1-3).  
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Table 1-1 Blood cellular morphology 
 
 
Monocytes represent ~10% of human blood leukocytes (Kratz et al., 2004) and 1.5-5% 
of murine blood leukocytes (http://phenome.jax.org). Research over the last 30 years 
has provided considerable insight into the blood monocyte compartment, revealing that 
these cells do not represent a homogeneous population, but display considerable 
heterogeneity, both phenotypically and functionally. In both humans and mice, two 
principal monocyte subsets have been described (Geissmann et al., 2003; Passlick et al., 
1989). In humans, these subsets are defined as CD14+ CD16- “classical” monocyte and 
the CD14dim CD16+ “non-classical” monocyte (Ziegler-Heitbrock et al., 2010). In mice, 
the two principal monocyte subsets are defined as Ly6C+ (GR-1+) “classical” or 
“inflammatory” monocyte and the Ly6Clow (GR-1low) “non-classical”, “patrolling” or 
“resident” subset (Figure 1-3) (Geissmann et al., 2003; Ziegler-Heitbrock et al., 2010). 
Cell type Cytospin Mouse markers 
Human 
markers 






















T cells: CD3, 
CD4, CD8 
 
B cells: CD19, 
B220 
T cells: CD3, 
CD4, CD8 
 




Furthermore, in both the human and mouse blood monocyte compartment, a third minor 
subset can be seen (Figure 1-3). In humans this is the double positive CD14+ CD16+ 
population. In murine blood, there is a third subset with varying levels of Ly6C 
expression that also expresses MHC II+ (major histocompatibility complex, class II) 
population (Carlin et al., 2013; Jakubzick et al., 2013). Whilst the main subsets have 
been relatively well defined phenotypically, there remains some debate as to how they 
interrelate with each other in vivo and how these, poorly characterised, minor subsets 
relate to the major monocyte subsets. 
  
Figure 1-3 Human and mouse monocyte subsets 
Human monocyte populations are CD14+ CD16- “classical” monocytes, which are analogous to 
murine Ly6C+ monocytes (pink gate); CD14dim CD16+ “patrolling” monocytes, which are 
thought to be analogous to murine Ly6Clow MHC II- monocytes (red gate). Both humans and 
mice have a third, intermediate monocyte population that are CD14+ CD16+ in humans and 
Ly6Cint MHC II+ in mice. These intermediate populations remain to be fully characterised. 
 
 










Gated on lineage- 
HLA-DR+ (MHC II) 
Human monocyte subsets Mouse monocyte subsets 
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1.2.1.1 Human blood monocytes 
Traditionally, human monocytes were thought to be a homogeneous blood circulating 
cell type, defined by expression of CD14 and HLA-DR (Human Leukocyte Antigen-
DR) whose principal function was considered to be replenishment of tissue 
macrophages in homeostasis and under pathological conditions.  
The work of Passlick, Flieger and Ziegler-Heitbrock in the late 1980’s shed light on the 
heterogeneity of the human monocyte compartment in terms of size, morphology, 
phagocytic and adherence capability as well as cell surface markers by identifying a 
population of CD14dim CD16+ monocytes (Passlick et al., 1989; Ziegler-Heitbrock et al., 
1988).  
At the time, the identification of monocyte heterogeneity was considered to be a 
reflection of tissue macrophage heterogeneity (Passlick et al., 1989). As a result there 
were many attempts to clearly discriminate and characterise monocyte subtypes, leading 
to an appreciation of heterogeneity within the CD16+ monocyte compartment. 
Consequently, the intermediate CD14+ CD16+ monocyte population was identified as a 
subset in their own right (Ancuta et al., 2003; Grage-Griebenow et al., 2001b; 
Moniuszko et al., 2009; Skrzeczynska-Moncznik et al., 2008).  
“Classical” CD14+ CD16- monocytes make up around 85% of human blood monocytes 
(Cros et al., 2010; Ziegler-Heitbrock, 2014); they are large (approximately 18-20µm in 
diameter) (Cros et al., 2010; Passlick et al., 1989), and express CSF1R (CD115), 
CD11b, CD64 (FcγRI), high levels of the chemokine receptor CCR2, L-selectin 
(CD62L), and low levels of the chemokine receptor CX3CR1 (Cros et al., 2010; Grage-
Griebenow et al., 2001a; Grage-Griebenow et al., 2000).  
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In contrast, the “non-classical” CD14dim CD16+ monocyte subset is smaller (around 
15µm in diameter) and less granular (Cros et al., 2010; Passlick et al., 1989) and make 
up approximately 7% of human blood monocytes (Cros et al., 2010). This population, 
by definition, expresses CD16 (FcγRIII) as well as CD115 and high levels of CX3CR1. 
Unlike classical monocytes, CD14dim CD16+ monocytes do not express CD62L or CD64 
and express lower levels of CD11b, HLA-DR and the scavenger receptor CD163 (Cros 
et al., 2010; Grage-Griebenow et al., 2001a; Grage-Griebenow et al., 2000; Passlick et 
al., 1989). 
The third subset of human monocytes, the CD14+ CD16+ monocytes, display an 
intermediate phenotype between the classical and non-classical subsets however gene 
expression profiling studies have shown that this subset selectively expresses markedly 
higher levels of HLA-DR compared to CD14+ CD16- and CD14dim CD16+ subsets. In 
addition, double positive monocytes express a variety of MHC II-restricted antigen 
processing genes such as CD74 (class II invariant chain) as well as the co-stimulatory 
molecule CD40 (Wong et al., 2011; Zawada et al., 2011). An overview of human 
monocyte subsets is set out in Table 1-2. 
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Table 1-2 Human blood monocyte subsets 
Human monocyte 
subsets 
Frequency of total 






































The differences observed in gene and protein expression patterns reflect functional 
differences of the three human monocyte subsets. Side by side gene expression profiling 
of human and mouse monocyte subsets has lent support to the contention that 
functionally, human CD14+ CD16- cells are analogous to murine Ly6C+ classical 
monocytes (see Figure 1-3) and that human CD14dim CD16+ monocytes are analogous to 
murine Ly6Clow monocytes, although both with important differences. This analogy was 
extended with intravital imaging demonstrating CD14dim CD16+ monocytes exhibiting 
patrolling behaviour when transferred to blood vessels in the mouse ear (Cros et al., 
2010). 
Functionally, human monocyte subsets have distinct responses to infectious agents. 
Serbina et al., demonstrated that in response to Aspergillus fumigatus conidia, CD14+ 
CD16- classical monocytes could inhibit fungal growth but produced little tumour 
necrosis factor α (TNFα), whereas the double positive, CD14+ CD16+ subset secreted 
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considerable quantities of TFNα but were unable to inhibit fungal growth (Serbina et 
al., 2009).  
In response to LPS stimulation, CD14+ CD16- monocytes produce high levels of 
reactive oxygen species (ROS), CCL2, CCL3, IL-6 and IL-8 but secreted comparatively 
low levels of TNFα and IL-1β. In contrast, CD14+ CD16+ monocytes produced very 
high levels of TNFα, IL-1β and IL-6 but lower levels of CCL3, IL-6 and IL-8 and 
considerably reduced CCL2 and ROS. In addition, both CD14+ monocyte subsets are 
highly efficient at phagocytosing latex beads and capable of producing the anti-
inflammatory cytokine IL-10 but with differing kinetics (Cros et al., 2010).  
Conversely, human CD14dim CD16+ monocytes do not respond strongly to LPS 
stimulation or phagocytose latex beads efficiently, however, they selectively respond to 
viral stimulation via TLR7 and TLR8 (Ancuta et al., 2006; Cros et al., 2010). In 
addition to their patrolling behaviour, this subset expresses very high levels of the 
fractalkine receptor CX3CR1 and is shown to traffic in response to CX3CL1 
(fractalkine) in transendothelial migration assays (Ancuta et al., 2004; Ancuta et al., 
2003).  In contrast, CD14+ monocytes express high levels of chemokine receptors 
CCR1, CCR2 and CXCR2 but lower levels of CX3CR1 (Weber et al., 2000) and 
therefore selectively traffic in response to the chemokine CCL2 (MCP-1).  
However, whether these differences in cell surface marker expression and functionality 
represent separate, bona fide monocyte subsets or different activation states within a 
single subset remains to be elucidated. To better understand the origin, function and 
interrelationship of monocyte subsets, the tools available within mouse models have 
been invaluable. Mouse models allow the use of several genetic approaches as well as in 
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vivo methods of tracing and labelling monocyte subsets. Therefore, the majority of this 
thesis will focus on murine monocyte subsets. 
1.2.1.2 Murine monocyte subsets 
The first indication of heterogeneity in murine monocyte subsets came from Palframan 
et al., based on the differential expression of CX3CR1-promoter driven green 
fluorescent protein (GFP) (Jung et al., 2000; Palframan et al., 2001). In 2003, 
Geissmann et al. described that in both murine and human blood two monocyte subsets 
could be identified by their expression level of CX3CR1 and other cell surface markers 
as well as by their migratory properties (Geissmann et al., 2003). Here it was observed 
for the first time that the heterogeneity in mouse monocyte subsets was related to 
function. In addition, it was shown that differential expression of CX3CR1 and Ly6C 
allowed the distinction between two major monocyte subsets. Ly6C+ monocytes express 
low/intermediate levels of CX3CR1 but high levels of the chemokine receptor CCR2, 
which they depend upon for their egress from the BM (Serbina and Pamer, 2006). 
Conversely Ly6Clow monocytes express high levels of CX3CR1 and low to negligible 
levels of CCR2. Further evidence of murine monocyte heterogeneity was demonstrated 
in 2013 when both Carlin et al., and Jakubzick et al., showed that a minority of blood 
monocytes express MHC II and are have high to intermediate expression of Ly6C 
(Carlin et al., 2013; Jakubzick et al., 2013). 
The CX3CR1low Ly6C+ CCR2+ monocyte subset was shown to preferentially home to 
inflamed tissues and have the capacity to differentiate into macrophages and dendritic 
cells thus they have subsequently become known as “inflammatory monocytes” 
(Geissmann et al., 2003). This study characterised for the first time the CX3CR1high 
Ly6Clow CCR2low monocyte subset. 
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Table 1-3: Murine blood monocyte subsets 
Mouse monocyte 
subset 
Frequency of total 
monocytes Phenotype Main functions 










Extravasate in response to 
inflammatory signals, 
produce inflammatory 
mediators and differentiate 
into DCs and macrophages 
Ly6Cint MHC II+ ~10% 





















As Ly6C+ monocytes have been observed giving rise to tissue resident cells in 
inflammatory conditions (Serbina et al., 2008; Serbina et al., 2003b), have a short half-
life (van Furth and Cohn, 1968; Yona et al., 2013) and the capacity to differentiate in 
dendritic cells (Serbina et al., 2008), it was often assumed that these cells were the 
blood circulating precursors for tissue macrophages and dendritic cells. In recent years, 
it has become clear that classical dendritic cells can be maintained independently of 
monocyte contribution (Liu et al., 2009; Liu et al., 2007; Varol et al., 2009). 
Furthermore, recent studies have demonstrated that tissue resident macrophages develop 
prior to the development of monocytes in embryogenesis and many tissue resident 
macrophage populations are maintained with little contribution from monocytes in the 
steady state (Gomez Perdiguero et al., 2015; Gomez Perdiguero et al., 2013; Kierdorf et 
al., 2013a; Schulz et al., 2012; Yona et al., 2013). 
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However, there are some tissue macrophage populations to which Ly6C+ monocytes 
contribute to in the steady state. For example, at the time of weaning, Ly6C+ monocytes 
colonise the gut lamina propria and differentiate into mature anti-inflammatory 
macrophages (Bain et al., 2014; Varol et al., 2007). This macrophage pool is constantly 
replenished throughout life by circulating Ly6C+ monocytes (Bain et al., 2014). 
The CX3CR1high Ly6Clow CCR2low MHC II- monocyte subset differs from Ly6C+ 
“inflammatory” monocytes: they are smaller in size, as well as the high expression level 
of CX3CR1. In addition, this subset expresses high levels of the orphan nuclear receptor 
NR4A1 and is highly dependent upon it for their development. Further, this subset 
requires the sphingosine 1 phosphate receptor 5 (S1PR5) for their egress from the BM 
(Debien et al., 2013). Ly6Clow monocytes have been shown to crawl along the luminal 
side of endothelium where they scavenge microparticles, the behaviour that earned the 
name “patrolling monocytes” (Auffray et al., 2007; Carlin et al., 2013). Thus, recent 
work has established that this subset has intravascular effector functions in their own 
right.  
In addition to being referred to as “patrolling” monocytes, this subset is sometimes 
known as “resident” monocytes. This is due to the observation that this subset persisted 
longer in tissues in the absence of inflammation and were shown to express CD11c and 
MHC II after adoptive transfer (Geissmann et al., 2003). These data were interpreted at 
the time as suggesting that Ly6Clow monocytes were a blood circulating precursor for 
tissue resident dendritic cells (DCs) and could potentially also represent a blood-
circulating progenitor population for tissue resident macrophages (Geissmann et al., 
2003). Despite the identification of the yolk sac origin of most tissue macrophages, this 
hypothesis of monocytes giving rise to tissue macrophages has persisted in the literature 
and will be addressed in this thesis. 
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1.2.1.3 Monocytes and dendritic cells 
The interrelationship between monocytes and DCs has become considerably clearer 
over the last two decades. DCs belong to the myeloid branch of the immune system and 
are specialised antigen presenting cells. DCs were originally described as cells enriched 
in the mouse spleen (Steinman and Cohn, 1973; Steinman et al., 1974) that were the 
most potent stimulators of T cells in primary mixed leucocyte reactions (Steinman and 
Witmer, 1978). DCs have now been identified in almost every tissue that has been 
studied, with the exception of the brain parenchyma, all of which are highly efficient at 
the uptake and processing of antigens for presentation to naïve T cells (Mildner and 
Jung, 2014). Broadly, DCs can be subdivided into three main categories: conventional 
DCs (cDCs), monocyte-derived DCs, known as TNFα/iNOS producing DCs (Tip-DCs) 
and plasmacytoid DCs (pDCs).  
After the identification of dendritic cells by Steinman et al., in 1973 (Steinman and 
Cohn, 1973) there was some controversy as to whether they should be included in the 
MPS, but eventually, van Furth included them and subsequent studies identified a 
common developmental pathway with monocytes (Fogg et al., 2006).  
Monocytes are highly plastic cells that have the potential to give rise to monocyte-
derived Tip-DCs (Auffray et al., 2009b; Gordon and Taylor, 2005; Randolph et al., 
1999; Serbina et al., 2008; Taylor and Gordon, 2003). Among circulating monocytes the 
Ly6C+ subset is the proposed precursor of Tip-DCs the in models of infection and tissue 
damage (Auffray et al., 2009b; Dominguez and Ardavin, 2010; Serbina et al., 2003b). 
However, differentiation of Ly6C+ monocytes into DCs is observed, for the most part, 
under inflammatory conditions.  For example, in the context of Listeria monocytogenes 
infection, Ly6C+ monocytes are recruited to the site of infection, where they produce 
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high levels of TNFα and iNOS, earning them the name Tip-DCs (Serbina et al., 2008; 
Serbina et al., 2003b). In addition, these monocyte-derived cells are efficient at priming 
naïve T cells, express high levels of MHC II and morphologically resemble DCs 
(Serbina et al., 2003b; Serbina et al., 2012). However, it has become clear in recent 
years that in steady state “classical” cDCs arise from the common dendritic cell 
precursor (CDP), independently of any monocyte contribution (Liu et al., 2009; Varol et 
al., 2007; Waskow et al., 2008). 
 
 Monocyte development 1.3
1.3.1 Haematopoiesis 
1.3.1.1 Haematopoietic stem cells 
The classical model of adult haematopoiesis is a hierarchical model of haematopoietic 
stem cell (HSC) commitment (Morrison and Weissman, 1994; Spangrude et al., 1988; 
Weissman, 2000). As far as we currently know, haematopoietic stem cells and their 
progenitors give rise to all immune cells with the exception of yolk sac derived 
macrophages. The sequence of differentiation that links multipotent HSCs, with their 
capacity for self-renewal, to terminally differentiated, mature cells that have lost the 
ability to self-renew, is still a matter of great discussion despite being extensively 
studied.  
However, the identification of a series of intermediates, characterised by their surface 
marker expression and clonogenic ability, has provided the foundation on which the 
classical model of haematopoiesis has been built. In this model, HSCs give rise to 
progeny that progressively become more restricted to a single lineage whilst losing their 
capacity for self-renewal. The definition of a haematopoietic stem cell in this context is 
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a self-renewing cell that can be transplanted to a lethally irradiated mouse and rescue 
this mouse from lethality by re-establishing long-term blood production (Eaves, 2015; 
Spangrude et al., 1988; Weissman, 2000).  
This stochastic model of haematopoiesis argues that a very small number of quiescent, 
self-renewing, long-term haematopoietic stem cells (LT-HSC) self-renew throughout 
the whole life of an organism (Christensen and Weissman, 2001; Laiosa et al., 2006; 
Morrison and Weissman, 1994; Osawa et al., 1996). These give rise to short-term HSCs 
(ST-HSC), which have limited capacity for self-renewal (Morrison and Weissman, 
1994; Yang et al., 2005). In contrast with these results obtained mostly by 
transplantation of HSCs, recent pulse labelling studies of adult HSCs in situ have 
demonstrated that such ST-HSCs nearly fully self-renew, sustain most adult 
haematopoiesis, only receiving rare but polyclonal input from LT-HSCs (Busch et al., 
2015).  
The next step in this model of haematopoiesis are multipotent progenitors (MPP) found 
within the HSC compartment (Morrison et al., 1997). These are the progeny of ST-
HSCs, which have to make a binary decision regarding the fate of their progeny, either 
to the lymphoid or myeloid lineage. Such fate decisions have been proposed to be a 
result of activation of lineage specific transcription factors (TF), triggering different 
genetic programmes. This will be discussed further in section 1.3.  
Classically, the progeny of MPPs are either the common lymphoid progenitor (CLP) or 
the common myeloid progenitor (CMP). Interestingly, whilst HSCs have the potential 
to give rise to all blood cells, they preferentially express more myeloid associated genes 
rather than lymphoid associated genes until the fate decision of CLP or CMP is made 
 
39 
(Miyamoto et al., 2002). This is in accordance with the strong myeloid bias observed in 
adult HSCs in vivo (Busch et al., 2015). 
The clonogenic progenitor common for cells of the lymphoid lineage was the first 
lineage-restricted MPP identified (Kondo et al., 1997). This IL-7Rα+ progenitor was 
shown to give rise to T cells, B cells and natural killer (NK) cells but could not give rise 
to cells of the myeloid lineage (Akashi et al., 1999; Kondo et al., 1997). This raised the 
obvious question of identifying a clonogenic progenitor that could give rise to cells of 
the myeloid lineage and in 2000, work from the Weissman lab demonstrated the 
presence of a common myeloid progenitor (CMP) (Akashi et al., 2000). Within the IL-
7Rα- fraction of murine BM cells, the CMP had the potential to give rise to either 
granulocyte/macrophage (GM) progenitors or megakaryocyte/erythrocyte (MegE) 
progenitors. From this work, it was proposed that commitment to the GM lineage was 
mutually exclusive from commitment to the MegE lineage.  
Whilst this model has been vital for our conceptual understanding of haematopoiesis 
and HSC commitment further studies and improving analytical techniques as well as 
experimental models have provided evidence for further hypotheses to emerge. For 
example, in 2005 work by the lab of Jackobsen and colleagues demonstrated the 
presence of a population within the HSC compartment, resembling MPPs but 
expressing high levels of Flt3. This population does not have the potential to generate 
megakaryocytes or erythrocytes but has the capacity to generate T-, B-, and myeloid-
cell restricted progenitors. This population is the most primitive HSC with lymphoid 
gene expression thus it was termed “lymphoid primed multipotent progenitor” (LMPP) 
(Adolfsson et al., 2005). While they can give rise to all lineages they are not bona fide 
HSCs as they only have a limited capacity of self-renewal – capable of short-term (up to 
8 weeks) multilineage repopulation. These studies indicated that a loss of MegE 
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potential is accompanied by a gain of expression of lymphoid associated genes and 
maintenance of myeloid potential, a phenomenon known as multilineage priming 
(Adolfsson et al., 2005; Hu et al., 1997; Mansson et al., 2007; Miyamoto et al., 2002). 
Importantly, no co-expression of lymphoid- and MegE-associated genes was observed, 
indicating that commitment of these cell fates is mutually exclusive. 
A recent study by Yamamoto et al., further challenged the step-wise hierarchical model 
of haematopoiesis by the identification of myeloid-restricted progenitors with long-term 
repopulating activity (MyRP). The authors in this study showed that HSCs could 
differentiate directly into MyRP via asymmetric cell division. By using single cell 
transplantation systems and paired daughter analysis the authors were able to show 
lineage commitment at the level of the HSC and bypass the step-wise lineage 
commitment steps of the classical model of HSC differentiation (Yamamoto et al., 
2013). 
To add a supplemental layer of complexity, HSCs found in the developing embryo 
(foetal HSCs) are not equivalent to their adult counterparts, as evidenced by their 
balanced or unbiased output (Crisan et al., 2015). In 1989, Leonore and Leonard 
Herzenberg (Herzenberg and Herzenberg, 1989) proposed that the immune system gives 
rise to distinct and successive waves (“layers”) of immune and progenitor cells during 
development and adulthood. In accordance, foetal HSCs are the only source for several 
foetal (B-1 B cells (Montecino-Rodriguez et al., 2006) and γ/δ T cells (Havran and 
Allison, 1988; Ikuta et al., 1990)) and adult lymphoid populations (resident dendritic γ/δ 
T cells (DETCs) in the adult mouse epidermis (Havran and Allison, 1990). 
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These findings are intriguing and provide insights into the fine nuances of how HSCs 
give rise to lineage committed progenitors and are helping to redraw our understanding 





Figure 1-4 A schematic illustrating different models of haemoatopoiesis 
(A) Illustrates the traditional, linear model of haematopoiesis that suggests a strict separation between myelopoiesis and lymphopoiesis; (B) illustrates 
the revised view of the haematopoietic model after the identification of LMPPs; (C) illustrates the myeloid bypass model (Yamamoto et al., 2013) 
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1.3.1.2 Macrophage and dendritic cell precursor (MDP) and common monocyte 
progenitor (cMoP) 
A major step forward in our understanding of monocyte development was the 
identification of the macrophage and dendritic cell precursor (MDP) in mouse BM 
(Fogg et al., 2006).  The MDP was so called because at the time of its identification, 
monocytes were still considered the obligate precursors to all tissue resident 
macrophage populations in steady state. While they are still the main source of 
“infiltrating” macrophages, most macrophages found in tissues are not maintained by 
differentiation of monocytes, but rather develop from yolk sac derived progenitors. 
However, the name macrophage and dendritic cell precursor has persisted although 
perhaps a more accurate name for this population now would be “monocyte and 
dendritic cell precursor”. 
The MDP is downstream of the common myeloid progenitor (CMP) and the 
granulocyte/macrophage progenitor (GMP), having lost granulocyte potential. MDPs 
express KIT (CD117), CSF1R (CD115) and FLT3 (CD135) whilst they are negative for 
lymphoid lineage markers such as CD3 and CD19. The MDP has been shown to be a 
proliferating subset of BM cells that can give rise to monocytes and the common 
dendritic cell progenitor (CDP) (Auffray et al., 2009a; Fogg et al., 2006; Naik et al., 
2007; Onai et al., 2007; Varol et al., 2007).  
The chemokine receptor CX3CR1 is not expressed on early haematopoietic progenitors 
but is subsequently upregulated on the MDP (Fogg et al., 2006), and its expression, 
using the CX3CR1GFP knock-in mouse (Jung et al., 2000) was instrumental in 
identifying the MDP population (Fogg et al., 2006). Thus, expression of CX3CR1 is 
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associated with commitment to monocyte and dendritic cell lineages (Auffray et al., 
2009a; Fogg et al., 2006). 
In 2013, the next commitment step along the pathway of monocyte development was 
elucidated. Hettinger et al., showed that the upregulation of Ly6C and loss of Flt3 
expression identified a monocyte-committed, proliferating BM population that the 
authors called the common monocyte progenitor (cMoP) (Hettinger et al., 2013). In this 
paper, the authors show the existence of heterogeneity within the KIT+ CD115+ 
compartment that has previously been considered to contain only the MDP/CDP, there 
is heterogeneity. By including Ly6C as a marker when investigating this compartment, 
the cMoP can be identified. Adoptive transfer in non-irradiated mice confirmed that this 
population could give rise to monocytes in vivo (Hettinger et al., 2013).  
1.3.2 Molecular control of monocyte development 
Commitment to the myeloid lineage and the subsequent development of blood 
monocytes is under tight control by both intrinsic and extrinsic factors. A number of 
transcription factors have been found to be key regulators in monocyte development; 
furthermore, extrinsic signals have been shown to be vital molecular cues directing the 
development of monocytes from multipotent progenitors. The understanding of these 
molecular cues remains incompletely elucidated, however, there have been several 
genetic models that have provided significant insight in to the molecular requirements 
for monocyte development. 
The cues and signals that push HSCs along the myeloid lineage as opposed to the 
lymphoid lineage are incompletely understood but genetic models have provided the 
tools to better understand myeloid lineage commitment. Disruption of specific myeloid-
associated genes is one of the most powerful tools available for understanding the 
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molecular requirements for monocyte development. Both naturally occurring mutations 
and laboratory engineered disruption of genes, either by complete ablation or by 
conditional deletion, has provided significant insights into the molecular control of 
monocyte development. 
1.3.2.1 cMyb 
During embryogenesis, there are three waves of haematopoiesis (Golub and Cumano, 
2013): an initial yolk sac (YS) primitive wave followed by two successive definitive 
waves, the definitive YS-derived progenitors and the foetal HSCs. During the latter, 
HSCs generated in the aorta-gonad-mesonephros (AGM) region of the embryo seed the 
foetal liver, where they expand (Golub and Cumano, 2013; Medvinsky and Dzierzak, 
1996; Muller et al., 1994). The proto-oncogene cMyb is required for expansion, self-
renewal and maintenance both foetal and adult HSCs, and a lack of cMyb expression 
leads to rapid HSC-derived haematopoiesis failure, including a complete absence of 
adult monocytes (Mucenski et al., 1991; Mukouyama et al., 1999; Schulz et al., 2012). 
Whilst cMyb is expressed by all definitive haematopoietic progenitors (both YS-
progenitors and HSCs) (Kierdorf et al., 2013a; Mucenski et al., 1991; Soza-Ried et al., 
2010), primitive haematopoiesis and YS-definitive myelopoeisis are unaffected in 
cMyb-deficient animals (Gomez Perdiguero et al., 2015; Schulz et al., 2012; Soza-Ried 
et al., 2010; Sumner et al., 2000; Tober et al., 2008). Thus, dependency on cMyb 
genetically separates the first two YS waves from the intra-embryonic HSC wave of 
haematopoiesis.  
1.3.2.2 PU.1 
PU.1 is a transcription factor belonging to the E-twenty six or E26 transformation-
specific (Ets) family of transcription factors, encoded by the Sp1 gene. Sometimes 
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considered the “master regulator” of lineage commitment, PU.1 is dispensable for the 
generation of HSCs but it is required for commitment to myeloid or lymphoid lineages 
(Dakic et al., 2005). PU.1 deficiency is lethal and mice lacking PU.1 die either at a late 
embryonic stage or shortly after birth. Analysis of these animals revealed severely 
impaired development of monocytes, granulocytes, T-cells, and B-cells (McKercher et 
al., 1996; Scott et al., 1994; Spain et al., 1999) and to a lesser extent, NK cells (Colucci 
et al., 2001). However, cells of the megakaryocyte/erythrocyte (MegE) lineage are 
intact in these animals (McKercher et al., 1996; Scott et al., 1994). Furthermore, 
conditional deletion of PU.1 in adult mice uncovers a complete ablation of the CLP, 
CMP and GMP and an increased frequency of megakaryocyte/erythrocyte progenitors 
(MEPs) (Dakic et al., 2005; Iwasaki et al., 2005). These studies show that PU.1 has an 
important role in the lineage commitment of MPPs to proceed to CMPs and CLPs but it 
is redundant for the development of cells in the MegE lineage. 
1.3.2.3 The role of Irf8 in determining monocytic and ganulocytic fates 
The decision to commit to monocytic versus granulocytic fates at the GMP is 
determined by PU.1 and it’s DNA binding partners. For cells to commit to the 
monocytic lineage, one such binding partner is IRF8 (Tamura et al., 2000). Irf8 is 
expressed by progenitors, monocytes and macrophages but not granulocytes. Indeed 
Irf8-deficient mice show increased susceptibility to intracellular infections such as 
vaccinia virus or tuberculosis (Holtschke et al., 1996; Marquis et al., 2009; Turcotte et 
al., 2007) which has been linked to reduced expression of IL-12p40 by monocytic cells 
resulting in impaired T cell activation (Giese et al., 1997; Scharton-Kersten et al., 
1997). Interestingly, immunodeficient humans with IRF8 mutations that affect DNA 
binding are also susceptible to tuberculosis infections, which are associated with 
impaired IL-12 production (Hambleton et al., 2011). 
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Furthermore, Irf8-deficiency is associated with a myeloproliferative syndrome that 
results marked increase in granulocyte numbers but significantly reduced monocytes 
and macrophages (Holtschke et al., 1996; Kierdorf et al., 2013a). Holtschke et al., 
demonstrated that Irf8-deficient mice have a differentiation block during 
haematopoiesis, which manifests in a myeloproliferative syndrome resembling human 
chronic myeloid leukaemia (Holtschke et al., 1996). Irf8 and its role in monocyte 
development will be discussed in more detail below. 
1.3.2.4 The role of Csf1r (CD115) signalling in myeloid development 
Monocyte development in mice is completely dependent upon Csf1r (also known as 
CD115 and M-Csfr) encoded by the proto-oncogene c-fms. Deficiency in Csf1r (Csf1r-/-
) results in a severe phenotype: small, toothless animals with shortened limbs due to a 
failure in osteoclast development that results in impaired bone remodelling finally 
resulting in a shortened adult life span (Dai et al., 2002). Furthermore, these mice are 
devoid of circulating monocytes and have significantly depleted F4/80+ tissue 
macrophage populations in many tissues (Dai et al., 2002).  
Csf1r-/- mice have a more severe phenotype than with the naturally occurring op/op 
mice, which have a mutation in the coding region of one of the Csf1r ligands, Csf1, and 
consequently, no CSF1 (also known as MCSF) protein can be detected in these animals 
(Wiktor-Jedrzejczak et al., 1990; Yoshida et al., 1990). Similarly to the Csf1r-/- mouse, 
the op/op mouse has a marked deficiency in osteoclasts that renders them osteopetrotic, 
a lack of circulating monocytes and a reduction in macrophage populations compared 
with littermates. The reduction of macrophages observed in these mice, rather than 
complete absence, is attributed to the fact that Csf1r has another ligand, IL-34 (Auffray 
et al., 2009b; Lin et al., 2008). Dai et al., showed in 2002 that mice with one copy of 
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Csf1r but with the op/op mutation (Csf1r+/- / Csf1op/op) showed the same phenotype as 
the op/op mice and not the same severity as Csf1r-/- which suggested that Csf1r was 
responding to second ligand. Consequently, IL-34 was identified by using a functional 
high-throughput screen of human monocytes (Lin et al., 2008). 
As discussed above, HSC lineage commitment decisions are usually explained by 
stochastic models (Till et al., 1964) and the prevailing model is that cytokines have little 
direct influence on HSC commitment (Cross and Enver, 1997; Enver et al., 1998; 
Metcalf, 2007). However, it was shown that under conditions of haematopoietic stress 
that induce systemically high levels CSF1 such as infection and inflammation, CSF1 
can directly influence differentiation of HSCs to a myeloid bias (Mossadegh-Keller et 
al., 2013). The authors demonstrate that CSF1 has the ability to directly induce PU.1, 
which instructs a transient and reversible change of HSC differentiation preference to a 
myelo-monocytic fate regardless selective survival or proliferation (Mossadegh-Keller 
et al., 2013). 
Thus, monocyte development is regulated by a number of genetic signals. However, 
different monocyte subsets have their own genetic requirements. The next section of 
this thesis will discuss the genetic requirements of the two principal murine monocyte 
subsets. 
1.3.2.5 Ly6C+ monocyte specific transcription factors 
The current model of monocyte development suggests that the MDP gives rise to the 
cMoP, which gives rise to Ly6C+ monocytes, which mature or undergo conversion into 
Ly6Clow monocytes (Sunderkotter et al., 2004; Varol et al., 2007; Yona et al., 2013; 
Yrlid et al., 2006). However, analysis of various genetic models have provided insights 
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that seemly contradict this model or at least bring into question some of the nuances of 
monocytes development.  
The Kruppel-like factor 4 (KLF4) was shown by Feinberg et al., to be a critical 
regulator of monocyte differentiation (Feinberg et al., 2007). In this study, it was 
demonstrated that KLF4 is a downstream target of PU.1 and KLF4 deficiency is 
associated with impaired monocyte development but increased granulocyte 
development. However, detailed in vivo studies of the role Klf4 plays in monocyte 
development were hampered by lethality shorty after birth in KLF4-deficient animals 
due to an inability of these mice to establish the barrier function of the skin (Segre et al., 
1999).  
In a study by Alder et al., (Alder et al., 2008), the authors were surprised to observe that 
Ly6Clow monocytes were still evident, albeit reduced; in KLF4-/- chimeras that were 
completely ablated of blood Ly6C+ monocytes. This was surprising given the current 
model of Ly6Clow monocyte development relies upon blood Ly6C+ monocytes maturing 
into Ly6Clow.  
Further investigations by Kurotaki et al., into the role of KLF4 in monocyte 
development by identified that Irf8-/- mice displayed similar but even more severe 
abnormalities than those observed in the KLF4 chimeras, most notably Irf8-/- mice are 
also devoid of blood Ly6C+ monocytes (Kurotaki et al., 2013). The authors 
demonstrated that KLF4 is directly induced by IRF8, thus identifying a KLF4-IRF8 axis 
vital for Ly6C+ monocyte development (Kurotaki et al., 2013). Of note, this study also 
observed blood Ly6Clow monocytes developing in the absence of Ly6C+, although 
reduced in numbers.  
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1.3.2.6 Ly6Clow monocyte specific transcription factors 
In 2011, Hanna et al., showed that mice lacking the transcription factor Nr4a1 have a 
defect in BM Ly6Clow monocyte development and survival, resulting in a lack of 
Ly6Clow monocytes in the blood, patrolling microvasculature and in the spleen (Hanna 
et al., 2011). This study demonstrated that Nr4a1-/- mice were unable to develop 
Ly6Clow monocytes whilst having normal numbers of myeloid progenitors including the 
MDP and Ly6C+ monocytes compared to wild type animals (Hanna et al., 2011). 
Furthermore, the few remaining patrolling monocytes that were observed in the BM of 
Nr4a1-/- mice were unable to complete cell cycle and accumulated in S phase of 
proliferation where they underwent apoptosis (Hanna et al., 2011). In addition, the few 
remaining Ly6Clow monocytes from Nr4a1-/- animals expressed lower levels of CX3CR1 
and were larger in size (Hanna et al., 2011). 
This led to the hypothesis that Ly6Clow monocytes develop independently of Ly6C+ 
monocytes in the BM, arising via a distinct differentiation pathway. This paper raised 
the possibility that, although it is accepted that both monocyte subsets arise from the 
MDP, the intermediate steps between MDP and mature blood monocytes remains 
unclear as both subsets require different molecular input for their differentiation and 
maturation.  
1.3.2.7 Ly6C+ and Ly6Clow monocytes rely on different mechanisms for bone marrow 
egress 
Ly6C+ monocytes are reduced in the periphery of Ccr2-/- mice whereas their BM 
contains normal or slightly increased Ly6C+ monocyte numbers (Tsou et al., 2007). 
Thus, Ccr2-deficiency causes a defect in Ly6C+ monocyte mobilisation, resulting in 
impaired BM Ly6C+ monocyte egress to the periphery (Serbina and Pamer, 2006; Tsou 
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et al., 2007). The principal chemokines responsible for Ly6C+ monocyte mobilisation 
from the BM are CCL1 (MCP-1) and CCL7 (MCP-3) and animals that lack either of 
these chemokines also have impaired monocyte mobilisation in response to 
inflammatory stimuli (Tsou et al., 2007). In addition, infection with Listeria 
monocytogenes results in BM accumulation of activated Ly6C+ monocytes in Ccr2-
deficient mice (Serbina et al., 2008; Serbina and Pamer, 2006).  
In a similar manner to Ly6C+ monocytes having an impaired egress from the BM to the 
periphery in Ccr2-/- mice, Ly6Clow monocytes require sphingosine-1 phosphate receptor 
5 (S1PR5) to mediate their egress from the BM (Debien et al., 2013). Debien et al., 
showed that S1pr5-/- mice had normal frequencies of Ly6Clow monocytes in the BM but 
significantly reduced frequencies of this subset in the periphery. Furthermore, the 
Ly6C+ monocyte frequency was unaffected by this mutation in the BM and in the 
periphery, arguing against the current model of monocyte development in which Ly6C+ 




Figure 1-5 Molecular control of monocyte development 
Commitment to the myelo-monocytic lineage is under the control of cMyb, PU.1, KLF4, and 
CSF1R. Ly6C+ monocyte development requires the transcription factor IRF8 for their 
development and CCR2 for their BM egress whereas Ly6Clow monocytes are selectively 
dependent on NR4A1 for their development and S1PR5 for their BM egress. 
 
 Monocyte effector functions 1.4
As long ago as 1939, it was observed, in vivo, that monocytes could extravasate in 
response to acute tissue injury by Ebert and Florey (Ebert and Florey, 1939). Using a 
chamber to observe monocyte extravascular development in response to tissue injury in 
rabbit ears, they directly observed monocytes leaving blood vessels and transforming 





























such as these (Ebert and Florey, 1939) aided the misconception that monocytes are 
solely the blood circulating precursors of tissue resident macrophages, they also 
provided early insight into the effector functions of monocytes in vivo.  
1.4.1 Ly6C+ monocyte effector functions 
Ly6C+ monocytes have been known to be involved in the inflammatory process for 
many years now and the majority of what is known about monocyte effector functions 
arises from studies investigating this subset using various inflammatory models, 
including infection, high fat diet and cancer (Auffray et al., 2009b; Gordon and Taylor, 
2005; Wynn et al., 2013).  
Both monocyte subsets have been shown to traffic to sites of infection but rely on 
different cues (Ancuta et al., 2003; Auffray et al., 2007; Serbina and Pamer, 2006; 
Tacke and Randolph, 2006) and with vastly different efficiencies.  
1.4.1.1 Bacterial infections 
As previously mentioned, Ly6C+ monocytes are frequently referred to in the literature 
as “inflammatory” monocytes reflecting their responsiveness to inflammatory stimuli 
including cytokine production and their readiness to extravasate. Ly6C+ monocytes have 
a pivotal role in immunity against pathogens and their recruitment and activation is 
required for effective control and clearance of many pathogens and their role has been 
extensively studied in particular, the work of Pamer’s lab has provided considerable 
insight into Ly6C+ monocyte effector functions particularly in the context of L. 
monocytogenes infection (Pamer, 2004; Serbina et al., 2008; Serbina and Pamer, 2006).  
L. monocytogenes is a facultative intracellular, Gram-positive bacterium that is acquired 
through the gastrointestinal tract. Innate immune responses in mice are quickly 
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triggered after infection, acting to restrict bacterial growth in the spleen and liver, the 
main infection sites (Rosen et al., 1989). Ly6C+ monocytes and Ly6C+ monocyte-
derived Tip-DCs are recruited to infection foci where they produce TNFα and iNOS 
(Kurihara et al., 1997; Serbina et al., 2003b). Ly6C+ monocyte mobilisation in response 
to infection is dependent upon the chemokine receptor CCR2 interacting with its 
ligands, the chemokines CCL2 and CCL7 (also known as MCP-1 and MCP-3, 
respectively) (Tsou et al., 2007). Thus, Ccr2-/- mice are less able to clear infections such 
as L. monocytogenes where in Ccr2-/- mice, activated Ly6C+ monocytes accumulate in 
the BM (Serbina and Pamer, 2006).  
Infection with L. monocytogenes induces the CCR2 ligands CCL2 and CCL7. Mice that 
lack these chemokines have reduced monocyte recruitment to the sites of infection and, 
like the Ccr2-/- animals, retain Ly6C+ monocytes in the BM (Jia et al., 2008). Thus, 
CCR2 signalling is critical for monocyte emigration from the BM into the blood.  
CCL2 production is induced in a wide variety of cell types in response to inflammatory 
stimuli via MyD88 and type I interferon (IFN) mediated signalling. Moreover, CCL2 
production is unaffected in MyD88-deficient (Serbina et al., 2003a) and the type I 
interferon receptor (IFNAR)-deficient animals (Jia et al., 2009). However, combining 
the two mutations to generate animals deficient for both genes (MyD88-/- and IFNAR-/-) 
results in a dramatic reduction of Ly6C+ monocyte recruitment during the early stages 
of infection (Jia et al., 2009). This indicates a level of redundancy in the molecular 
mechanisms leading to Ly6C+ monocyte mobilisation, highlighting the critical 
importance to host immunity of CCR2 signalling and Ly6C+ monocyte recruitment to 
sites of inflammation. 
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Whether CCR2 signalling is required for tissue infiltration of monocytes is less clear, 
data from Serbina and Pamer demonstrates that monocyte/Tip-DC localisation within 
spleens of CCR2-deficient animals infected with L. monocytogenes is comparable to 
wild type littermates (Serbina and Pamer, 2006). This suggests that within the context 
of infection, Ly6C+ migration from the blood to infected tissue is Ccr2-independent.  
Monocytes themselves are capable of producing reactive oxygen species and reactive 
nitrogen intermediates (ROS and RNI, respectively) (Fang, 2004) during L. 
monocytogenes infection, in addition to differentiating into Tip-DCs. The TNFα and 
iNOS produced by these cells contributes significantly to the innate defence against L. 
monocytogenes, (Pamer, 2004; Serbina et al., 2008; Serbina et al., 2003a). 
Whilst it is clear that Ly6C+ monocytes are reduced in the periphery of Ccr2-/- mice, 
there have been some inconsistencies in the reported effect of Ccr2-deficiency on 
Ly6Clow monocytes. Tsou et al., reported a small but significant reduction of Ly6Clow 
monocytes (Tsou et al., 2007) under physiological conditions, whereas Qu et al., 
reported similar frequencies of Ly6Clow monocytes in Ccr2-/- and littermate controls (Qu 
et al., 2004). Thus, further clarification is required to ascertain whether this subset is 
affected by Ccr2-deficiency: a question this thesis aims to address. 
Another bacterial infection model in which the role of monocytes has been well 
characterised is Mycobacterium tuberculosis (MTb). MTb is an airborne pathogen that 
infects dendritic cells and macrophages (Cooper, 2009). Whilst Ccr2-/- mice respond 
normally when given a low-dose inoculation of M. tuberculosis, they present with a 
more severe phenotype to high dose infection with MTb. The Ccr2-dependent Ly6C+ 
monocyte recruitment protects mice after a high-dose inoculum of MTb (Scott and 
Flynn, 2002). During MTb infection, Ly6C+ monocytes are thought to differentiate into 
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F4/80dim and CD11cdim/+ cell populations, expand and subsequently activate T cells 
(Peters et al., 2004). Ccr2-deficiency markedly reduces the expansion of these 
populations in the lung and consequently T cell responses to MTb in these mice are 
defective (Peters et al., 2004). 
1.4.1.2 Viral infections 
Murine cytomegalovirus (MCMV) is possibly one of the most widely studied murine 
models of viral infection. Ly6C+ monocytes are essential for the recruitment of NK cells 
to the foci of infection in the liver via production of CCL3 (MIP-1α) (Salazar-Mather et 
al., 1998). Both MCMV and vaccinia virus stimulate the expression of type I interferons 
(IFNs) in Ly6C+ monocytes via a TLR2 mediated signalling pathway (Barbalat et al., 
2009). As TLR2 is endosomal, viral ligands within infected cells stimulate the TLR2 
pathway and induce type I IFNs expression by Ly6C+ monocytes. This contrasts with 
bacterial infections in which the Ly6C+ monocytes produce TNFα and iNOS. 
Ly6C+ monocytes are also implicated in West Nile Virus (WNV), where they are 
recruited to the brain and aid viral clearance (Lim et al., 2011). Ccr2-deficient mice 
studied in the context of both WNV and MCMV are less efficient at viral clearing, 
however, as discussed above, this is due to defective egress from the BM into the blood 
whereas migration from the blood to infected tissues is Ccr2-independent. 
The role of classical monocytes in infection is not without collateral damage. Using 
influenza virus as a model, Ccr2-deficient mice have decreased mortality and 
immunopathology, associated with their impaired recruitment of Ly6C+ monocytes, and 
therefore Tip-DCs to the lungs (Aldridge et al., 2009; Dawson et al., 2000). Conversely, 
these mice show delayed viral clearance and priming of virus-specific T cells is 
impaired (Aldridge et al., 2009). 
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1.4.1.3 Fungal and parasitic infections 
A model for fungal infection, Cryptococcus neoformans, has been investigated in Ccr2-
deficient mice and it has been demonstrated that impaired BM egress of Ly6C+ 
monocytes results in more severe and prolonged pulmonary infection. This is thought to 
be due to a shift in CD4-T cell polarisation from a mainly T helper 1 (TH1) response to 
a T helper 2 (TH2) bias (Traynor et al., 2000). 
Further investigations using the Ccr2-deficient animals have provided insight into the 
role of Ly6C+ monocytes in parasitic infections. The parasitic protozoa, Plasmodium 
chabaudi are used extensively as a murine model of malaria. Ccr2-/- mice have 
considerably higher parasitemia during acute stages of malarial infection due to reduced 
Ly6C+ monocyte derived iNOS and ROS (Sponaas et al., 2009). 
Infection with the helminth parasite Schistosoma mansoni is characterised by 
granulomatous lesions, which form around eggs that get trapped within organs such as 
the intestines. Granulomas are macrophage-dense, nodular aggregations that are 
protective to the host due to their role in skewing T cell responses towards TH2-type 
during infection with S. mansoni (Herbert et al., 2010; Pesce et al., 2009). Hallmarks 
TH2-type responses are the cytokines IL-4 and IL-13 produced by T helper 2 (TH2) cells 
and expanded populations such as mast cells, eosinophils, basophils and “alternatively 
activated macrophages” (AAMø). AAMø’s can be defined as macrophages that respond 
to signalling via IL-4Rα (Gordon and Martinez, 2010). Two recent studies demonstrated 
that, in the context of S. mansoni infection, recruitment of Ly6C+ monocytes from the 
blood was principally responsible for macrophage accumulation around schistosome 
eggs forming granulomas in the liver, and were critical for host survival (Girgis et al., 
2014; Nascimento et al., 2014). However, Ly6C+ monocytes are not always critical for 
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macrophage accumulation during helminth infection. For example, in the filarial 
nematode Litomosoides sigmodontis infection model, it has been demonstrated that 
AAMø arise by local proliferation of resident macrophages rather than recruited 
monocytes (Jenkins et al., 2011; Jenkins et al., 2013). 
1.4.1.4 Sterile inflammation 
Just as monocyte infiltration is a common feature of infection, Ly6C+ monocytes are 
also associated with sterile inflammation including cardiovascular disease, adipose 
tissue inflammation in models of obesity and related metabolic disorders such as type 2 
diabetes (T2D).  
For some time now, it has been recognised that proportion of macrophages in the 
adipose tissue of obese mice is significantly increased (Weisberg et al., 2003; Xu et al., 
2003). This observation was key to advancing our understanding how of obesity 
propagates inflammation via macrophage-derived pro-inflammatory cytokine 
production (Olefsky and Glass, 2010). This is as a result of chronic stimulation of 
pattern recognition receptors (PRRs) and the subsequent activation of the AP-1 and NF-
κB signalling pathways, crucial for the initiation of adipose tissue inflammation, which 
can lead to insulin resistance and T2D (Gordon and Taylor, 2005; Olefsky and Glass, 
2010). Evidence from the Ccr2-/- mice fed high fat diet has demonstrated that, in 
contrast to infection models described above, this accumulation of macrophages is due 
to the recruitment of Ly6C+ monocytes in a Ccr2-dependent manner (Kanda et al., 
2006; Weisberg et al., 2006). Furthermore, Ccr2-deficient mice are less likely to 
develop insulin resistance and obesity (Chawla et al., 2011; Weisberg et al., 2006), 
indicting a crucial role for Ly6C+ monocytes in the development of metabolic disease.  
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Atherosclerosis has long been considered an inflammatory disease, with monocytes and 
macrophages being the first immune cells described within atherosclerotic plaques in 
pigs (Gerrity et al., 1979; Ross, 1999). Atherosclerotic plaques are well-defined 
structures that can develop in mammals with hyperlipidaema and local endothelial cell 
dysfunction within arteries, particularly at branch points of the arterial tree (Hahn and 
Schwartz, 2009). These plaques consist of a necrotic core surrounded by accumulated 
lipids, areas of calcified tissue, inflamed smooth muscle cells, foam cells, endothelial 
cells and immune cells (Woollard and Geissmann, 2010). In recent years, various 
studies have demonstrated the close relationship between monocytes and atherosclerotic 
plaque formation (Galkina and Ley, 2009; Ley et al., 2011; Weber et al., 2008), in 
particular Ly6C+ monocytes (Robbins et al., 2012; Swirski et al., 2007). The 
macrophage populations that reside in atherosclerotic plaques are Ly6C+ monocyte 
derived cells recruited during early pathogenesis (Robbins et al., 2012), process 
sustained by splenic extramedullary haematopoiesis (Leuschner et al., 2012; Robbins et 
al., 2012). As atherosclerotic plaques mature, local macrophage proliferation is thought 
to contribute to the vast macrophage pool within the lesions (Robbins et al., 2013). The 
recruited blood monocytes scavenge cell-activating oxidised low-density lipoproteins 
(oxLDL) and other lipids and then accumulate, forming lesions in the arterial wall, 
which develop into plaques (Weber et al., 2008; Woollard and Geissmann, 2010).  
A key mediator of lipid metabolism and removal from the blood is apolipoprotein E 
(apoE) (Plump and Breslow, 1995) and mice deficient in apoE have been used 
extensively as a model to study atherosclerosis because they develop more 
atherosclerotic lesions when fed a high fat diet compared to controls (Combadiere et al., 
2008; Zernecke et al., 2008; Zhang et al., 1992). A study by Swirski et al., demonstrated 
that Ly6C+ monocyte numbers expanded dramatically in apoE-/- mice fed on a high fat 
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diet. Furthermore, it was observed that Ly6C+ monocytes adhered to activated 
endothelium and infiltrated atherosclerotic lesions where they differentiated into 
atherosclerotic macrophages (Swirski et al., 2007).  
A further important role of Ly6C+ monocytes is their differentiation into tumour-
associated macrophages (TAMs). Again, this is an example of a sterile, inflammatory 
microenvironment. A study by Franklin et al., demonstrated that, in a murine mammary 
gland cancer model, TAMs were Ly6C+ monocyte-derived and distinct from tissue 
resident mammary macrophages (Franklin et al., 2014). Furthermore this study 
demonstrated that monocyte-derived TAMs were critical for tumour growth due to their 
role in inhibiting lymphocyte-mediated responses to tumour inflammation (Franklin et 
al., 2014). 
1.4.2 Ly6Clow monocyte effector functions 
The Ly6Clow monocyte subset effector functions remain more elusive, they do not share 
the functional characteristics that define classical Ly6C+ monocytes, as they extravasate 
rarely in comparison to Ly6C+ monocytes in steady state and do not differentiate into 
inflammatory macrophages or dendritic cells in response to Listeria infection (Auffray 
et al., 2007).  However, in recent years, a number of studies have provided significant 
insight into the functional roles of Ly6Clow monocytes in vivo.  
1.4.2.1 Patrolling and scavenging 
A major advance in our understanding of the role of Ly6Clow monocytes in vivo and in 
steady state came in 2007 with the observation that Ly6Clow monocytes appear to 
“patrol” vasculature by slowly crawling along endothelium, against the direction of 
blood flow in an LFA-1 integrin dependent manner (Auffray et al., 2007). Carlin et al., 
demonstrated that a functional contribution of this behaviour, showing that this subset is 
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continuously scanning endothelial cells lining the capillaries and scavenging 
microparticles from the luminal side of the microvasculature in steady state (Carlin et 
al., 2013). 
In response to TLR7-specific nucleic acid stimulation in the kidney, Ly6Clow monocytes 
were recruited to the damaged kidney endothelium and increased the length of time they 
adhered to the endothelium, a process referred to as “retention”. TLR7 stimulation of 
the kidney cortex was shown to result in endothelial fractalkine (CX3CL1) expression 
followed by retention of Ly6Clow monocytes by the endothelium in a process that 
requires both CX3CR1 and CD11b. Once recruited and retained, Ly6Clow monocytes 
initiate necrosis of the endothelial cells, by in turn recruiting neutrophils (Carlin et al., 
2013). 
Thus, this crawling and scavenging behaviour of Ly6Clow monocytes suggests an 
important role as caretakers of the endothelium, carefully and safely orchestrating 
endothelial cell death in response to danger signals. However, in pathogenic contexts, it 
has been suggested that this process could become damaging to the kidney vasculature 
(Carlin et al., 2013). Indeed, it has been suggested by several studies that Ly6Clow 
monocytes or their human counterparts, the CD14dim monocyte subset, are activated in 
several murine models of systemic lupus erythematosus (SLE) or human SLE patients 
(Amano et al., 2005; Carlin et al., 2013; Cros et al., 2010; Nakatani et al., 2010; 
Santiago-Raber et al., 2009; Santiago-Raber et al., 2011). These studies raise the 
hypothesis that Ly6Clow monocytes, whilst protecting against endothelial damage in 
healthy individuals, may contribute to tissue and vascular injury in pathological 
conditions.   
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Furthermore, a recent study highlighted a potential role for Ly6Clow monocytes in the 
initiation and propagation of rheumatoid arthritis in a murine model during the effector 
phase of the disease (Misharin et al., 2014). In this study they demonstrated that 
Ly6Clow monocytes were recruited to the joint during inflammation and may have roles 
both in promoting tissue injury during the early stage of disease and then tissue repair 
during later stages of disease (Misharin et al., 2014).  
In line with this functional behaviour, Ly6Clow monocytes express a full set of FcγR 
(Biburger et al., 2011), vital for facilitating IgG-dependent effector functions, such as 
phagocytosis. The family of FcγR consists of four members: three activating (FcγRI, 
FcγRIII and FcγRIV) and one inhibitory member (FcγRIIB), which are involved in 
mediating the activity of different IgG subclasses. (Nimmerjahn and Ravetch, 2008). 
Biburger et al., demonstrated that Ly6Clow monocytes were unique among innate 
immune cells in their expression of both FcγRI and FcγRIV and their data suggested a 
selective role for Ly6Clow monocytes in antibody-mediated phagocytosis of platelets 
(Biburger et al., 2011). This may provide a hypothesis as to why FcγRIV-positive 
monocytes are selectively increased in murine lupus models (Santiago-Raber et al., 
2009), if this cell population is fundamentally involved in IgG-dependent tissue 
damage. 
The patrolling behaviour of Ly6Clow monocytes is also implicated in Alzheimer’s 
disease (Michaud et al., 2013; Michaud et al., 2011). Michaud et al., demonstrated that 
Ly6Clow monocytes targeted veins with amyloid-β (Aβ) deposition within the central 
nervous system where they scavenged and facilitated Aβ removal.  
Thus, since the demonstration of Ly6Clow monocytes ability to patrol by Auffray et al., 
in 2007 (Auffray et al., 2007), it has become clear that Ly6Clow monocytes have effector 
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functions in their own right and are implicated as having both beneficial roles, for 
example in Alzheimer’s disease, as well as potentially detrimental pathogenic roles in 
other contexts such as Lupus nephritis. 
1.4.2.2 Ly6Clow monocytes in MCMV infection 
Consistent with their close interplay between patrolling monocytes and endothelial cells 
(Carlin et al., 2013), Ly6Clow monocytes have been implicated in the dissemination of 
the murine cytomegalovirus (MCMV) as mediators of systemic infection (Daley-Bauer 
et al., 2014). This study demonstrated that MCMV uses virus-encoded chemokines to 
recruit Ly6Clow monocytes to infection sites, where they become infected and then 
disseminate the virus through the body, thus hijacking the early immune response as a 
strategy for viral dissemination (Daley-Bauer et al., 2014). Whether Ly6Clow monocytes 
become infected directly by the virus or indirectly by phagocytosing infected 
endothelial cells remains unclear. 
Thus, it can be seen that a diverse range of studies utilising a variety of models, have 
demonstrated subset specific functions for Ly6C+ and Ly6Clow monocytes. However, the 
relationship between Ly6C+ and Ly6Clow monocytes remains to be fully clarified. 
Because of the subset specific roles of monocytes in inflammatory conditions, a more 
refined understanding of their development pathways could have important therapeutic 
implications. This thesis aims to analyse monocyte interrelationships and improve our 
understanding of the monocyte development in vivo and in the steady state. 
 Tissue resident macrophages 1.5
For many years, peripheral blood monocytes were considered the obligate precursor to 
tissue resident macrophages as a result of studying inflammatory models and BM 
irradiation chimeras. Irradiation generates an inflammatory-like setting by causing 
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tissue damage in addition to a loss of vascular and basal membrane integrity (Diserbo et 
al., 2002; Kierdorf et al., 2013b; Mildner et al., 2007). Thus, both inflammatory and 
irradiation models cause monocyte recruitment and their subsequent differentiation into 
macrophages or DCs. In recent years, it has become increasingly clear that macrophages 
appear in the embryo before the emergence of haematopoietic stem cells and monocytes 
and that these YS derived macrophages persist into adulthood. 
1.5.1 Macrophage development 
1.5.1.1 Embryonic haematopoiesis 
During embryogenesis, there are three waves of haematopoiesis termed the primitive 
and the definitive waves (Cumano and Godin, 2007). Within the latter, the first wave of 
definitive haematopoiesis originates in the YS and is dedicated to erythromyeloid 
development. This is followed by the intra-embryonic wave of definitive 
haematopoiesis after the foetal liver is colonised by HSCs generated in the AGM region 
of the embryo at around E10.5 (Cumano and Godin, 2007). The first primitive 
haematopoietic wave starts as early as E7.5 in the YS blood islands, a transient structure 
before vascularisation of the YS (Golub and Cumano, 2013; Gomez Perdiguero et al., 
2015). Primitive progenitors are mono-potent and comprise primitive erythrocyte 
progenitors and restricted macrophage progenitors (Gomez Perdiguero et al., 2015). 
Whilst primitive haematopoiesis is fairly well understood in the zebrafish model 
(Herbomel et al., 1999), it is technically very challenging to investigate in mouse 
development in vivo and has been rather evidenced in vitro (Bertrand et al., 2005; Palis 
et al., 1999). Primitive and definitive haematopoiesis have differing transcription factor 
requirements as definitive haematopoiesis is absent from Runx1-defincient embryos 
while primitive haematopoiesis is unaffected (Chen et al., 2009; Lacaud et al., 2002; 
Lancrin et al., 2010)  
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YS macrophages appear in mice around E8.5-E9.0 (Takahashi et al., 1989). Moreover, 
these primitive macrophages do not require the transcription factor cMyb (Schulz et al., 
2012), which is essential for the development of BM, HSC-derived cells (see section 
1.3.2.1).  
Use of tamoxifen inducible Csf1rMer-iCre-Mer mouse model with pulse labelling in utero at 
E8.5 provided a model in which to trace into adulthood, cells and/or their progeny that 
expressed CSF1R at E8.5, prior to the start of definitive haematopoiesis thus, HSC-
derived, Myb-dependent cells are not labelled (Schulz et al., 2012). These data showed 
that tissue resident macrophages, including microglia, Langerhans cells and Kupffer 
cells arose from cells expressing CSF1R at E8.5 (Schulz et al., 2012). Complementary 
approaches in which HSCs can be pulse-labelled with an inducible Tie2Cre model or 
where HSC-derived cells and monocytes can be genetically labelled in a Flt3Cre mouse 
model further demonstrated that foetal and adult HSCs are not the main contributor to 
tissue resident macrophage pools (Gomez Perdiguero et al., 2015; Schulz et al., 2012). 
These studies and others have shown that tissue resident macrophages arise early in 
embryogenesis and independently of monocyte contribution in the steady state 
(Kierdorf et al., 2013a; Schulz et al., 2012; Yona et al., 2013).  
1.5.1.2 Macrophage maintenance throughout life 
In parallel with the evidence of YS derived macrophages, is the question as to whether 
these cells self maintain in steady state throughout life or if they are constantly being 
replenished by haematopoietic stem cell derived populations. As macrophages are an 
extremely diverse group of cells, the answer to this question is also diverse. A 
pioneering study established that most adult tissue resident macrophages persist in 
tissues after birth without further input from HSC-derived progenitors under steady 
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state conditions (Schulz et al., 2012). These findings have subsequently been 
independently confirmed using a wide array of different techniques (Hashimoto et al., 
2013; Hoeffel et al., 2015; Sheng et al., 2015; Yona et al., 2013). For many tissue 
resident macrophage populations, it seems clear that they self maintain throughout life 
through local proliferation both in the steady state and under inflammatory conditions 
(Bruttger et al., 2015; Chorro et al., 2009; Davies et al., 2013b; Davies et al., 2011; 
Hashimoto et al., 2013; Jenkins et al., 2011; Yona et al., 2013). However, this is not the 
case for all tissue macrophage populations, for example, lamina propria macrophages in 
the gut. Bain et al., demonstrated that embryonic macrophages seed the foetal gut, 
however unlike other tissue resident macrophage populations, they did not persist into 
adulthood. At the point of weaning, the lamina propria is colonised by an influx of 
CCR2-dependent Ly6C+ monocytes, which differentiate in situ into mature gut 
macrophages (Bain et al., 2014). This pool of intestinal macrophages is constantly being 
replenished by Ly6C+ monocytes throughout life; indeed, gut macrophages have a very 
short half-life, compared to other macrophage populations, of around three weeks 
(Varol et al., 2009).  
Importantly for this thesis, Ly6Clow monocytes have often been thought of as 
contributing to the tissue macrophage pool in the steady state. Fate-mapping studies 
have demonstrated that macrophage populations within adult tissues are heterogeneous 
populations comprising both YS- and HSC- derived macrophages (Gomez Perdiguero et 
al., 2015). Currently, there are no known cell surface markers that would allow the 
discrimination between YS- and HSC-derived macrophages. Thus this thesis aims to 
use genetic models to understand the contribution of Ly6Clow monocytes to tissue 
macrophage populations.  
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1.5.2 Tissue resident macrophage activation 
Appreciation of macrophage activation is vital for our understanding of tissue 
homeostasis, disease pathogenesis, the mechanisms of acute and chronic inflammation 
and what makes the difference between resolving and non-resolving inflammatory 
responses (Biswas and Mantovani, 2010; Gordon and Martinez, 2010; Lawrence and 
Natoli, 2011; Murray et al., 2014). Over recent years, macrophage activation has been 
intensively studied, arising from the observations that macrophages stimulated in vitro 
with interferon γ (IFNγ) and IL-4 or IL-13 became polarised metabolically and in terms 
of anti-microbial activity (Doyle et al., 1994; Nathan et al., 1983; Stein et al., 1992).  
The balance between iNOS and arginase within macrophages was shown to be directly 
related TH1 or TH2 polarisation, respectively (Munder et al., 1998). From this, and from 
studies into mice with differing genetic backgrounds, the concept of the M1/M2 
dichotomy arose (Mills et al., 2000).  
Based on the TH1/TH2 model of T cell polarisation (Gazzinelli et al., 1993; Mosmann 
and Coffman, 1989; O'Garra and Murphy, 1994), Mills et al., demonstrated that 
macrophages from mouse strains with TH1 (C57BL/6; B10D2) background behaved in a 
metabolically distinct way to macrophages from mice with TH2 background (Balb/c). 
On stimulation with LPS or IFNγ, TH1 mouse strains produced more nitric oxide (NO), 
a metabolic process that requires L-arginine as a substrate. In contrast, macrophages 
from mice with TH2 background increased their metabolism of L-arginine to ornithine 
production in response to LPS (Mills et al., 2000).  
It has subsequently been realised that the differences in arginine metabolism by 
C57BL/6 and Balb/c mice are due C57BL/6 mice harbouring a deletion in the promoter 
region of a key macrophage arginine transporter, Slc7a2 (Sans-Fons et al., 2013), 
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which, in part, is attributable for the strain-specific arginine utilisation. Nonetheless, the 
M1/M2 dichotomy persists: classical macrophage activation is associated with increased 
antigen presenting function coupled with increased production of IL-1β, IL-6 and 
TNFα, all of which can contribute to driving a TH1 polarised T cell response (Martinez 
and Gordon, 2014; Mosser and Edwards, 2008). Whereas alternatively activated 
macrophages (MMAø) are associated with IL-4 and IL-10, and TH2-polarised 
responses.  
Whilst it has been suggested that AAMø represent a transition from inflammatory to 
reparative phenotype (Mills, 2012), in vivo data of AAMø during helminth infections 
has demonstrated a distinct molecular signature and a vital role in TH2 environments, 
such as allergy or helminth infection (Loke et al., 2002; Nair et al., 2003; Raes et al., 
2002). These data illustrate that alternative activation is not a transition state, rather a 
distinct molecular signature of effector functions that are not fully understood. 
Furthermore it is now appreciated that, just as T cell responses cannot be confined 
solely to TH1 and TH2 activation, macrophage activation cannot be considered purely 
classical or alternative states. More accurately, there is a spectrum of macrophage 
activation and activated macrophages are associated with substantial changes in gene 
expression profiles depending upon the stimulus to which they are exposed (Murray et 
al., 2014). 
 Thesis outline 1.6
1.6.1 The origin and fate of Ly6Clow monocytes 
This thesis focuses on the development and fate of Ly6Clow monocytes under 
physiological conditions. Of particular interest is the interrelationship between 
monocyte subsets in the blood and BM. Previous studies have divided the murine 
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monocyte compartment into two subsets (Geissmann et al., 2003; Hanna et al., 2011; 
Yona et al., 2013). Strong evidence has been provided indicating that Ly6Clow 
monocytes develop from Ly6C+ monocytes in the blood (Sunderkotter et al., 2004; 
Yona et al., 2013; Yrlid et al., 2006). However, some genetic studies appear to 
contradict these data. The study presented here uses a combination of fate mapping 
approaches and genetic tools to dissect and further clarify the murine monocyte 
interrelationships.  
1.6.2 General hypothesis 
Blood Ly6Clow monocytes develop independently of blood Ly6C+ monocytes in the BM 
from an Nr4a1-dependent precursor population. 
1.6.3 Thesis structure 
The materials and methods used during the course of this study are described in Chapter 
2. Chapter 3 describes in depth phenotypic analysis of blood and BM monocyte 
compartments of wild type animals in the steady state. Chapter 3 confirms the presence 
of a third monocyte subset that expresses MHC II (Carlin et al., 2013; Jakubzick et al., 
2013). Chapter 3 also introduces the cell cycle analysis and kinetic analysis of 
monocyte dynamics in wild type animals. These techniques are used again in genetic 
models described in the next chapter. 
Chapter 4 describes the thorough characterisation of different genetic models, 
confirming the dependence of Ly6Clow monocytes on Nr4a1 for their development but 
their development is independent of Ccr2 and Irf8. Furthermore, the analytical 
techniques introduced in Chapter 3 of cell cycle and kinetic analyses are applied to 
genetic mutants in order to further understand monocyte interrelationships. 
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Chapter 5 asks the question of whether Ly6Clow monocytes contribute to tissue resident 
macrophage populations in vivo and under steady state conditions. In addition, Chapter 
5 investigates the ontogeny of macrophage populations from two tissues in greater 
depth. 
Chapter 6 is a discussion of the data presented in this thesis in relation to what is known 

















2.1.1 Animal strains used in this thesis 
Nr4a1-/- animals (Lee et al., 1995), which lack Ly6Clow monocytes (Hanna et al., 2011), 
were purchased commercially from Jackson Laboratories (B6.129S2-Nr4a1tm1Jmi/J) as 
frozen embryos and re-derived in-house. These mice were bred on a C57BL/6J 
background as heterozygotes to produce homozygous Nr4a1-knockout animals, along 
with heterozygous and wild type littermate controls.  
Csf1riCre animals (Deng et al., 2010) were generated and bred on an FVB/N background 
and kindly provided by Jeffery W. Pollard.  
Nr4a1f/f mice (Kadkhodaei et al., 2009) were generated on a C57BL/6 (CD45.2) 
background and were provided by Pierre Chambon. The Nr4a1 locus (chromosome 15) 
was engineered with two LoxP recognition sites flanking exons 2 and 4. In the presence 
of CRE recombinase, the LoxP sites are cleaved deleting the N-terminus and functional 
DNA binding domain of Nr4a1. This results in a truncated 3’ region of the gene 
sequence lacking an in-frame ATG for the translation of any remaining protein coding 
sequence (Boudreaux et al., 2012; Kadkhodaei et al., 2009). Nr4a1fl/fl mice were bred 
and maintained as homozygotes. 
Nr4a1GFP reporter mice (Moran et al., 2011) were generated by Kristin A. Hogquist and 
provided by George Kassiotis (NIMR). These Nr4a1GFP reporter mice are a bacterial 
artificial chromosome (BAC) transgenic line that were developed by obtaining a 
~170kbp C57BL/6J mouse BAC #RP24-366J14 which contained the entire Nr4a1 
locus. A GFP-Cre fusion protein was inserted to the ATG start site of the BAC Nr4a1 
gene along with an frt-flanked neomycin cassette and a TGA-STOP codon via 
homologous recombination. Subsequently, the frt-flanked neo cassette was removed 
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and a ~135kbp fragment from the modified BAC containing the targeted Nr4a1 locus 
was purified and microinjected into C57BL/6J embryos (Moran et al., 2011) (Figure 2-
2). 
A ~135kb fragment from the modified BAC containing the targeted Nr4a1 locus as well 
as 60kb sequence flanking each side of the Nr4a1 locus was purified and then 
microinjected into C57BL/6J embryos.  
 
Figure 2-1 Generation of Nr4a1GFP BAC 
The BAC contains the whole Nr4a1 locus and a GFP-Cre fusion protein was inserted into the 
ATG start site of Nr4a1 along with a TGA stop codon. 
 
Flt3Cre mice (Benz et al., 2008) were generated on a C57BL/6 background by Conrad 
Bleul and provided by Sten-Eirik Jacobsen. The Flt3Cre containing BAC is on the Y 
chromosome therefore only males are FLT3CRE+.  
Rosa26YFP reporter mice (Srinivas et al., 2001) (B6.129X1-Gt(Rosa)26Sortm1(EYFP)Cos/J) 
were purchased from Jackson Laboratories and maintained on a C57BL/6 background. 
BAC Nr4a1 gfp 
1 2 3 4 5 6 
Nr4a1 locus 
1 2 3 4 5 6 Cre GFP 
TGA STOP 
Protein coding 
5 Non-protein coding 
ATG start site 
Inserted STOP codon 
BAC Transgene containing Nr4a1GFP 
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Cx3cr1GFP/+, Rag2-/-, Il2rg-/- mice, which are devoid of all lymphoid cells and the only 
circulating cells expressing GFP are monocytes (Auffray et al., 2007) were generated 
in-house and maintained on a C57BL/6 background. 
Ccr2-/- mice were generated as previously described (Boring et al., 1997) and were 
provided by Israel Charo and maintained on a C57BL/6 background. 
Irf8-/- were provided by Marco Prinz (University of Freiburg) were maintained on a 
C57BL/6 background and generated as previously described (Holtschke et al., 1996). 
 Animal crosses used in this thesis 2.2
2.2.1 Csf1riCre Rosa26YFP and Flt3Cre Rosa26YFP reporter mice 
Csf1riCre mice (FVB/N) were crossed to Rosa26YFP (C57BL/6) reporter mice (Srinivas et 
al., 2001), generating Csf1riCre Rosa26YFP reporter strain (FVB/N: C57BL/6 mixed 
background) to assess Csf1riCre mediated recombination.  
Flt3Cre mice (C57BL/6) were crossed to Rosa26YFP (C57BL/6) reporter mice as a 
reporter of Flt3Cre mediated recombination. 
2.2.2 Nr4a1 conditional knockout 
In order to generate animals in which Nr4a1 is deleted only within the haematopoietic 
system, Nr4a1f/f mice were crossed with Csf1riCre animals (FVB/N background) to 
generate conditional deletion of Nr4a1. Thus, Csf1riCre Nr4a1f/f animals analysed in this 




Figure 2-2 Csf1riCre conditional Nr4a1 deletion  
Nr4a1 locus was engineered with LoxP recognition sites for CRE recombinase flanking exons 2 
- 4. In the presence of CRE recombinase the N-terminus and functional DNA binding domain of 
Nr4a1 are excised. 
 
2.2.3 Generation of Nr4a1GFP Nr4a1-/- double mutants 
To generate Nr4a1GFP Nr4a1-/- mice, Nr4a1-/- animals were crossed with Nr4a1GFP 
animals. The F1 breeding produced animals heterozygous for endogenous Nr4a1 and 
positive for the Nr4a1GFP BAC construct  (Nr4a1GFP Nr4a1+/-). These F1 animals 
heterozygous for endogenous Nr4a1 (Nr4a1GFP Nr4a1+/-) were crossed together and the 
F2 breeding produced the following genotypes used for experimental purposes: 
Nr4a1GFP Nr4a1+/+;  Nr4a1GFP Nr4a1+/- and Nr4a1GFP Nr4a1-/- offspring. 
 Genotyping 2.3
2.3.1 DNA isolation 
Genomic DNA was isolated from ear biopsies by incubating the tissue with 300µl 
50mM NaOH at 97˚C for 1 hour before being neutralised with 30µl Tris-HCl. The 
extract was vortexed and subsequently centrifuged at 20,000 x g for 5 minutes. Samples 
were stored at 4˚C until analysis.  
1 2 3 4 5 6 7 
LoxP LoxP 
1 5 6 7 
Csf1riCre Protein coding 
5 Non-protein coding 






Post-PCR reaction, all samples were run on a 2% agarose gel made with 
Tris/borate/Ethylenediaminetetraacetic acid (EDTA) (TBE) containing ethidium 
bromide. Gels were imaged using a Bio-Rad Gel Doc EZ system. 
2.3.1.1 Csf1riCre Genotyping protocol 
Csf1riCre mice were genotyped as previously described (Deng et al., 2010). Briefly, one 
PCR reaction per mouse with 2 primers per tube was carried out. Each tube contained 
12.5µl of HotStartTaq (Qiagen) master mix, 2.5µl of CoralLoad DNA loading buffer 
(Qiagen), 7µl of RNAse and DNase free water and with 2µl of genomic DNA extracted 
as above and 0.5µl each of the following two primers: 
Csf1riCre Forward (10µM): 5’TCTCTGCCCAGAGTCATCCT3’  
Csf1riCre Reverse (10µM): 5’CTCTGACAGATGCCAGGACA3’ 
The PCR reaction was carried out for 30 cycles, performed at the following reaction 
conditions: denaturing temperature of 95˚C for 45 seconds, annealing temperature of 
60˚C for 45 seconds and elongation temperature of 72˚C for 45 seconds. 
The expected band size for this PCR is 400bp. 
 
Figure 2-3 Csf1riCre genotyping PCR gel 
 
350bp mutant band 





wild type 215bp 
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2.3.1.2 Nr4a1-/- Genotyping protocol 
One PCR reaction per mouse with 3 primers per tube was carried out to genotype 
Nr4a1-/- animals. Each tube contained 10µl of HotStartTaq (Qiagen) master mix, 2µl of 
CoralLoad DNA loading buffer (Qiagen), 4µl of RNAse and DNase free water and with 
2µl of genomic DNA extracted as above and the following three primers: 
Nr4a1-/- common primer: 1µl (10µM): 5’ CCACGTCTTCCTCATCC 3’ 
Nr4a1-/- wild type reverse primer: 0.5µl (10µM): 5’ TGAGCAGGGACTATAGT 3’ 
Nr4a1-/- mutant primer: 1.5µl (10µM): 5’ CACGAGACTAGTGAGACGTG 3’ 
The PCR reaction was carried out for 35 cycles, performed with the following reaction 
conditions: denaturing temperature of 94˚C for 30 seconds, annealing temperature of 
62˚C for 1 minute and elongation temperature of 72˚C for 1 minute. 
Wild type band is 180bp and the mutant band is 350bp. 
 
Figure 2-4 Nr4a1-/- genotyping PCR gel 
 
2.3.1.3 Flt3Cre Genotyping protocol 
One PCR reaction was carried out per mouse containing 2 primers per tube for the 
dentification of Flt3Cre mice. Each tube contained 12.5µl of HotStartTaq (Qiagen) 
350bp mutant band 





wild type 215bp 
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master mix, 2.5µl of CoralLoad DNA loading buffer (Qiagen), 7µl of RNAse and 
DNase free water and with 2µl of genomic DNA extracted as above and 0.5µl each the 
following two primers:   
Flt3Cre forward (10µM): 5’ACGGAGTCCAGGCAACTTCC 3’ 
Flt3Cre reverse (10µM): 5’GAAGCATGTTTAGCTGGCCC 3’ 
The PCR reaction was performed for 44 cycles with the following reaction conditions: 
denaturing temperature of 95˚C for 30 seconds, annealing temperature of 58˚C for 35 
seconds and elongation temperature of 72˚C for 60 seconds. 
Expected band size for this PCR is 400bp.  
 
Figure 2-5 Flt3Cre genotyping gel 
The Flt3Cre is inserted on the Y chromosome: all males are Cre+ and all females are Cre. 
2.3.1.4 Nr4a1fl/fl genotyping protocol  
One PCR reaction per mouse with 2 primers per tube was carried out for the 
identification of Nr4a1fl/fl animals. Each tube contained 10µl of HotStartTaq (Qiagen) 
master mix, 2µl of CoralLoad DNA loading buffer (Qiagen), 4µl of RNAse and DNase 
free water and with 2µl of genomic DNA extracted as above and 1µl each of the 
following two primers: 
Nr4a1fl/fl Forward (10µM): 5’ TTTTGAGAGTTGTCTTTTCTCCAGT 3’  
300bp Cre 
500bp knock out 





Nr4a1fl/fl Reverse (10µM): 5’ TCTGTAACTCTAGCTCCAGGACATC 3’ 
The PCR reaction was carried out for 35 cycles, performed at the following reaction 
conditions: denaturing temperature of 94˚C for 45 seconds, annealing temperature of 
60˚C for 56 seconds and elongation temperature of 72˚C for 1 minute. 
The expected band sizes for this PCR are:  
Wild type (unfloxed): 215bp 
Floxed: 300bp 
 
Figure 2-6 Nr4a1fl/fl genotyping PCR 
 
2.3.1.5 Genotyping Ccr2-/- mice 
One PCR reaction per mouse with 4 primers per tube was carried out for the 
identification of Ccr2-/-, Ccr2-/+ and Ccr2+/+ animals. Each tube contained 12.5µl of 
HotStartTaq (Qiagen) master mix, 2.5µl of CoralLoad DNA loading buffer (Qiagen), 
6µl of RNAse and DNase free water and with 2µl of genomic DNA extracted as above 
and 1µl each of the following two primers: 
Ccr2+/+ Forward (10µM): 5’ CCACAGAATCAAAGGAAATGG 3’  
Ccr2+/+ Reverse (10µM): 5’ CCAATGTGATAGAGCCCTGTA 3’ 
Ccr2-/- Forward (10µM): 5’ CTTGGGTGGAGAGGCTATTC 3’ 
350bp mutant band 





wild type 215bp 
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Ccr2-/- Reverse (10µM): 5’ AGGTGAGATGACAGGAGATC 3’ 
The PCR reaction was carried out for 35 cycles, performed at the following reaction 
conditions: denaturing temperature of 94˚C for 30 seconds, annealing temperature of 
60˚C for 30 seconds and elongation temperature of 72˚C for 1 minute. 
The expected band sizes for this PCR are:  
Wild type: 424bp 
Mutant: 280bp 
 
Figure 2-7 Ccr2-/- genotyping gel 
 
2.3.1.6 Phenotyping Nr4a1GFP animals 
Tail vein bleeding and analysis by flow cytometry detected the presence or absence of 
GFP in Nr4a1GFP animals crossed to C57BL/6J (see section 2.3.1.1). This was carried 
out at least 1 week before experimental use.  
2.3.1.7 Genotyping Nr4a1GFP Nr4a1-/- animals 
To identify the double mutant Nr4a1GFP Nr4a1-/- animals, genotyping of the Nr4a1 
deletion was assessed using the Nr4a1-/- as outlined above.  
300bp Cre 
424bp wild type 





The BAC has been inserted to generate Nr4a1GFP mice contains the whole NR4A1 locus 
although the insertion of a STOP codon ensures that the protein is not transcribed from 
the BAC. However, this means that all animals will express the wild type band (see 
figures 2-1 and 2-4), regardless of genotype. Thus, the genotyping PCR was carried out 
to detect presence of the mutant allele (see section 2.3.1.2).  
Once the presence of the mutant allele was obtained, mice were blood phenotyped to 
assess presence or absence of GFP and to detect presence or absence of Ly6Clow 
monocytes. 
  
Figure 2-8 Blood phenotyping of Nr4a1GFP Nr4a1-/- mice and littermates.  
Double mutant mice were assessed by flow cytometry for presence of GFP and Ly6Clow 
monocytes to confirm genotyping results. 
 
2.3.1.8 Nr4a1 deletion PCR 
To assess genetic Nr4a1 deletion in the Csf1riCre Nr4a1f/f animals a three-primer 
reaction was carried out with 1µl each of the following oligonucleotides:  
p1 (10µM): 5’ TTTTGAGAGTTGTCTTTTCTCCAGT 3’  
p2 (10µM): 5’ TCTGTAACTCTAGCTCCAGGACATC 3’ 











Unfloxed: p1 ! p2 = wt ~215 bp 
Undeleted, floxed: p1 ! p2 = ~300 bp 
Deleted: p1! p3 ~425 bp 








Figure 2-9 Schematic of 3-primer Nr4a1 deletion PCR 
 
Each tube contained 10µl of HotStartTaq (Qiagen) master mix, 2µl of CoralLoad DNA 
loading buffer (Qiagen), 3µl of RNAse and DNase free water and with 2µl of genomic 
DNA extracted as above.  
The PCR was performed for 35 cycles with the following reaction conditions: 
denaturing temperature of 94˚C for 45 seconds, annealing temperature of 56˚C for 45 
seconds, elongation temperature of 72˚C for 1 minute. 
  Flow cytometry 2.4
2.4.1  Blood Isolation for flow cytometry 
Mice were bled either from the tail vein or by intra-cardiac puncture.  
2.4.1.1 Tail vein bleeding 
For tail vein bleeding: animals were heated to 38˚C before being bled from the tail vein 
using a micro-lance. Blood was collected into pediatric EDTA-containing blood tubes 
and subsequently resuspended in 1ml of RBC lysis buffer (8.3g NH4Cl, 1g NaHCO3, 
1ml EDTA (100mM) in 1L of dH2O) and incubated on ice for 5 minutes. After which, 
the lysis reaction is stopped by the addition of 1ml of PBS 1X; 0.5% BSA (w/v); 2mM 











Unfloxed: p1 ! p2 = wt ~215 bp 
Undeleted, floxed: p1 ! p2 = ~300 bp 
Deleted: p1! p3 ~425 bp 







supernatant removed by aspiration. Lysis was repeated with a further 1ml RBC lysis 
buffer, on ice. 
2.4.1.2 Intracardiac puncture 
For intra-cardiac puncture: animals were lethally anaesthetised by intaperitoneal 
injection of anaesthetic cocktail containing ketamine (50 mg/kg), xylazine (10 mg/kg), 
and acepromazine (1.7 mg/kg). Anaesthetised mice were kept warm on a heating pad 
and between 0.5ml and 1ml of blood was collected using a 25-gauge x 16mm needle 
and syringe containing 50µl of EDTA (100mM) by intracardiac puncture. Blood was 
then transferred to a 15ml tube containing a further 50µl of 100mM EDTA. Blood was 
resuspended in 5ml RBC lysis buffer and incubated on ice for 5 minutes. Subsequently, 
5ml of staining buffer was added to stop the lysis reaction and cells were centrifuged at 
400 x g for 10 minutes (4˚C) and the supernatant removed by aspiration. The lysis 
reaction was repeated twice more, firstly with a further 3ml RBC lysis buffer and 
secondly with 1ml of RBC lysis buffer. 
After the final lysis step, cells were resuspended in 50µl of Fc block (FcγRIII/II; clone 
2.4G2) diluted 1/50 in staining buffer for 15 minutes in round-bottomed 96 well plates 
on ice. Blocking was carried out to avoid non-specific binding of the staining antibodies 
to Fc receptors on the surface of cells. Cells were then stained for surface markers by 
incubating for 30 minutes, on ice, protected from the light with fluorochrome-
conjugated antibodies (see table 2-1). 
2.4.2  Tissue isolation for flow cytometry 
Mice were culled by cervical dislocation, lethal anaesthesia (intaperitoneal injection of 
anaesthetic cocktail containing ketamine (50 mg/kg), xylazine (10 mg/kg), and 
acepromazine (1.7 mg/kg)) or CO2 inhalation.  
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2.4.2.1 Peritoneal lavage  
Animals were culled using CO2 inhalation, after which the outer skin was cut to expose 
the inner skin. 5ml of PBS + 3% foetal bovine serum was gently injected into the 
peritoneal cavity using a 27-gauge needle, being careful not to pierce any internal 
organs in the process. The peritoneum was then massaged for 30 seconds before the 
fluid aspirated using a 25-gauge needle. The process was repeated once more before 
cells were centrifuged at 320 x g for 7 minutes at 4˚C. The supernatant was then 
discarded and cells resuspended in cells 50µl of Fc block (FcγRIII/II; clone 2.4G2) 
diluted 1/50 in staining buffer for 15 minutes. Cells were then stained for surface 
markers by incubating for 30 minutes, on ice, protected from the light with 
fluorochrome-conjugated antibodies (see table 2-1). 
2.4.2.2 Isolation of macrophages from internal organs  
After cervical dislocation or lethal anaesthesia brain, spleen, left liver lobe, right lung 
lobe, thymus and inguinal lymph nodes were harvested and placed immediately in ice 
cold PBS. To obtain single cell suspensions, organs were finely chopped and incubated 
for 30 minutes at 37˚C in PBS containing 1mg/ml Collagenase D (Roche), 100U/ml 
Deoxyribnuclease I (DNAse I, Sigma), 2.5mg/ml Dispase (Invitrogen) and 3% foetal 
bovine serum (Invitrogen).  
Ears were excised from mice, separated into dorsal and ventral halves and placed 
dermis side down in PBS containing 2.4mg/ml Dispase (Invitrogen) for 1 hour at 37˚C 
or overnight at 4˚C. The dermis and epidermis were then carefully separated before 
digestion at 37˚C for 30 minutes in 1ml PBS containing 1mg/ml Collagenase D (Roche, 
Burgess Hill, UK), 100U/ml Deoxyribonuclease I (DNAse I, Sigma), 2.4mg/ml Dispase 
(Invitrogen, Paisley, UK) and 3% foetal bovine serum. The digestion mix was then 
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diluted in 6ml of staining buffer. The tissues were then mechanically dissociated by 
passing through a 100µm cell strainer (BD). Cells were centrifuged at 320 x g for 7 
minutes at 4˚C before proceeding to staining as described above in section 2.3.2.1. 
2.4.2.3 Isolation of monocytes from the spleen  
For analysis of monocytes subsets in the spleen, half of the spleen was directly 
mechanically dissociated through a 100µm strainer without being digested to preserve 
CD115 expression. After dissociation, the cell suspension was filtered again through a 
70µm filter before being spun down at 320 x g for 7 minutes, 4˚C. Cells were further 
prepared and stained for flow cytometry as described above.  
2.4.2.4 Bone marrow isolation  
Hind limbs were excised, cleaned of muscle tissue and the ends of the bones, including 
the iliac crest, were trimmed. BM was flushed using a 27-guage needle and 10ml 
syringe containing RPMI-1% penicillin/streptomycin. Cells were pelleted at 320 x g for 
10 minutes (4˚C) and then resuspended in staining buffer before being passed through a 
100µm filter. Cells were spun down at 320 x g for 5 minutes, supernatant discarded and 
cells resuspended in staining buffer containing 10µM/ml of rat anti-mouse 1A8 and 
20µM/ml of rat anti-mouse Ter119 to deplete granulocytes and erythrocytes, 
respectively.  
BM was depleted of 1A8 and Ter119 expressing cells using sheep anti-rat Dynabeads 
(Life Technologies). Depleted BM cells were counted prior to blocking with anti-
CD16/32 (FcγRIII/II; clone 2.4G2) diluted 1/50 in staining buffer for 15 minutes in 
round-bottomed 96 well plates. Antibody mixes were added and cells were incubated 
for 30 minutes on ice, protected from light. Where appropriate, cells were incubated 
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with a secondary streptavidin conjugate for a further 20 minutes (see antibody list 
below).  
2.4.3  Flow cytometry 
Unstained samples and single stained cells were passed to set up photomultiplier tube 
(PMT) voltages. Single stained cells were used to compensate on the flow cytometer 
and recorded for post-acquisition compensation during analysis.  
Fluorescence minus one (FMO) controls were acquired for each fluorochrome used 
during the optimisation of all new antibody panels. 
Flow cytometry was performed using BD Biosciences Aria II, BD Biosciences 
FACSCanto II or BD Biosciences LSR Fortessa.  
All data were analysed using FlowJo version 9.5 (Tree Star Inc.). 
2.4.3.1 Antibodies for flow cytometry 
The antibodies used in this thesis are listed in table 2.1.  
It was important to exclude NK cells from the analyses presented in this thesis, 
however, in setting up the antibody panels it was observed the NK1.1 antibody was 
non-specifically staining the Ly6Clow monocyte subset, whereas NKp46 did not. 
Therefore, throughout this study, NKp46 was used to exclude NK cells rather than 
NK1.1. This phenomenon has subsequently been observed by others (Biburger et al., 
2015). 
Using Ly6C to differentiate between the two principal monocyte subsets was critical for 
the analysis in this thesis. The monoclonal antibody Gr1 recognises both Ly6C and 
Ly6G epitopes, expressed on both granulocytes and monocytes. These are 
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glycosylphosphatidyl-inositol (GPI) linked proteins that were first reported on murine 
lymphocytes in the 1977 (McKenzie et al., 1977) and are part of the wider Ly6 
superfamily. In this thesis, monocytes were distinguished from granulocytes by CD115 
and CD11b staining and from each other by expression of Ly6C. Whilst the Ly6C 
epitope is expressed on both granulocytes and monocytes, Ly6G is not expressed by 
monocytes; consequently Ly6C and Ly6G antibodies were preferentially used over Gr1 
so that granulocytes could be excluded 
Furthermore, there are two clones available for Ly6C, HK1.4 and AL-21. Both clones 
were tested in setting up antibody panels and HK1.4 was chosen to be preferable over 
AL-21 due to much brighter staining and therefore better separation of the Ly6C+ and 
Ly6Clow monocyte subsets. 
All antibodies were titrated to find the optimal dilution for staining 5 million cells. 
Titrations were done starting with 10µl/ 100µl of cell suspension containing 5 million 
cells and titrated down to identify the optimal concentration for use. 
2.4.3.2 Fluorescently Activated Cell Sorting 
Cells were sorted using BD Biosciences Aria II into tubes containing RPMI medium 
supplemented with 10% foetal bovine serum (FBS) and 1% penicillin/streptomycin 
(P/S), TRIzol (Life Technologies) or Cell Lysis Solution (DNA Purification KIT, 
Promega). For every sort, unstained samples were analysed first in order to calibrate the 
sorter for detection of fluorochromes. Single stained cells were acquired for 
compensation, which was carried out on the sorter prior to starting the sort to ensure any 
spectral overlap between fluorochromes was corrected.  
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To ensure that the sort streams were correctly aligned, 200 cells of each population were 
sorted and reacquired to ensure 100% purity. In addition, for adoptive transfer, 10µl of 





Table 2-1: Murine antibodies used for flow cytometry 
Antibody Clone Conjugate Company 
CD3e 145-2C11 Biotin BD Pharmingen 
CD3e 145-2C11 PE  Biolegend 
CD3e 145-2C11 FITC ebioscience 
CD4 H129.19 PE or FITC Biolegend 
CD8a 53-6.7 PE Biolegend 
CD8a 53-6.7 FITC ebioscience 
CD11b M1/70 PE or PE Cy7 BD Pharmingen 
CD11b M1/70 BV605 or BV711 or FITC Biolegend 
CD11c N418 PerCP Cy5.5 or APC ebioscience 
CD16/32  2.4G2 uncoupled BD Pharmingen 
CD19 1D3 Biotin or PE or PE Cy7 BD Pharmingen 
CD45 30-F11 APC Cy7 Biolegend 
CD45.1 A20 PE BD Pharmingen 
CD45.2 104 APC Cy7 BD Pharmingen 
CD48 HM48-1 APC Biolegend 
CD64 X54-5/7.1 PE BD Pharmingen 
CD103 M290 Biotin or APC BD Pharmingen 
CD104 346-11A Biotin Biolegend 
CD115 AFS98 PE or APC ebioscience 
CD117 (c-KIT) 2B8 BV605 BD Pharmingen 
CD117 (c-KIT) 2B8 APC Cy7 Biolegend 
CD135 A2F10 PerCP eFluor 710 ebioscience 
CD150 TC15-12F12.2 PE Cy7 Biolegend 
CD326 (EpCAM) G8.8 PE Cy7 ebioscience 
CD335 (NKp46) 29A1.4 PE or FITC ebioscience 
F4/80 2M8 e450 ebioscience 
Ki67 B56 PE BD Pharmingen 
Ly-6A/E (Sca-1) D7 PE or FITC or PerCP Cy5.5 ebioscience 
Ly-6A/E (Sca-1) D7 BV421 Biolegend 
Ly-6C HK1.4 PE Cy7 or BV421 Biolegend 
Ly-6C/6G (Gr-1) RB6-8C5 APC BD Pharmingen 
Ly-6C/6G (Gr-1) RB6-8C5 PE or FITC Biolegend 
Ly-6G 1A8 PE or FITC BD Pharmingen 
Ly-76 Ter119 PE Biolegend 
MHC class II M5/114.15.2 FITC or PE Cy7 BD Pharmingen 
MHC class II M5/114.15.2 PerCP eFluor 710 ebioscience 
Siglec F E50-2440 PE BD Pharmingen 
TIM4 RMT4-54 Alexa Fluor 647 Biolegend 
    
DAPI - - Invitrogen 
Streptavidin - Pacific Blue Invitrogen 




  Absolute cell counts 2.5
To obtain absolute cell counts to measure the size of haematopoietic compartments and 
compare absolute cell numbers between different genetic models, an automated cell 
counter was used. A Sysmex KX-21N Haematology cell counter was used throughout 
the experiments presented in this thesis.  
Whole blood samples or diluted samples were aspirated by the haemocytometer, which 
then feeds the sample through transducers. Each transducer chamber has an aperture 
with electrodes on both sides between which direct current flows. As the cell suspension 
passes through the aperture, the electrical resistance between the two electrodes changes 
creating pulses. The size of these pulses allow discrimination between red and white 
blood cells (RBC and WBC respectively) and cell counts are calculated by counting the 
pulses.  
The reliability and accuracy of this machine for WBC counts was assessed by 
comparison with manual counting using a Malessez counting chamber.  
2.5.1  Blood cell counts 
To obtain total RBC and WBC counts, an aliquot of 10µl of whole (unlysed) blood was 
diluted and analysed on the Sysmex KX-21N Haematology cell counter using the 
programmed pre-diluted mode. This pre-diluted mode requires a 1/26 dilution of whole 
blood prior to sample aspiration and provides a read-out of cells per µl. 
To obtain a count for the number of individual cell populations per µl of blood, the 
volume of blood taken from each animal was recorded. After lysis, (as described above) 
cell pellets are resuspended in an appropriate volume of Fc block from which a 10µl 
was taken and diluted 1/10. This 1/10 dilution was measured using the Sysmex KX-21N 
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haemocytometer. The following formula was applied to the reading from the automated 
cell counter: 
Cell count = (10x)VFC 
Where: x = reading from automated cell counter (cells/µl) 
10 = dilution factor 
VFC = volume of FC block used for cell pellet was resuspension 
Thus providing a post-lysis cell count. After analysis of samples, the post-lysis cell 
count was multiplied by the frequency of each population as determined by flow 
cytometry in order to calculate relative compartment size. 
To calculate relative compartment size of blood monocytes, it was considered that the 
total blood volume an adult mouse was 80ml/kg and that adult C57BL/6 mice weighted 
25g (Harkness and Wagner, 1995; Mitruka and Rawnsley, 1981). Consequently, it was 
considered that the total blood volume per mouse was 2ml.  
2.5.2  Bone marrow cell counts 
After isolation of BM cells, an aliquot was taken BM cell suspension was taken for pre-
depletion count. After depletion of 1A8 and Ter119 expressing cells, BM cells were 
resuspended in an appropriate volume of FC block and a 10µl aliquot was taken and 
diluted 1/10. A cell count per µl of this dilution was acquired using the Sysmex 
automated cell counter. The total number of cells for 2 hind limbs (minus iliac crests) 
was calculated with the following formula: 
Cell count = (10x)VFC 
Where: x = reading from automated cell counter (cells/µl) 
10 = dilution factor  
VFC = volume of FC block used for cell pellet was resuspension 
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The cell count was then multiplied by the frequency of each population as determined 
by flow cytometry in order to calculate relative compartment size. 
To calculate relative compartment size of BM populations, the cell count two hind 
limbs was taken to represent ~20% of total BM cellularity (Colvin et al., 2004; Colvin 
et al., 2000; Lambert et al., 2000). 
  Cell cycle analysis 2.6
After staining with surface marker antibodies, cells were fixed in 4% formaldehyde 
solution weight/volume (w/v) for 20 minutes on ice. Cells were then permeabilised with 
PBS 1X; 0.5% BSA (w/v); 2mM EDTA; 0.5% saponin (w/v). Cells were blocked with 
anti-CD16/32 (FcγRIII/II; clone 2.4G2) diluted 1/50 in saponin buffer (PBS 1X; 0.5% 
BSA (w/v); 2mM EDTA; 0.5% saponin (w/v)) for 30 minutes prior to incubation with 
Ki67 (BD Pharmingen) and 0.05ng/ml of DAPI (Invitrogen) for 1 hour on ice. DAPI 
signal was acquired on a linear scale and used to quantify total DNA levels, 2N was 
defined as fluorescence=50 (x1000). Diploid (2N) were defined as G0/G1 and either 
Ki67- or Ki67+. G2M phase cells were defined as Ki67+ with 4N (tetraploid). S-phase 
cells were characterized by Ki67+ staining and >2N<4N ploidy. 
  BrdU incorporation  2.7
Mice were treated with a single i.p. injection of 1.5mg BrdU (bromodeoxyuridine) (BD 
Pharmingen FITC BrdU Flow KIT). To assess BrdU incorporation, blood, BM and 
spleen cells were isolated as above, stained with primary antibodies. Samples were then 
fixed with BD Cytofix/Perm buffer for 20 minutes on ice then washed with BD 
Perm/Wash Buffer. Samples were re-fixed with BD Cytoperm Plus buffer for 10 
minutes on ice before treatment of cells with DNase (300µg/ml) for 1 hour at 37˚C. 
Samples were then stained with FITC-conjugated anti-BrdU for 20 minutes at room 
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temperature. After which, samples were washed, supernatant discarded and cells were 
resuspended in 20µl 7-aminoactinomycin D (7AAD). A further 200µl of staining buffer 
was added and samples were acquired on a BD FACS Aria II. 
2.7.1  Measurement of apoptosis  
Apoptotic cells have incomplete DNA content due to losing chromatin in apoptotic 
bodies and because fragmented DNA is extracted during the staining procedure 
(Pozarowski and Darzynkiewicz, 2004). Thus, they can be quantified as samples with 
DNA content <G0G1. During processing of samples for kinetic analysis, cells were 
additionally stained with 7AAD and analysed on BD Biosciences LSR Fortessa. 7AAD 
signal was acquired on a linear scale and used to quantify total DNA levels. 2N was 
defined as fluorescence=50 (x1000) and apoptotic cells were defined as sub-2N. 
  
Figure 2-10 Gating of apoptotic cells using BrdU and 7AAD 
  Feeder culture 2.8
Unfractionated BM from CD45.1 mice were plated out into flat-bottomed 96-well plates 
at a density of 50x104 cells/ml in RPMI medium supplemented with 10% FBS and 1% 
P/S.  
Cell populations of interest were FACS sorted from Nr4a1GFP (CD45.2) animals into 
RPMI medium supplemented with 10% FBS and 1% P/S. Post sort, cells were washed 












5x104 cells/ml. Aliquots of 100µl were added to 96-well plates containing 100µl of 
CD45.1 feeder cell suspension. Populations were plated in triplicate. 
Cells were incubated at 37˚C, 5% carbon dioxide (CO2) for 1, 12, 24 and 48 hours 
before washing and staining for reanalysis.    
  Adoptive transfer 2.9
Populations for adoptive transfer were FACS sorted as above into RMPI medium 
supplemented with 10% FBS 1% P/S. Post sort, cells were washed, supernatant 
discarded and resuspended in RPMI with 1%P/S (no FBS) at a density of 200,000 cells 
per 100µl. 200,000 cells (100µl) were injected directly into the tail vein of congenic 
animals. Animals were sacrificed 3.5 days post transfer and blood and spleen were 
prepared as above (see sections 2.3.1.2 and 2.3.2.3 respectively). 
  Quantitative real-time PCR  2.10
2.10.1  cDNA preparation 
Cells were sorted directly into Eppendorf tubes containin 500µl TRIzol (Life 
Technologies) at 4˚C. Once the sort was complete, the samples were vortexed and 
incubated for 5 minutes at room temperature. Phenol-chloroform-isoamyl alcohol was 
added to each sample, shaken vigorously and incubated at room temperature for 2 
minutes before being centrifuged at 12,000 x g for 15 minutes at 4˚C. 
The upper aqueous phase of the sample was transferred to a new Eppendorf tube to 
which 5µg of RNase-free glycogen (Invitrogen) was added. 250µl of isopropanol was 




Samples were then centrifuged for 10 minutes at 12,000 x g 4˚C and the supernatant 
was removed and discarded. Subsequently, the pellet was washed in 250µl of 75% 
ethanol before repeating centrifugation (10 minutes, 12,000 x g, 4˚C) after which the 
supernatant was discarded. The pellet was then allowed to air dry and then resuspended 
in 17µl of RNase- and DNase-free water. 
RNA was then treated for 30 minutes with DNase I (Fermentas) at 37˚C to remove any 
residual genomic DNA. cDNA synthesis was carried out using the First Strand cDNA 
Synthesis KIT (Fermentas). First, samples were primed with random hexamers for 5 
minutes at 70˚C before being treated with M-MuLV Reverse Transcriptase (Fermentas), 
10mM deoxyribonucleotides (dNTPs) and RNasin (Fermentas) RNAse inhibitors for 1 
hour at 37˚C. Finally, heating samples to 70˚C for 10 minutes inactivated enzymes and 
cDNA samples were stored at -20˚C until use in RT qPCR experiments. 
2.10.2  RT qPCR 
The resulting cDNA from the protocol described above was used to generate a 1:3 serial 
dilution, resulting in a set of 7 standards before being diluted 1:5 in RNase- and DNase-
free water and run alongside a no-template control. RT qPCR was carried out using 
Sensimix SYBR Green No-Rox (Bioline) on a Corbett Rotor Gene 600. The cycling 
settings were: 95˚C hold for 10 minutes followed by 35 cycles of 95˚C for 15 seconds, 
63˚C for 30 seconds, 70˚C for 30 seconds. RT-qPCR primer sequences are found in the 
table below and were used at a concentration of 10µM. 
Table 2-2 RT-qPCR Primers 
Gene Forward Primer Reverse Primer 
18S 5'-AACGGCTACCACATCCAAGG 5'-GGGAGTGGGTAATTTGCGC 




  Immunofluorescence 2.11
2.11.1  Epidermis 
Ears were harvested from sacrificed mice and any hair was removed using hair removal 
cream (Veet). Ears were separated into dorsal and ventral halves and placed dermis side 
down into PBS (1X) containing 2.4mg/ml Dispase; 3% foetal bovine serum. The 
epidermal sheets were carefully separated from the dermis and placed on slides. 
Epidermal sheets were fixed for 10 minutes with 4% formaldehyde before blocking 
overnight with PBS (1X) containing 5% normal goat serum (Invitrogen), 0.5% BSA 
(w/v) and 0.1% Triton X-100. Epidermal sheets were stained with primary antibody 
over night at 4˚C, followed by secondary antibody for 2 hours at room temperature.  
Table 2-3 Antibodies for epidermal immunofluorescence 
Primary antibody Dilution Secondary antibody Dilution 
Rabbit anti-GFP 1/200 
Goat anti-Rabbit 
Alexa fluor 488 1/200 
Rat anti-IA/IE 
(clone 2G9) 1/100 
Donkey anti-Rat 
Cyanine Cy3 1/100 
 
Sheets were post-fixed with 1% formaldehyde for 1 minute and mounted with mounting 
medium (Vector Laboratories). Images were acquired using a Leica TCS SP5 confocal 
microscope. Image analysis was performed using the Image J software (National 
Institute of Health) or Imaris (Bitplane) software. 
2.11.2  Spleen 
Spleens were fixed for 4 hours in 4% formaldehyde, incubated overnight in 30% 
sucrose and embedded in OCT compound (Sakura Finetek). Cryoblocks were cut at a 
thickness of 15µm and then blocked with Streptavidin/Biotin blocking KIT (Vector 
laboratories) followed by further blocking with 1X PBS containing 5% normal goat 
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serum (Invitrogen); 0.5% BSA (w/v); 0.3% Triton X-100 for 1 hour at room 
temperature. Samples were incubated overnight at 4˚C with primary antibodies. 
Samples were washed and incubated with secondary antibodies for 2 hours at room 
temperature. Samples were then mounted with mounting medium (Vector Laboratories). 
Images were acquired using a Leica TCS SP5 confocal microscope. Image analysis was 
performed using the Image J software (National Institute of Health) or Imaris (Bitplane) 
software. 
Table 2-4 Antibodies for spleen immunofluorescence 
Primary antibody Dilution Secondary antibody Dilution 
Rat anti-MARCO 1/50 Anti-Rat Alexa fluor 555 1/100 




fluor 488 1/100 
 
  Statistical analysis 2.12
2.12.1  Statistical significance 
In all experimental figures included in this thesis, statistical significance is indicated by 
stars or with the p value written above. Statistical significance was considered to be 
p<0.05. 
Table 2-5 Levels of statistical significance 
Statistical significance Wording Summary 
≥0.05 Not significant ns (or blank) 
0.01 to 0.05 Significant * 
0.001 to 0.01 Very significant ** 
0.0001 to 0.001 Highly significant *** 




2.12.2  Statistical analysis of flow cytometry data 
Flow cytometry data was analysed using FlowJo (Tree Star Inc) and population 
frequencies amongst CD45+ cells were exported from FlowJo. Data were graphically 
visualised with error bars representing standard deviation (SD) using GraphPad Prism 6. 
Normal distribution of samples was assessed using D'Agostino-Pearson normality test 
(D'Agostino and Stephens, 1986) to confirm Guassian distribution and unpaired t-tests 
were applied to data using GraphPad Prism 6 (GraphPad Software Inc).   
2.12.3  Half-life calculations from BrdU experiments 
To calculate the half-lives of monocytes and their progenitors, exponential trend lines 
were fitted to the data using the following one-phase exponential decay equation:  
Y = (Y0-Plateau)*exp(-K*X)+Plateau 
Where: X = time 
Y = BrdU+ cells  
K= Rate constant 
 
Figure 2-11 One phase exponential decay trendline fitting 

















  Introduction, aims and objective 3.1
3.1.1 Introduction 
Monocytes belong to the myeloid arm of the immune system and develop normally in 
lymphocyte deficient Rag2-/- Il2rg-/- animals (Auffray et al., 2007; Mazurier et al., 
1999). Monocytes can be defined by expression of CD115 (also called Csf1r or M-csfr) 
and CD11b (MacDonald et al., 2005; Sasmono et al., 2003), together with the lack of 
expression of T cell, B cell, granulocyte and NK cell markers. In mice, two principal 
subsets have been described (Geissmann et al., 2003): the “inflammatory” Ly6C+ 
CX3CR1int subset which are thought to correlate to the human CD14+ monocytes and the 
“patrolling” Ly6Clow CX3CR1bright subset which are thought to be analogous to human 
CD14dim CD16+ monocytes.  
This chapter establishes that murine monocytes in the blood and BM can be separated 
into three subsets monocyte based on their cell surface expression of Ly6C and MHC II 
in the blood and BM.  
The chemokine receptor Cx3cr1 is widely expressed within myeloid lineages and 
Cx3xr1GFP knock-in mice (Jung et al., 2000) have been a vital tool in the identification 
and characterisation of myeloid BM progenitors (Fogg et al., 2006; Liu et al., 2009) and 
monocyte subsets (Geissmann et al., 2003; Yona et al., 2013). However, Cx3cr1 
expression is not exclusive to myeloid cells (Auffray et al., 2007; Jung et al., 2000). 
Accordingly, experiments using Cx3cr1GFP animals should be carried out on mice with a 
lymphocyte-deficient Rag2-/- Il2rg-/- background to confirm if cells belong to the 
myeloid lineage, however, it is important to analyse these animals bearing in mind the 
caveat it is not technically steady state conditions.  
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This chapter validates the third, minor Ly6Cint MHC II+ monocyte subset by analysing 
Cx3cr1GFP/+ animals on a lymphocyte-deficient Rag2-/- Il2rg-/- background (Auffray et 
al., 2007; Jung et al., 2000). In addition, Nr4a1GFP mice were analysed to assess the 
level of NR4A1 expression in different monocyte subsets in the blood and BM and their 
progenitors, confirming and building upon the work by Hanna et al., (Hanna et al., 
2011). Furthermore, this chapter uses to C57BL/6 wild type mice to analyse the cell 
cycle dynamics of the monocytes in the blood and BM along with their progenitors. In 
conjunction with this, the dynamics of monocyte subsets were interrogated using BrdU 
incorporation pulse-chase analysis. This enabled the establishment monocyte half-lives 
in vivo when three separate subsets are considered. 
3.1.2  Objective and aims 
Chapter 3 objective: Detailed definition of the murine monocyte compartment and the 
interrelationships between different monocyte subsets in the blood and BM of wild type 
adult mice.  
The aims of this chapter are: 
1. Characterisation of blood and BM monocyte subsets and their BM progenitor/ 
precursor populations in adult, wild type mice 
2. Investigate blood and BM monocyte subsets and their BM progenitor/ precursor 
populations proliferation using Ki-67 and DAPI staining 




  Characterisation of monocyte subsets and their precursors 3.2
3.2.1  Blood monocytes 
3.2.1.1 Blood monocyte subsets  
Blood monocytes express the growth factor receptor CD115 (also known as CSF1R and 
M-CSFR) and the integrin CD11b (also known as Mac-1). For isolating blood 
monocyte subsets in this thesis, an antibody mix was developed, excluding CD3+, 
CD19+ and Ly6G+ cells and selecting the CD115+ CD11b+ population (Figure 3-1). To 
confirm this antibody mix was identifying monocytes as have previously been 
described, blood from CX3CR1GFP reporter mice on a Rag2-/- Il2rg-/- background was 




Figure 3-1 Isolation of blood monocyte subsets  
(A) Blood monocyte isolation by selection of CD11b+ CD115+ cells and exclusion of doublets, T cells, B cells and granulocytes in C57BL/6 wild type mice and 
Cx3cr1GFP/+ Rag2-/- Il2rg-/- animals. (B) Blood monocytes can be divided into three subsets based on expression of Ly6C and MHC II. (C) Backgating of 3 monocyte 
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Figure 3-1 shows the gating strategy used to isolate blood monocytes. In 3-1a, it can be 
seen that monocytes were selected as CD11b+ CD115+ cells after exclusion of doublets, 
CD3+, CD19+ and Ly6CG+ cells. Furthermore, in the Cx3xr1GFP/+ Rag2-/- Il2rg-/- 
animals, CX3CR1 expression demonstrates Ly6Clow monocytes express this reporter 
very strongly and GFP expression is lower in Ly6C+ monocytes as has previously been 
described (Geissmann et al., 2003). 
Within the CD115+ CD11b+ compartment a third monocyte subset, characterised by the 
expression of MHC II and variable levels of Ly6C, could be identified (Figure 3-1b), as 
was previously shown by both Jakubzick et al., and Carlin et al., (Carlin et al., 2013; 
Jakubzick et al., 2013). This CD11b+ CD115+ MHC II+ population was found in 
lymphocyte deficient mice showing that this population develops in the absence of the 
common gamma chain (Il2rg) and backgating shows characteristic monocyte forward 
and side scatter profiles in both wild type and Rag2-/- Il2rg-/- animals (Figure 3-1c). 
Henceforth throughout this thesis, this population will be referred to as Ly6Cint MHC II+ 
monocytes. Finally, Figure 3-1d demonstrates that no differences were observed in the 
frequencies of all three monocyte subsets between C57BL/6 mice and Rag2-/- Il2rg-/- 
animals.  
Collectively, these data confirm the presence of a third blood monocyte subset that can 
be identified by expression of MHC II and intermediate expression of Ly6C. In 
addition, this population develops normally in Rag2-/- Il2rg-/- animals. Consequently, to 
fully understand wild type monocyte dynamics, monocytes were analysed as three 
separate subsets throughout this study. 
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3.2.1.2 Blood monocyte subset characterisation 
To characterise the three separate monocyte subsets, expression levels of CX3CR1 and 
NR4A1 were investigated using GFP reporter mice (Figure 3-2). Blood cells were 
additionally stained with CD11c and Flt3 (CD135) or an appropriate isotype control. It 
was observed that expression of both CX3CR1GFP and NR4A1GFP increase incrementally 
from Ly6C+ MHC II- to Ly6Cint MHC II+ and again from Ly6Cint MHC II+ to Ly6Clow 
MHC II-. Thus, Ly6Clow MHC II- monocytes in the blood express high levels of 
NR4A1, in addition to their requirement of this transcription factor for their 
development (Hanna et al., 2011). 
  
Figure 3-2 Blood monocyte subset characterisation 
Expression patterns of CX3CR1GFP, NR4A1GFP, CD11c and Flt3 in blood monocyte subsets 
when separated into three populations as indicated in the dot plot on the left-hand side. White 
histograms represent GFP reporter signal or antibody staining, grey histograms represent GFP- 



























The level of expression for both CX3CR1GFP and NR4A1GFP increases as Ly6C 
expression decreases between subsets. The most probable explanation for this is a 
reflection of higher gene expression levels in Ly6Cint MHC II+ and Ly6Clow MHC II- 
monocyte subsets; however, an alternative interpretation should also be considered. 
GFP has a long half-life in cells (~26 hours (Corish and Tyler-Smith, 1999)), and one 
could speculate that the inverse correlation of both NR4A1 and CX3CR1 with Ly6C 
could be that the GFP is accumulating over time as Ly6C+ monocytes convert into 
Ly6Clow monocytes. This could potentially lend support to the current model of Ly6Clow 
monocytes maturation from blood Ly6C+ monocytes (Sunderkotter et al., 2004; Varol et 
al., 2007; Yona et al., 2013). However, this interpretation of the data would suggest that 
such a conversion requires Ly6C+ monocytes passing through an MHC II+ intermediate 
step; and the biological rationale for MHC II+ upregulation followed by downregulation 
is not obvious. Conversely, the same reasoning could be applied when considering that 
Ly6Clow monocytes have a significantly longer life span compared to the Ly6C+ subset 
(Yona et al., 2013) and brighter GFP signals in the Ly6Clow subset could also be a 
reflection of their longer half-life in which to accumulate GFP.  
In addition, CD11c staining shows a successive increase in expression as monocytes 
lose expression of Ly6C, which could be interpreted, along with the GFP observations, 
to fit the maturation hypothesis or alternatively, these data together could be indicative 
of three distinct subsets and not a maturation pathway. Interestingly, Ly6Cint MHC II+ 
population only expresses Flt3 (CD135), albeit at very low levels, in addition to MHC 
II, which may point towards a dendritic cell-like function, a hypothesis that requires 
investigating. Purely phenotypical data such as these are not sufficient to answer 
questions of blood monocyte interrelationships however it provides insight into the 
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subtle differences in cell surface marker expression which may provide clues as to 
functional differences between subsets. 
 
3.2.2  Bone marrow monocytes and their progenitors 
3.2.2.1 MDP, cMoP and bone marrow monocyte definitions 
In this thesis, one of the principal aims is to clarify the development pathway of 
Ly6Clow monocytes. There have been some seemingly contradictory results regarding 
the immediate precursor cell to Ly6Clow monocytes. Some studies have indicated that 
Ly6C+ blood monocytes are the immediate precursor cell of Ly6Clow blood monocytes 
(Hettinger et al., 2013; Sunderkotter et al., 2004; Varol et al., 2007; Yona et al., 2013; 
Yrlid et al., 2006). However, genetic studies have also reported Ly6Clow monocytes 
develop in the absence of Ly6C+ monocytes in Irf8- and Klf4-deficient mice (Alder et 
al., 2008; Kurotaki et al., 2013). Furthermore, Ly6Clow monocyte development and/or 
survival is dependent upon the transcription factor Nr4a1 (Hanna et al., 2011), and their 
egress from the BM is selectively dependent upon sphingosine-1 phosphate receptor 5 
(S1pr5) (Debien et al., 2013). Thus, uniting these observations into a single hypothesis 
has proved problematic and this thesis proposed to re-examine the development 
pathways of Ly6C+ and Ly6Clow MHC II- monocytes and shed new light on the 
interrelationships by including the Ly6Cint MHC II+ monocyte subset. 
Ly6C+ monocytes have been shown to differentiate from BM myeloid progenitors from 
the CX3CR1+ MDP (Fogg et al., 2006).  The MDP, defined as CD115+ KIT+ Flt3+ 
(CD135) CD11blow, is a clonogenic BM progenitor population capable of giving rise to 
both monocytes and dendritic cells but has lost the ability to give rise to granulocytes 
(Auffray et al., 2009a; Fogg et al., 2006).  
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Subsequently, in 2013, the monocyte-restricted precursor population, the cMoP, was 
described (Hettinger et al., 2013). This population of BM cells is one step further along 
the differentiation pathway, having lost expression of Flt3 (CD135) and the capacity to 
give rise to DCs, the cMoP is a Ly6C-expressing dedicated monocyte precursor. 
Thus, an important starting point for BM analysis in this thesis was to develop an 
antibody panel that enabled analysis of the MDP and cMoP along with BM monocyte 
populations. Whilst the MDP was identified using CX3CR1GFP reporter mice, deficient 
of lymphocytes (Fogg et al., 2006), for this thesis it was necessary to isolate the MDP 
without the use of CX3CR1GFP and in animals with lymphocytes. The development an 
antibody panel that isolated the MDP, cMoP and BM monocytes without the aid of 
CX3CR1GFP and in immunocompetent mice was necessary to allow consistent analysis 
of BM populations between different genetic models and reporter strains. 
Figure 3-3 shows the gating strategies used for identifying these BM populations 
throughout the thesis. Gating on CD45+ and lineage negative cells isolated myeloid 
populations of interest. The lineage in this antibody panel contained CD3, CD19, Ly6G, 
NKp46 and Sca-1 to exclude T cells, B cells, granulocytes, NK cells and HSCs, 
respectively. Considering CD45+ lineage negative cells in terms of KIT and CD115 
expression allowed the isolation of the populations of interest. Within the KIT+ CD115+ 
compartment were the MDP (lineage negative, KIT+ CD115+ CD11blow Ly6C-) and the 







Figure 3-3 BM monocyte and progenitor gating strategy 
Gating strategy for selecting BM monocytes and their progenitors by gating on CD45+ lineage 
(CD3 CD19 NKp46 Sca-1 Ly6G) negative cells and selecting either KIT CD115+ for the MDP 
(light blue) and cMoP (orange) or KIT- CD115+ for BM monocytes: Ly6C+ MHC II- (purple) 
Ly6Cint MHC II+ BM (green) and Ly6Clow MHC II- (red). 
 
BM monocytes were identified as KIT- CD115+ CD11b+. All three monocyte subsets 
that were identified in the blood were also found in the BM (Figure 3-3). BM 
monocytes were previously described as pro-monocytes (Shand et al., 2014) as they 
were shown to be proliferating, but considered by others as mature monocytes 
(Hettinger et al., 2013; Yona et al., 2013) because they lack KIT (also known as c-KIT 
or CD117) expression. In this thesis, they will be referred to as BM monocytes but their 
precursor potential shall be further investigated.  
3.2.2.2 Bone marrow myeloid population characterisation 
To further characterise the BM myeloid populations, expression levels of CX3CR1 and 
NR4A1 were assessed using GFP reporter mice. The MDP and the cMoP express 
intermediate levels of CX3CR1 and low levels of NR4A1 (Figure 3-4). As in the blood, 
expression of both CX3CR1GFP and NR4A1GFP increased as Ly6C expression reduced 
among the three BM monocyte subsets. Thus, Ly6Clow monocytes express the highest 



































Figure 3-4 Characterisation of BM monocyte progenitors and BM monocytes 
Expression of CX3CR1GFP and NR4A1GFP (white histograms) in BM myeloid progenitors and 
BM monocytes compared to GFP-negative controls (grey histograms). Expression of CD11c 
and Flt3 (white histograms) compared to isotype controls (grey histograms). 
 
 
BM Ly6C+ monocytes were not found to express CD11c or Flt3, whereas the Ly6Clow 
monocytes express CD11c and the Ly6Cint MHC II+ subset expresses both CD11c and 
Flt3, showing a very similar expression pattern to the blood monocyte subsets (Figure 
3-4). 
Interestingly, within the BM lineage negative Ly6Clow CD11b+ compartment, a second 
cell population could be identified that expressed high levels of GFP in NR4A1GFP 
animals as well as high GFP expression in CX3CR1GFP animals, in a very similar 
manner to Ly6Clow MHC II- monocytes (Figure 3-5a and 3-5b). However, this 
population did not express high levels of the monocyte marker CD115. Backgating 
analysis demonstrated that this population has very similar forward and side scatter 
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Figure 3-5 Identification and characterisation of a Ly6Clow CD11b+ CD115low myeloid 
population 
(A) Gating strategy to identify Ly6Clow CD11b+ CD115low population (blue) and Ly6Clow BM 
monocytes (red). (B) Expression of CX3CR1GFP (top) and NR4A1GFP (bottom) in both Ly6Clow 
CD11b+ CD115low (blue) and Ly6Clow BM monocytes (red). (C) Backgating analysis of BM 
monocytes and Ly6Clow CD11b+ CD115low population. (D) Analysis and quantification of 
Ly6low CD11b+ CD115low (blue) and Ly6Clow BM monocytes (red) in Rag2-/- Il2rg-/- animals n=3 
per genotype, symbols represent individual animals (E) RT-qPCR analysis of CD115 (Csf1r) in 
sorted Ly6low CD11b+ CD115low (blue) and Ly6Clow BM monocytes, n=6, symbols represent 
individual animals, error bars represent standard deviation (SD). 
 
This population was found to be present in normal numbers in Rag2-/- Il2rg-/- animals 
indicating it develops independently of Il2rg (Figure 3-5d). In addition, RT-qPCR 
analysis carried out on FACS sorted cells from this compartment revealed similar 
CD115 mRNA levels in both the NR4A1bright CD115low novel population and in the 
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All together, these data demonstrate the presence of an Il2rg-independent CX3CR1bright 
NR4A1bright Ly6Clow CD11b+ bona fide myeloid population that only expresses CD115 
at the mRNA level. As this population was novel and potentially related to Ly6Clow 
monocytes, it was included in all further analysis carried out in this thesis and 
henceforth referred to as CD11b+ CD115low cells. 
3.2.3 Dynamics of blood and bone marrow subsets 
3.2.3.1 Proliferation rates of monocytes and their precursors in vivo 
To understand the dynamics of BM myeloid progenitors, as well as BM and blood 
monocytes in wild type animals under steady state conditions, it was necessary to assess 
what proportion of each population was actively cycling at a single time point. Staining 
with the nuclear dye 4',6-diamidino-2-phenylindole (DAPI) allows measurement of 
DNA content, revealing the percentage of cells in G0/G1 (2N) vs S phase (>2N<4N) vs. 
G2M (4N) (Pozarowski and Darzynkiewicz, 2004). All cells in G0/G1 phases have 
uniform DNA content that can be set to 50,000 DAPI fluorescence (2N) and cells in 
G2M should have exactly twice this much (4N DAPI fluorescence = 100,000) (Figure 3-
6a and b). However, in reality, there is some variation in the spread of cells representing 
2N DNA content. This variation can be measured when DAPI fluorescence is 
represented as a histogram and width of the G0/G1 peak is measured (coefficient of 
variation, CV). The CV is a direct reflection of the accuracy of DNA measurement, thus 
to ensure maximal accuracy, only samples with DAPI CV of <6% were considered. 
Using DAPI in conjunction with Ki-67, a marker expressed during the active phases of 
the cell cycle (G1, S and G2M phases) but not resting cells (G0) (Challen et al., 2009), it 
is possible to determine what proportion of a population is in a particular phase of cell 




Figure 3-6 Cell cycle analysis  
The phase of cell cycle a cell is in can be ascertained by staining with Ki-67 and DAPI (A).  
Representative dot plots of cell cycle analysis gating from a Ki-67 isotype control staining (left) 
and Ki-67 antibody staining (right) from C57BL/6 BM (B). (C) Representative dot plots of Ki-
67 and DAPI staining of monocyte subsets from the BM (top panel) and blood (lower panel) in 
C57BL/6 mice. 
 
This analysis revealed that the MDP was highly active with 36.03±3.68% (±standard 
deviation, SD) in S+G2M phases and 87.81±1.53% of the MDP compartment was 
positive for Ki-67. The cMoP was similarly found to be highly active with 46.5±9.13% 
of cells in S+G2M phases and with 87.67±3.09% of the cMoP population expressing Ki-






































BM Ly6C+ monocytes were also still actively cycling despite loss of KIT expression 
with 15.85±1.83% of the population in S+G2M phases and more than 76.65±5.55% Ki-
67+ (Figure 3-6c and 3-7a). Thus, these data confirmed the observations of Shand et al., 
who referred to BM Ly6C+ monocytes as “pro-monocytes” after demonstrating their 
proliferation using Fucci mice (Shand et al., 2014). 
 The Ly6Cint MHC II+ BM monocyte population showed an intermediate phenotype 
with 46.83±7.38% of the compartment quiescent (Ki-67- and 2N DNA content) and 
6.68±1.83% of the population actively cycling in S+G2M phase (Figure 3-6c and 3-7a).  
In contrast, the majority of BM Ly6Clow MHC II- monocytes were quiescent with 
91.62±2.94% of the population lacking expression of Ki-67 and having 2N DNA 
content and only 1±0.27% of the Ly6Clow MHC II- BM compartment was actively 
cycling (Figure 3-6c and 3-7b).  
Interestingly, the CD11b+ CD115low population was also mostly quiescent with 
70.37±7.96% of the population in G0 and this population only had slightly more cells 
actively cycling (3±1.1%) in G2M. Whilst this is a very small proportion of the 
population, it could be indicative of a slowly proliferating population that might 






Figure 3-7: Cell cycle analysis of blood and BM monocytes and their progenitors  
(A) Frequency of BM monocyte progenitors and BM Ly6C+ and Ly6Cint MHC II+ monocytes in 
cell cycle phases G0 (2N Ki-67-), G1 (2N Ki-67+) and S+G2M (>2N Ki-67+) n=6 (B) Percentage 
of BM CD11b+ Ly6Clow cells and Ly6Clow MHC II- BM monocytes in G0, G1 and S+G2M, n=6 
(C) Percentage of blood monocytes in G0, G1 and S+G2M, n=3. Symbols represent individual 
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As expected, cells were observed to be in G0 or G1 phase in blood monocyte subsets. 
Interestingly, 91.24±4.76% of the Ly6C+ monocyte subset was positive for Ki-67 
whereas in the blood Ly6Clow MHC II- monocyte compartment only around 
16.54±0.77% of the population still expressed Ki-67 (Figure 3-6c and 3-7c). This is 
could be due to Ly6Clow MHC II- monocytes being out of active cell cycle for long 
enough to down regulate Ki-67 expression. But whether this is a reflection of their 
longer half-life (Yona et al., 2013) or because they are further differentiated remains to 
be clarified. In contrast, Ly6C+ monocytes have a short life span, and having recently 
finished cycling, it is possible that they have not yet lost expression of Ki-67. 
3.2.3.2 Half-lives of monocytes and their progenitors/precursors 
Whilst the “snapshot” measurement of a single time point that Ki-67 and DAPI analysis 
provides, it does not inform on cell cycle kinetics, and in particular, the length of time 
different populations remain in each phase of the cell cycle. In order to evaluate the 
dynamics and establish half-lives of monocyte progenitors and the three separate 
monocyte subsets, both in the blood and BM, a pulse-chase labelling protocol was used. 
Wild type mice were pulsed with the synthetic nucleoside, 5’-bromo-2’-deoxyuridine 
(BrdU) which, as an analogue of the pyrimidine deoxy-nucleoside thymidine, is 
permanently incorporated into DNA of actively dividing cells. This was followed by a 
chase to examine rate of BrdU dilution over time, either by subsequent cell divisions 
during the chase phase or by death of labelled daughter cells. 
As proliferation in blood monocytes was undetectable using Ki-67 and DAPI (Figure 3-
6c and 3-7c) (Shand et al., 2014), time-lapse analysis of blood monocyte BrdU content 
following a single pulse should allow to measure their rate of production and their half-
life in vivo (Yona et al., 2013). C57BL/6 wild type mice were given a single dose of 
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1.5mg BrdU by intraperitoneal (i.p.) injection. Blood and BM were analysed for BrdU 
incorporation in the different myeloid subsets at regular intervals from 1-hour post-
injection through to 240-hours post-injection (10 days), with three animals per time 
point.  
Visually, it can be seen from the graphs in Figure 3-8 that Ly6Clow MHC II- monocytes, 
both in the BM and the blood, have a much slower rate of BrdU incorporation and 
subsequent loss of BrdU signal (decay) compared to the other subsets analysed. The 
MDP, the cMoP and the Ly6C expressing monocyte populations appear to follow a 
similar pattern of incorporation and rapid decay of BrdU signal consistent with a short 






Figure 3-8: BrdU incorporation in monocytes and their progenitors from wild type mice  
BrdU incorporation after 1.5mg i.p. injection. (A) Frequency of BrdU+ cells among MDP (left, 
light blue) and cMoP (right, orange) (B) Frequency of BrdU+ cells among Ly6C+ monocyte 
populations in the BM (left, purple) and blood (right, pink). (C) Frequency of BrdU+ cells 
among Ly6Cint MHC II+ cells in the BM (left, green) and blood (right, turquoise) (D) BrdU 
incorporation within the BM (left, red) and blood (right, burgundy) Ly6Clow monocytes 
populations (E) BM Ly6Clow CD11b+ CD115low cells BrdU incorporation; n=3 mice per time 
point, error bars represent standard deviation. 
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Fitting exponential trend lines from the peak of BrdU incorporation and measuring the 
rate of decay provides an estimation of half-life. The results indicated that the steady 
state half-life the MDP was 39.99 hours or 1.7 days (r2 = 0.94), the half-life of the cMoP 
was similar at 35.67 hours or 1.49 days (r2 = 0.90). Interestingly, the steady state half-
life of the BM Ly6C+ monocyte was much shorter at 13.81 hours or 0.58 days (r2 = 
0.98) and similarly, blood Ly6C+ monocytes were calculated to have a half-life of 12.31 
hours or 0.51 days (r2 = 0.95). The Ly6Cint MHC II+ BM monocytes were found to have 
a slightly longer half-life of 18.79 hours or 0.78 days (r2 = 0.98) and the corresponding 
MHC II+ blood population had a half-life of 16.38 hours or 0.68 days (r2 = 0.94).  
In stark contrast, BM Ly6Clow MHC II- monocytes were calculated as having a half-life 
of 80.6 hours or 3.36 days (r2 = 0.91) and in the blood the Ly6Clow monocyte half-life 
was 77.21 hours or 3.2 days (r2 = 0.88), 6 times longer than that of blood Ly6C+ 
monocyte subset (Figure 3-8). The half-life of Ly6Clow MHC II- monocytes was 
therefore found to be longer than previously calculated (Yona et al., 2013). A possible 
explanation for this could be the separation of MHC II+ monocytes from the Ly6Clow 
compartment, as MHC II+ monocytes have a shorter half-life and their kinetic seems to 
be much more closely related to the kinetic of the Ly6C+ subset. Furthermore, 
investigating the BrdU incorporation of the BM Ly6Clow CD11b+ population revealed 
this population also has a long half-life of 66.41 hours or 2.8 days (r2 = 0.89). Again, 
this lends support to the conjecture that this population may be related to BM Ly6Clow 
MHC II- monocytes and is worthy of continued investigation.  
The kinetics of BrdU incorporation and loss for each blood monocyte subset was very 
similar to its corresponding BM counterpart albeit with a slight delay, validating the 




These data demonstrate a very different kinetic for Ly6Clow MHC II- monocytes, both in 
the BM and in the blood, compared to Ly6C+ monocytes. This prompted further probing 
into the interrelationships of monocyte subsets using genetic models. 
 Overview and Discussion 3.3
3.3.1 Rationale for considering three monocyte subsets 
Traditionally, murine monocytes are divided into two subsets based on expression of 
Ly6C and CX3CR1 (Geissmann et al., 2003; Gordon and Taylor, 2005; Yona et al., 
2013) although the presence of intermediate populations has previously been alluded to 
(Carlin et al., 2013; Jakubzick et al., 2013; Sunderkotter et al., 2004). Flow cytometry 
analysis of monocyte subsets including MHC II as a marker allows the separation of a 
third, minor monocyte population.  
Monocytes expressing intermediate levels of Ly6C have been considered representative 
of the transition or maturation of Ly6C+ monocytes into Ly6Clow however; the 
expression of MHC II on this subset does not fit comfortably with this interpretation. 
The expression of MHC II could be indicative of activation or of unique effector 
functions for this subset. Both possibilities require investigation to fully understand 
whether or not this is monocyte differentiation/maturation from Ly6C+ or Ly6Clow 
MHC II- monocytes or a fully separate subset. However, the additional heterogeneity 
inferred by the presence of a third, phenotypically distinct subset might explain the 
conflicting reports regarding monocyte interrelationships. 
3.3.2 Bone marrow monocytes and their progenitors 
All three monocytes can be identified in the BM, which could indicate that monocyte 
subsets differentiate in the BM before their egress to the periphery. Furthermore blood 
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monocyte BrdU incorporation mirrored bone monocyte incorporation with a slight 
delay, which suggests BM origin of all three subsets.  
This interpretation is in contrast to previous reports which suggest that BM and blood 
Ly6Clow monocytes are independent. Yona et al., demonstrated that BrdU incorporation 
into Ly6Clow monocytes was reduced after treatment with a Ly6C+ monocyte ablation 
strategy using the CCR2 antibody, MC21 (Bruhl et al., 2007; Yona et al., 2013). MC21 
depletes blood Ly6C+ monocytes but not Ly6C+ BM monocytes, in line with Ly6C+ 
monocytes dependency on CCR2 for their BM egress. Treatment with MC21 was found 
to reduce BrdU incorporation in the blood Ly6Clow monocytes but not in the BM 
Ly6Clow monocytes which indicated that Ly6C+ monocytes controlled development of 
Ly6Clow monocytes in both the blood and BM.  
In light of data presented here of increased monocyte heterogeneity, in both the blood 
and BM, a new hypothesis was developed in which Ly6C+ monocytes give rise to MHC 
II+ monocytes in both the blood and BM whereas Ly6Clow MHC II- monocytes develop 
independently in the BM via a CD11b+ CD115low intermediate before egressing to the 
periphery. This hypothesis will be explored and interrogated further in the next chapter 














 Introduction, aims and objectives 4.1
 Genetics of Monocyte development in mice 4.2
There are several known mutations that affect the development of monocytes. Mice 
deficient in Csf1r (also called c-fms, M-Csfr or CD115) have a severe reduction in blood 
monocytes (Dai et al., 2002). Furthermore, animals that are deficient in Csf1, a ligand of 
Csf1r, are also deficient in blood monocytes (Kodama et al., 1991; Wiktor-Jedrzejczak 
and Gordon, 1996).  
Adult monocytes arise from BM haematopoietic stem cells, which have to pass through 
various stages of commitment before they mature to blood circulating monocytes. It is 
known that at several of these commitment steps, the Ets family transcription factor, 
PU.1 is required as PU.1 can induce commitment to the myeloid lineage in HSCs 
(Mossadegh-Keller et al., 2013) and in immature multi-potent progenitors (Nerlov and 
Graf, 1998). These genetic requirements occur early in cell fate decisions and commit 
cells to the myeloid lineage.  
Of particular interest to this thesis is the analysis of different genetic mouse models in 
which monocyte subsets show differing genetic requirements. This chapter will focus 
mainly on the nuclear receptor Nr4a1, an ideal example of a selective genetic 
requirement in monocyte development.  
Nr4a1 belongs to a family of orphan nuclear receptors, known as the NR4A-subfamily. 
This subfamily consists of three members: NR4A1 (also known as Nur77, TR3 and 
NGFI-B), NR4A2 (also known as Nurr1) and NR4A3 (also known as NOR-1). These 
receptors are considered “orphan” as they have no known ligands.  
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Nr4a1 is known to act as a transcription factor, directly binding to DNA either as a 
monomer or as a homodimer (Kurakula et al., 2014). Nr4a1 can also form heterodimers 
with retinoid X receptors (RXRs) and has been shown to interact with both RXRα and 
RXRγ (Kurakula et al., 2014; Roszer et al., 2013). Thus, Nr4a1 has the capacity to 
influence gene expression in multiple ways, many of which remain to be elucidated. As 
a consequence, Nr4a1 has been implicated in many different biological processes 
including cell survival, proliferation and apoptosis in a vast array of cell types, both 
haematopoietic and non-haematopoietic.  
This chapter will focus on understanding the differentiation pathway of Ly6Clow MHC 
II- monocytes in light of the heterogeneity described in Chapter 3, using a variety of 
genetic models to facilitate unravelling the intricacies of monocyte development. In 
particular, this chapter and the next will fully characterise a novel conditional Nr4a1-
knock out model developed for this project, Csf1riCre Nr4a1fl/fl animals, which confines 
Nr4a1 deletion to the haematopoietic compartment thus minimising the possibility that 
the loss of Ly6Clow MHC II- monocytes observed in Nr4a1-/- mice is due to deletion of 
Nr4a1 in stromal cells. 
  Nr4a1 and Ly6Clow MHC II- monocyte development 4.3
The current model of Ly6Clow monocyte development proposes that blood Ly6C+ 
classical monocytes undergo a maturation or “conversion” step into Ly6Clow monocytes 
(Hettinger et al., 2013; Sunderkotter et al., 2004; Varol et al., 2007; Yona et al., 2013; 
Yrlid et al., 2006). However, there are a number of genetic studies that are in conflict 
with this model of Ly6Clow monocyte development. It has been reported that Ly6Clow 
monocytes can develop in the absence of Ly6C+ monocytes in Irf8-deficient and Klf4-
deficient mice (Alder et al., 2008; Kurotaki et al., 2013). Furthermore, Hanna et al., 
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demonstrated Ly6Clow monocyte differentiation and/or survival is dependent upon the 
transcription factor Nr4a1, whereas Ly6C+ monocytes are found at normal frequencies 
in Nr4a1-deficient mice (Hanna et al., 2011). 
In this chapter, the development of Ly6Clow MHC II- monocytes is systematically 
analysed using a number of genetic models, in particular Csf1riCre Nr4a1fl/fl, in order to 
understand the development pathway of Ly6Clow MHC II- monocytes and their 
relationship with Ly6C-expressing monocyte subsets by investigating Irf8- and Ccr2-
deficient animal models. 
4.3.1 Hypothesis and aims 
Chapter 4 objective: To dissect the genetic requirements of blood and BM monocyte 
subsets using different gene knock out models.  
The aims of this chapter are as follows: 
1. To assess expression of NR4A1GFP in haematopoietic and non-haematopoietic 
populations;  
2. To analyse the effects of Nr4a1-deficiency in Csf1riCre Nr4a1fl/fl conditional 
deletion animals and in Nr4a1GFP Nr4a1-/- double mutant animals; 
3. To extend the analysis of monocyte subsets to other genetic ablation models 
including Irf8-/- and Ccr2-/-. 
4. To gain further understanding of Ly6Clow MHC II- monocyte development using 
adoptive transfer and in vitro culture systems.  
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  The role of Nr4a1 in Ly6Clow MHC II- monocyte 4.4
development 
4.4.1  Characterisation of NR4A1GFP expression 
The pattern of NR4A1GFP expression in a BAC transgenic mouse line was shown to be 
consistent with endogenous NR4A1 expression (Moran et al., 2011), was used to 
analyse NR4A1 expression in blood, BM and tissue myeloid cells. 
To start, NR4A1GFP in haematopoietic stem cells in the BM was analysed. Lineage 
(CD3, CD4, CD8, CD11b, CD19, Gr1) negative Sca-1+ KIT+ long term HSCs (LT-
HSCs; CD150+ CD48-), short term HSCs (ST-HSCs; CD150- CD48-) and multipotent 






Figure 4-1 NR4A1GFP expression in HSCs, lymphocytes, granulocytes, dendritic cells and 
splenic macrophages  
(A) NR4A1 is expressed by LT-HSCs, ST-HSCs and MPPs, white histograms represent GFP+ 
animals, and grey histograms represent GFP- littermate controls. (B) NR4A1GFP is highly 
expressed by part of the CD11b+ CD115low population (blue) and by Ly6Clow MHC II- BM 
monocytes (red). (C) T cells, B cells, NK cells, and cDC subsets express NR4A1GFP whereas 
granulocytes, PDCs and F4/80bright macrophages do not, white histograms represent GFP+ 




























































As previously discussed in Chapter 3, later BM progenitors, the MDP, cMoP, BM 
monocyte subsets and CD115low cells all express NR4A1GFP  (See Chapter 3 section 
3.2.2.2 and Figure 3-4). A proportion of the newly identified KIT- CD11b+ CD115low 
population expresses NR4A1GFP very brightly, and to the same level as Ly6Clow MHC 
II- monocytes (Figure 4-1b). 
In the blood, T cells, B cells and NK cells express NR4A1 (Figure 4-1c), as do all three 
monocyte populations (Figure 3.2) however, PMNs do not (Figure 4-1c). In the spleen, 
both CD11b- and CD11b+ subsets of cDCs express NR4A1GFP however; plasmacytoid 
dendritic cells (PDCs) and F4/80bright splenic macrophages do not (Figure 4-1c). 
In order to characterise NR4A1GFP expression by tissue resident macrophages and 
myeloid cells within the tissues, brain, liver and lung were analysed by flow cytometry. 
As expected, classical, F4/80bright tissue resident macrophages in the brain, liver and 
lung did not express NR4A1GFP (Figure 4-2). However, some tissue F4/80int CD11b+ 
populations did express NR4A1 in the liver and lung (Figure 4-2b and 4-2d). As the 
mice were not perfused prior to excision of tissues, it is likely that these NR4A1-
expressing cells within the tissue are monocytes and other circulating leukocytes from 
within the tissue capillary network. 
In addition, the skin from NR4A1GFP reporter mice was analysed. Epidermal sheets 
were taken for immunofluorescence and both dermis and epidermis were analysed by 
flow cytometry. Immunofluorescence staining and confocal imaging of the epidermis 
revealed widespread NR4A1GFP expression. Flow cytometry analysis confirmed that 
keratinocytes (CD45- CD104+), Langerhans cells (F4/80bright) and epidermal T cells 
(CD3+) all expressed NR4A1GFP (Figure 4-2e). Furthermore, in the dermis, both dermal 





Figure 4-2 NR4A1GFP expression in tissue cells  
(A) NR4A1GFP expression in brain F4/80bright macrophages (1) and microglia (2). (B) NR4A1GFP 
expression in liver F4/80bright Kupffer cells (1) and liver myeloid cells (2 and 3). (C) NR4A1GFP 
expression in alveolar macrophages (1) and lung eosinophils (2). (D) NR4A1GFP expression in 
lung CD11b+ Siglec F- lung myeloid cells. (E) NR4A1GFP expression in epidermal 
haematopoietic and non-haematopoietic cells by immunofluorescence (left) and flow cytometry 
(right). (F) NR4A1GFP expression in dermal macrophages and non-haematopoietic cells. White 











































































4.4.2 Characterisation of Csf1riCre as a driver for conditional Nr4a1 
deletion 
As discussed above, and previously widely reported, many different haematopoietic and 
non-haematopoietic cell types express Nr4a1 (see above) (Davis and Puhl, 2011; Lee et 
al., 1995; Winoto and Littman, 2002). In addition, the Nr4a1-null mice were generated 
by the insertion of a phosphoglycerate kinase-neomycin resistance cassette (neo 
cassette) into the coding region of exon 2 of the Nr4a1 gene (Lee et al., 1995). This neo 
cassette has not been excised from the genome of Nr4a1-/- animals, which may perturb 
expression of neighbouring genes (Meier et al., 2010; Pham et al., 1996; Rijli et al., 
1994).  
Furthermore, in the study by Hanna et al., identifying the role of Nr4a1 in Ly6Clow 
monocyte development, a statistically significant increase in granulocytes in Nr4a1-null 
mice, which may suggest an inflammatory phenotype (Hanna et al., 2011; Hanna et al., 
2012). Thus, a cleaner, more targeted knockout system would be preferable to study the 
role of Nr4a1 in monocyte development.  
In order to generate such an improved model, to analyse the role of Nr4a1 in the 
development of Ly6Clow MHC II- and Ly6Cint MHC II+ monocytes, this study took 
advantage of the Cre-lox system. To generate conditional Nr4a1-knock out animals, 
mice harbouring the Cre recombinase under the control of the promoter for Csf1r (also 
known as CD115, c-fms or M-csfr) (Deng et al., 2010) were crossed to mice in which 
exons 2 and 4 of the Nr4a1 gene (on chromosome 15) had been flanked by loxP sites 
(see Figure 2-2) (Boudreaux et al., 2012; Kadkhodaei et al., 2009).  
In mature cells, CSF1R (CD115) expression is primarily restricted to monocytes and 
macrophages, although low-level expression on neutrophils has been reported (Sasmono 
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et al., 2007). Furthermore, the common dendritic cell progenitor (CDP) is defined, in 
part, by its expression of CSF1R. Consequently, it was important to ascertain where the 
Csf1riCre was active and which cells would be targeted by this approach. Thus, Csf1riCre 
mice were crossed to Rosa26LSLYFP reporter mice. In these animals, any cell that 
expresses Csf1r and its progeny will have the lox-STOP-lox sequence excised and YFP 
will be expressed. HSCs and myeloid BM progenitors from Csf1riCre RosaYFP were 
analysed by flow cytometry (Figure 4-3).  
 
Figure 4-3 Assessment of Csf1riCre activity using Rosa26LSLYFP reporter  
(A) Csf1riCre activity in haematopoietic stem cell populations, white histograms represent iCre+ 
animals, grey histograms represent iCre- littermate controls. (B) Quantification of proportion 
YFP+ HSCs, monocyte progenitors and in CD45+ lineage+ cells from Csf1riCre YFP+ animals, n=3 
for each genotype. 
 
It can be seen that 50% of LT-HSC have had the LSL sequence excised and express 
YFP and at the stage of MPP’s 75% of cells are YFP positive. The MDP, cMoP and 
consequently all downstream progeny including BM monocytes are all >90% YFP 
positive. In addition, CD45+ lineage positive cells (including CD3 CD19 and NKp46) 
were also >90% YFP+, providing an approximation of Csf1riCre mediated recombination 



































highly efficient and effective resulting in pan-haematopoietic expression of Cre 
recombinase and consequently could also lead to pan-haematopoietic deletion of Nr4a1. 
In order to validate the potential for efficient pan-haematopoietic deletion at the Nr4a1 
locus mediated by Csf1riCre in the Nr4a1fl/fl model, a blood sample was taken from Csf1r 
Nr4a1fl/+ (heterozygous, iCre-); Csf1r Nr4a1fl/fl (homozygous, iCre-); Csf1riCre Nr4a1∆ /+ 
(heterozygous, iCre+) and Csf1riCre Nr4a1∆/∆ (homozygous, iCre+) littermates and an 
allele-specific PCR was carried out on this blood to assess deletion (Figure 4-4a). In this 
PCR, (detailed in Chapter 2: Materials and Methods) three primers are used to identify 
wild type DNA fragments (band at 215bp), the Nr4a1-floxed DNA fragments (band at 
300bp) and the Nr4a1-deleted (Δ) DNA fragments after recombination (band at 425bp). 
In whole blood, the deletion of Nr4a1fl/fl was efficient with no residual bands (wild type 
or floxed) visible in the blood from Csf1riCre animals (Figure 4-4a). 
This PCR was repeated on purified (FACS sorted) cell populations from Csf1riCre 
Nr4a1Δ/+, Csf1riCre Nr4a1Δ/Δ and Nr4a1fl/fl animals. Sorted splenic CD3+ T cells, CD19+ 
B cells (Figure 4-4b), CD11b+ and CD11b- cDCs, PDCA1+ pDCs, Ly6G+ granulocytes 
and Ly6C+ monocytes (Figure 4-4c) all show efficient deletion of the Nr4a1 gene with 
the only visible residual floxed band being present in pDCs, indicating incomplete 
recombination in this population. In addition, brain microglia and liver Kupffer cells 
were also sorted and analysed in the same manner, both populations show efficient 
deletion of the Nr4a1 gene (Figure 4-4c). Collectively these deletion PCR data 
demonstrate Csf1r is effective and efficient at driving pan-haematopoietic deletion of 
Nr4a1.  
In order to assess the level of deletion in haematopoietic vs. non-haematopoietic cells 
from within the same organ, epidermal Langerhans cells, CD3+ T cells and CD45- 
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CD104+ (integrinβ4) keratinocytes were FACS sorted and analysed using the same allele 
specific PCR. As shown in Figure 4-4d, Nr4a1 is deleted in the F4/80+ Langerhans cells 
and CD3+ T cells in the Nr4a1Δ/Δ animals, as indicated by the DNA fragment band at 
425bp whereas the CD45- CD104+ keratinocytes have the undeleted floxed band at 
300bp. These data confirm that Csf1riCre is a good driver of pan-haematopoietic Nr4a1 
deletion in this model and that Csf1riCre is not expressed sufficiently in CD45- CD104+ 





Figure 4-4 PCR analysis of Nr4a1 deletion by Csf1riCre  
Nr4a1 deletion in whole blood (A), sorted splenic T and B cells (B), sorted splenic dendritic cell 
subsets, Ly6G+ granulocytes, Ly6C+ monocytes, liver Kupffer cells and brain microglia (C). 
Nr4a1 deletion in non-haematopoietic and haematopoietic epidermal cell populations (D). 
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4.4.3 Characterisation of blood from Csf1riCre Nr4a1Δ/Δ mice 
In order to assess whether the Csf1riCre Nr4a1∆/∆ mice recapitulated the monocyte 
phenotype observed in the Nr4a1-/- mice (Hanna et al., 2011), littermates were blood 
phenotyped by flow cytometry.  
This analysis demonstrated Ly6Clow MHC II- monocytes are selectively, and almost 
completely, dependent upon Nr4a1 for their development, recapitulating the phenotype 
from the Nr4a1-/- mice in a separate genetic model (Figure 4-5a and 4-5b). Ly6C+ and 
Ly6Cint MHC II+ monocytes were unaffected by Nr4a1-deficiency in this model. This is 
in contrast to the previously reported trend towards a slight reduction of Ly6C+ 
monocytes in Nr4a1-null animals (Hanna et al., 2011). As Ly6Cint MHC II+ cells were 
unaffected by Nr4a1 deficiency (Figure 4-5a and 4-5b), it is likely that this population 
accounts for the residual cells within the Ly6Cint/Ly6Clow compartment observed in 
Nr4a1-/- mice (Hanna et al., 2011).  
Ly6Clow MHC II- monocytes were shown to exhibit a strong gene dose effect: Nr4a1+/Δ 
mice have a reduction of 75% (p<0.0001) compared with Nr4a1fl/fl littermate controls, 
and Nr4a1Δ/Δ animals have a 98% reduction (p<0.0001) in Ly6Clow MHC II- monocytes 
(Figure 4-5b).  
Analysis of Ly6Clow MHC II- monocytes from animals housed in conventional units 
compared to specific pathogen free (SPF) showed that conventional housing increased 
the number of Ly6Clow MHC II- monocytes in littermate controls but failed to do so in 
the Nr4a1Δ/Δ animals (Figure 4-5c). In addition, no differences in Ly6Clow MHC II- 
monocytes were observed between male (blue circles) and female (red circles) 








Figure 4-5 Analysis of blood granulocytes and monocytes from Csf1riCre Nr4a1fl/fl mice  
(A) Representative dot plots illustrating gating strategy of blood CD115+ monocyte subsets in 
Nr4a1Δ/Δ mice and littermates. (B) Number/µL blood of CD115+ monocytes in Nr4a1fl/fl (closed 
circles, n=12), Nr4a1Δ/+ (open triangles, n=9) and Nr4a1Δ/Δ mice (open circles, n=9). (C) 
Frequency of Ly6Clow MHC II- monocytes in Nr4a1Δ/Δ mice (open circles, n=20 males, n=13 
females) and littermates (closed circles, n=14 males, n=12 females) under conventional and SPF 
housing conditions and colour coded by sex (males=blue, females=red). Symbols represent 
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Figure 4-6 Blood analysis of Csf1riCre Nr4a1fl/fl littermates 
(A) Total red blood cell (RBC) and white blood cell (WBC) counts from Nr4a1+/fl (closed 
triangles, n=8), Nr4a1fl/fl (closed circles, n=17), Nr4a1+/Δ (open triangles, n=9) and Nr4a1Δ/Δ 
littermates (open circles, n=9). (B) Gating and frequency of Ly6G+ granulocytes in Nr4a1Δ/Δ 
(open circles, n=20 males, n=13 females) mice and littermates (closed circles, n=14 males, n=12 
females) under conventional and SPF housing conditions and by sex (males = blue circles, 
females = red circles). (C) Frequency of CD3+ T cells, CD19+ B cells and NKp46+ NK cells in 
Nr4a1Δ/Δ mice (open circles, n=8-14) and Nr4a1+/fl (closed triangles, n=8), Nr4a1fl/fl (closed 
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To confirm that the phenotype was selective for Ly6Clow MHC II- monocytes total red 
blood cell (RBC) counts and white blood cell (WBC) counts in unlysed blood were 
analysed revealing no significant differences between the four phenotypes (Figure 4-
6a). 
Flow cytometry analysis of Ly6G+ granulocytes demonstrated that these cells are 
unaffected by Csf1riCre mediated deletion of Nr4a1 (Figure 4-6b), in contrast to the 
reported increase observed in Nr4a1-null mice (Hanna et al., 2011). Thus, despite 
efficient deletion of the floxed alleles in granulocytes (Figure 4-4c) from Nr4a1∆/∆ 
animals, the frequency of granulocytes amongst WBC was unperturbed (Figure 4-6b). 
This may suggest that the reported increase in granulocyte frequency in Nr4a1-/- mice 
could be due to Nr4a1-deficiency in non-haematopoietic cells.  
To further confirm the specificity of Nr4a1-deficiency on Ly6Clow MHC II- monocytes 
and to ensure that other blood cells were not affected by this deletion, CD3+ T cells, 
CD19+ B cells and NKp46+ NK cells were analysed. There were no differences detected 
in the cell frequencies of these populations between Nr4a1fl/fl, Nr4a1+/Δ and Nr4a1∆/∆ 
littermates (Figure 4-6c).  
Extending this analysis to the spleen showed that Ly6Clow MHC II- monocytes were 
reduced in the spleen by 98% in Nr4a1Δ/Δ mice compared with littermate controls 
(Figure 4-7a and 4-7b). In contrast, all other spleen myeloid subsets were unaffected, 
including Ly6C+ and Ly6Cint MHC II+ monocyte subsets, conventional dendritic cell 





Figure 4-7 Splenic monocytes and DCs in Csf1riCre Nr4a1fl/fl mice  
(A) Representative dot plots of splenic monocyte populations from Nr4a1fl/fl and Nr4a1Δ/Δ 
littermates (B) Frequency of splenic monocyte subsets among CD45+ cells from Nr4a1fl/fl (n=6) 
and Nr4a1Δ/Δ (n=6) littermates. (C) Frequency of splenic DC subsets amongst CD45+ cells from 
Nr4a1fl/fl (n=5) and Nr4a1Δ/Δ (n=6) littermates. Symbols represent individual animals. Data 
analysed using unpaired t-test 
 
Together, these data confirmed and extend, using an independent genetic model, the 
dependency of Ly6Clow MHC II- monocytes on Nr4a1 for their development. The use of 
Ly6C combined with MHC II allows the division of the CD115+ monocyte 
compartment into three separate subsets, it can be seen that Ly6Clow MHC II- monocytes 
are almost completely absent in Nr4a1Δ/Δ and the residual cells that remained in the 
previous report (Hanna et al., 2011) can be accounted for by the MHC II+ fraction of the 
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demonstrate strong haploinsufficiency in animals with only one copy of Nr4a1 
(Nr4a1+/Δ). 
  Bone marrow analysis of Csf1riCre Nr4a1fl/fl mice 4.5
4.5.1 Bone marrow frequencies of monocytes and their progenitors 
The paper by Hanna et al., (Hanna et al., 2011) demonstrated that Ly6Clow monocyte 
development was arrested in the BM. In order to confirm and extend these observations 
using the Csf1riCre Nr4a1fl/fl model, BM monocyte subsets and their progenitors were 
systematically analysed. 
In line with the previously published data (Hanna et al., 2011), within the BM 
compartment, the MDP (KIT+ CX3CR1+ CD115+ Flt3 (CD135)+ Ly6C- cells) (Auffray et 
al., 2009a; Fogg et al., 2006; Liu et al., 2009; Varol et al., 2007) and the cMoP (KIT+ 
CX3CR1+ CD115+ Flt3 (CD135)- Ly6C+ cells) (Hettinger et al., 2013) were found in 
similar numbers in Nr4a1Δ/Δ and Nr4a1+/Δ when compared with Nr4a1fl/fl wild type 
littermate controls (Figure 4-8a).  
Analysis of the KIT- CD115+ compartment showed that Ly6C+ and Ly6Cint MHC II+ 
BM monocytes were present in in normal numbers in Nr4a1Δ/Δ and Nr4a1+/Δ when 
compared with Nr4a1fl/fl wild type littermate controls (Figure 4-8b and 4-8c). However, 
BM Ly6Clow MHC II- monocytes were markedly decreased by 72% in Nr4a1+/Δ 
(p=0.007) and by 94% in Nr4a1Δ/Δ (p<0.0001) compared to littermate controls (Figure 





Figure 4-8 Selective loss of BM Ly6Clow MHC II- monocytes in Csf1riCre Nr4a1fl/fl animals  
(A and B) MDP and cMoP (A), and BM monocyte (B) cell counts per hind limb from Nr4a1fl/fl 
(closed circles, n=5), Nr4a1fl/Δ (open triangles, n=3) and Nr4a1Δ/Δ (open circles, n=6). (C) 
Representative dot plots of BM monocyte subsets from Nr4a1fl/fl, Nr4a1fl/Δ and Nr4a1Δ/Δ animals. 
Symbols represent individual animals. Data analysed using unpaired t-test. 
 
As previously described in Chapter 3, this study had identified a new population of 
CD11b+ CD115low NR4A1+ cells within the Ly6Clow CD11b+ MHC II- CD115low BM 
compartment, thus the question arose as to whether this population is affected by Nr4a1 
deficiency. Accordingly, the lineage negative, KIT- Ly6Clow CD11b+ MHC II- CD115low 
compartment was analysed. In this compartment it can be seen that the CD115low 
population was decreased in the Nr4a1+/Δ animals by 44% (p=0.035) and by 67% in 
Nr4a1Δ/Δ (p=0.0004) (Figure 4-9), indicating a dependence on Nr4a1 for their 
development and/or maintenance.  
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Figure 4-9 Nr4a1-deficiency leads to reduction of Ly6Clow MHC II- CD11b+ CD115low BM 
cells  
(A) Representative dot plots showing Ly6Clow MHC II- CD11b+ KIT- populations in Nr4a1fl/fl, 
Nr4a1fl/Δ and Nr4a1Δ/Δ animals. (B) Number of cells per hind limb of CD11b+ CD115low (blue) 
and BM Ly6Clow MHC II- monocytes (red) from Nr4a1fl/fl (closed circles, n=5), Nr4a1fl/Δ (open 
triangles, n=3) and Nr4a1Δ/Δ (open circles, n=6) animals. Symbols represent individual animals. 
Statistical significance assessed using unpaired t-test. 
 
These data confirm that BM Ly6Clow MHC II- monocytes require Nr4a1 for their 
differentiation, in a gene dose dependent manner. In addition, the newly identified 
CD11b+ CD115low population of cells that express high levels of Nr4a1 were shown to 
exhibit similar dependency on Nr4a1 as Ly6Clow MHC II- monocytes for their 
development or survival. Thus, it was hypothesised that Nr4a1 deficiency may cause a 
differentiation or maturation blockade within this subset. 
4.5.2  Analysis of bone marrow monocytes and progenitors proliferation 
rates 
It was previously reported that Nr4a1-/- BM Ly6Clow monocytes were unable to progress 
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whether this cell cycle arrest could be seen in Nr4a1Δ/Δ compared with littermate 
controls. As shown before, Ki67/DAPI staining was used for cell cycle analysis.  
As expected, the MDP and cMoP compartments in the BM were highly actively 
proliferating with approximately a quarter of both MDP and cMoP populations were in 
S+G2M phases of cell cycle in Nr4a1Δ/Δ, Nr4a1+/Δ and wild type littermate controls 
(Figure 4-10a).  
 
Figure 4-10 Cell cycle analysis of MDP, cMoP and BM LyC-expressing monocytes  
(A) Frequency of cells in each cell cycle phase in monocyte progenitors MDP and cMoP. (B) 
Frequency of cells within each phase of cell cycle in BM Ly6C+ monocytes and BM Ly6Cint 
MHC II+ monocyte subsets from Nr4a1fl/fl (dark grey bars, closed circles, n=8), Nr4a1fl/Δ (light 
grey bars, open triangles, n=3) and Nr4a1Δ/Δ (white bars, open circles, n=10) littermates. 













































Moreover, in line with a previous report BM monocyte populations were also found to 
be proliferating (Shand et al., 2014). BM monocytes were found to be actively 
proliferating and no differences in proportion of the population in S+G2M phases were 
detected between Nr4a1Δ/Δ, Nr4a1+/Δ and Nr4a1fl/fl littermate controls (18.33%, 18.70% 
and 17.57% respectively) (Figure 4-10b). The Ly6Cint MHC II+ BM monocyte 
population was also found to be actively cycling and no differences were detected 
between genotypes with 6.68% vs. 6.42% vs. 7.91% in S+G2M phases in Nr4a1fl/fl, 
Nr4a1+/Δ and Nr4a1Δ/Δ respectively (Figure 4-10b).  
In contrast, analysis of the cell cycle profile of the CD11b+ CD115low population 
revealed a very small cycling proportion, 3.2% of cells in S+G2M, in wild type 
littermates. However, the percentage of cells in S+G2M doubled to 6.6% in Nr4a1Δ/+ 
and increased further to 19.5% in Nr4a1Δ/Δ animals (Figure 4-11a).  
In addition, a negligible 0.8% of Ly6Clow MHC II- BM monocytes were actively 
proliferating in wild type animals, which increased to 27% in the few remaining cells in 
Nr4a1Δ/Δ animals (Figure 4-11b). These data confirm the previous reports that BM 
monocytes are actively proliferating (Shand et al., 2014) and demonstrate that this 
proliferation is mostly attributable to Ly6C+ BM monocytes in wild type mice. 
However, in the absence of Nr4a1 Ly6Clow MHC II- monocytes exhibit increased 
proliferation (Figure 4-11b) confirming previously published data (Hanna et al., 2011). 
Nevertheless, it is clear from this genetic analysis and from the data presented in 
Chapter 3 that the vast majority of BM Ly6Clow MHC II- monocytes do not actively 




Figure 4-11 Cell cycle analysis within the Ly6Clow MHC II- CD11b+ BM compartment in 
Csf1riCre Nr4a1fl/fl animals  
(A) CD11b+ CD115low population cell cycle analysis. (B) Cell cycle analysis of Ly6Clow MHC 
II- BM monocytes from Nr4a1fl/fl (dark grey bars, closed circles, n=6), Nr4a1fl/Δ (light grey bars, 
open triangles, n=3) and Nr4a1Δ/Δ (white bars, open circles, n=7) littermates. Symbols represent 
individual animals. Statistical significance assessed using unpaired t-test. 
 
Thus, these data indicate that Nr4a1 deficiency is associated with increased 
proliferation in both Ly6Clow CD11b+ CD115low cells and Ly6Clow MHC II- monocyte 
BM populations (Figure 4-10a and b). Interestingly, the Ly6Clow CD11b+ CD115low 
population showed a slow turn over which drastically increase in Nr4a1∆/∆ mice, 
indicating a possible role as an intermediate population for Nr4a1-dependent Ly6Clow 
monocytes. 
4.5.3  Kinetic analysis of monocytes and their progenitors in Csf1riCre 
Nr4a1∆/∆ mice and littermates 
To confirm the increased proliferation of Ly6Clow MHC II- monocytes in Nr4a1Δ/Δ 
compared to their littermate controls and to gain insight into monocyte 
interrelationships in the absence of Nr4a1, the same BrdU pulse-chase methodology 
detailed in Chapter 3 was employed to complement the snapshot insight that Ki67/DAPI 
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injected with 1.5mg of BrdU and blood and BM were analysed at regular time points. In 
accordance with the cell cycle analysis, incorporation of BrdU in wild type littermate 
controls and Nr4a1Δ/Δ was identical in MDP, cMoP, BM Ly6C+ and BM Ly6Cint MHC 





Figure 4-12 BrdU incorporation in BM from Nr4a1fl/fl and Nr4a1Δ/Δ mice  
(A) Percentage of BrdU+ cells in MDP, cMoP, Ly6C+ and Ly6Cint BM monocyte compartments 
over time from Nr4a1fl/fl (closed circles) and Nr4a1Δ/Δ (open circles) animals. (B) Frequency of 
BrdU+ cells in BM Ly6Clow MHC II- monocytes and BM Ly6Clow MHC II- CD11b+ CD115low 
cells from Nr4a1fl/fl (closed circles) and Nr4a1Δ/Δ (open circles) animals. n=3 per genotype per 
time point, error bars represent SD. 
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In contrast, the few remaining Ly6Clow MHC II- BM monocytes in the Nr4a1Δ/Δ animals 
rapidly labelled – 80% BrdU+ Ly6Clow MHC II- monocytes were detected at 48 hours 
compared to 10% labelling in wild type animals at the same time point (Figure 4-12b). 
Similarly, incorporation by CD115low was increased four fold at 48 hours in Nr4a1Δ/Δ 
compared with littermate controls (80% versus 20%).  
 
Figure 4-13 Blood monocyte BrdU labelling  
(A) Frequency of BrdU+ Ly6C+ blood monocytes (left, n=3 mice per time point, error bars 
represent SD) and Ki-67/DAPI cell cycle analysis of Ly6C+ blood monocytes (right) from 
Nr4a1fl/fl (closed circles, n=3) and Nr4a1∆/∆ (open circles, n=3) littermates. (B) Frequency of 
BrdU+ Ly6Cint MHC II+ blood monocytes (left, n=3 mice per time point, error bars represent 
SD) and Ki-67/DAPI cell cycle analysis of Ly6Cint MHC II+ blood monocytes (right) from 
Nr4a1fl/fl (closed circles, n=3) and Nr4a1∆/∆ (open circles, n=3) littermates.  
 
Blood Ly6C+ monocytes are widely regarded as the obligate precursor to blood Ly6Clow 
monocytes (Sunderkotter et al., 2004; Varol et al., 2007; Yona et al., 2013), 
Blood Ly6C+ monocytes 
 
BrdU incorporation 
Blood Ly6Clow MHC II+ monocytes 
Blood Ly6Cint MHC II+ monocytes 
 
BrdU incorporation 








































































furthermore, it has been suggested that blood and BM Ly6Clow MHC II- monocyte 
compartments develop and are maintained independently of each other (Yona et al., 
2013). In light of these hypotheses it was reasoned that, in Nr4a1∆/∆ animals where the 
development of Ly6Clow MHC II- monocytes is defective in both the blood and the BM, 
there should be some perturbation in blood monocyte BrdU incorporation and/or cell 
cycle profile in Nr4a1∆/∆ compared to littermate controls. Thus, the blood from Nr4a1∆/∆ 
and littermate controls was analysed to assess BrdU incorporation and to assess 
Ki67/DAPI profile. It is not possible to compare Ly6Clow MHC II- blood monocytes 
from Nr4a1∆/∆ mice compared to littermates due to the absence of these cells in this 
model. However, Ly6C+ (Figure 4-13a) and Ly6Cint MHC II+ (Figure 4-13b) were 
analysed. No differences in BrdU incorporation were observed between Nr4a1∆/∆ mice 
and littermates indicating that BrdU+ Ly6C+ monocytes do not accumulate in the blood 
because they are unable to differentiate into blood Ly6Clow MHC II- monocytes. 
Furthermore, no differences in Ki-67/DAPI profile were observed in Nr4a1∆/∆ animals 
compared to littermate controls. Whilst it has already been noted that blood monocytes 
do not proliferate under homeostatic condition (Figure 3-7), this demonstrates that 
Nr4a1-deficiency does not induce Ly6C+ (or Ly6Cint MHC II+) blood monocytes to 
proliferate (Figure 4-13a).  
These data demonstrate that BrdU incorporation in the MDP, cMoP, and both BM and 
blood Ly6C+ and Ly6Cint MHC II+ monocytes are unaffected by Nr4a1-deficiency. The 
differentiation block that prevents the development of Ly6Clow MHC II- monocytes 
appears to be within the Ly6Clow MHC II- CD11b+ CD115low compartment. The cells 
within this compartment of Nr4a1-deficient animals are more actively cycling, as 
confirmed by two independent methodologies, but maturation of Ly6Clow MHC II- 
monocytes is blocked. Thus, it was reasoned that there must be increased apoptosis 
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within the Ly6Clow MHC II- CD11b+ CD115low compartment, otherwise an 
accumulation of cells would be observed. This reasoning prompted analysis of apoptotic 
particles within this compartment, defined as sub-2N (Pozarowski and Darzynkiewicz, 
2004). Within the BrdU incorporation experiment, cells were stained with the nuclear 
dye 7AAD, which allows the measurement of DNA content. Ly6Clow MHC II- CD11b+ 
CD115low cells were analysed for the proportion of events that were BrdU+ and sub-2N, 
as a measure of BrdU-labelled, apoptotic fragments during early time points (Figure 4-
14).  
 
Figure 4-14 Measurement of apoptotic events in Ly6Clow MHC II- CD11b+ CD115low 
compartment  
Linear acquisition of 7AAD allows quantification of apoptotic particles defined as sub-2N (left) 
and quantification of frequency of BrdU+ sub-2N particles from Nr4a1fl/fl (closed circles, n=3 
mice per time point) and Nr4a1∆/∆ (open circles, n=3 mice per time point). Error bars represent 
SD. 
 
Within the Ly6Clow MHC II- CD11b+ CD115low population there were considerably 
increased frequencies of BrdU+ sub-2N events in Nr4a1∆/∆ animals compared with 
littermate controls at 12 hours post-BrdU administration, demonstrating an increase in 






































Altogether, these data can be interpreted as an absolute requirement of Nr4a1 for 
Ly6Clow MHC II- monocyte maturation. Further, these data suggest that cells from 
Nr4a1-deficient mice undergo apoptosis within the BM during a maturation step from a 
Ly6Clow MHC II- CD11b+ CD115low NR4A1+ intermediate into BM Ly6Clow MHC II- 
CD115+ monocytes. Finally, these data indicate that blood Ly6Clow MHC II- monocytes 
are generated in the BM and not in the blood, as has previously been suggested and 
blood Ly6Clow MHC II- monocytes do not seem to be derived from blood Ly6C+ or 
Ly6Cint MHC II+ monocytes in the blood. 
 Nr4a1GFP Nr4a1-/- mice analysis 4.6
4.6.1 Rationale for creating double mutants 
One difficulty in analysing Ly6Clow MHC II- monocytes is the lack of specific, positive 
marker for which there is a good and reliable antibody. However, Ly6Clow MHC II- 
monocytes express very high levels of NR4A1GFP, considerably higher than other cell 
types (Figures 3-2, 3-4 and 4-2). Furthermore, this reporter strain was made by 
microinjection of a BAC (Moran et al., 2011) rather than being a knock-in (in which 
one copy of GFP allele replaces an endogenous allele for the gene of interest). This fact 
made it possible to cross Nr4a1GFP animals with Nr4a1-null animals (Lee et al., 1995) 
to generate double mutants: Nr4a1GFP Nr4a1-/- animals as well as Nr4a1GFP Nr4a1+/- 
and Nr4a1GFP Nr4a1+/+ controls. Thus, this model provided a tool to analyse BM and 
blood monocytes whilst using NR4A1GFP as a positive marker for Ly6Clow MHC II- 




4.6.2  Bone marrow analysis of Nr4a1GFP Nr4a1-/- animals 
As expected, analysis of the BM Ly6Clow MHC II- CD11b+ compartment in Nr4a1GFP 
Nr4a1+/+, Nr4a1GFP Nr4a1+/- and Nr4a1GFP Nr4a1-/- animals shows that the CD115+ 
Ly6Clow MHC II- BM monocytes are significantly reduced in the heterozygous animals 
compared with wild type and almost completely absent from Nr4a1GFP Nr4a1-/- 
littermates (Figure 4-15).  
Interestingly, the CD115low NR4A1bright cells are also reduced in the same manner, 
indeed the ratio of CD115+ cells to CD115low cells remains consistent at approximately 
70%:30% in heterozygous animals and wild type littermate controls, although the 
overall number of cells in heterozygous animals is significantly reduced (by 93%) when 




Figure 4-15 Analysis of Ly6Clow MHC II- CD11b+ compartment of Nr4a1GFP Nr4a1-/- 
animals and littermate controls.  
(A) Dot plot and histogram representations of Nr4a1GFP and CD115 expression in CD45+ Lin- 
Ly6Clow MHC II- CD11b+ BM cells from Nr4a1GFP Nr4a1+/+, Nr4a1GFP Nr4a1+/-, Nr4a1GFP 
Nr4a1-/- littermates. (B) Quantified as absolute cell counts/hind limb BM from Nr4a1GFP 
Nr4a1+/+ (closed squares, n=3), Nr4a1GFP Nr4a1+/- (open triangles, n=4), Nr4a1GFP Nr4a1-/- 
(open squares, n=4) littermates. Error bars represent SD, statistical significance determined 





























































This model allows the separation of Ly6Clow MHC II- CD11b+ CD115low NR4A1int   
from of Ly6Clow MHC II- CD11b+ CD115low NR4A1bright, providing a means to dissect 
Nr4a1-dependency within this compartment. The NR4A1int cells did not vary between 
Nr4a1GFP Nr4a1+/+, Nr4a1GFP Nr4a1+/- and Nr4a1GFP Nr4a1-/- littermates (Figure 4-15) 
and therefore can develop independently of NR4A1. This suggests that Ly6Clow MHC 
II- CD11b+ CD115low NR4A1int cells are not related to Ly6Clow MHC II- monocytes.  
This model has confirmed that the CD115low NR4A1bright BM population identified in 
this study behave in an identical manner to Ly6Clow MHC II- BM monocytes with 
regards to Nr4a1, both in terms of dependency and high level of expression of 
NR4A1GFP reporter. Taken together in conjunction with the apoptosis analysis (Figure 
4-14), the few remaining GFPbright cells that are found in the Ly6Clow MHC II- CD11b+ 
compartment of Nr4a1∆/∆ animals undergo apoptosis. 
Altogether these data provide a genetic basis, from two independent models, for the 
hypothesis that the Ly6Clow MHC II- monocyte maturation occurs in the BM and 
requires the transition through a CD115low Nr4a1-dependent intermediate before surface 
expression of CD115 is upregulated. Thus, it was important to demonstrate that the 
Ly6Clow MHC II- CD11b+ CD115low cells are capable of upregulating CD115. 
4.6.3 In vitro culture  
In order to assess whether the NR4A1bright CD11b+ CD115low population is capable of 
upregulating cell surface expression of CD115, this study resorted to an in vitro culture 
system. Ly6Clow MHC II- CD11b+ NR4A1int CD115low and Ly6Clow MHC II- CD11b+ 
NR4A1bright CD115low populations from NR4A1GFP (CD45.2 background) animals were 
FACS sorted. The sorted cells were cultured with unfractionated “feeder” BM cells 
from CD45.1 animals so that no cytokine was artificially added.  
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In the Ly6Clow MHC II- CD11b+ NR4A1int CD115low population (black circles, Figure 
4-16), expression of both CD115 and GFP remained at baseline low levels (Figure 4-
16). In contrast, Ly6Clow MHC II- CD11b+ NR4A1bright CD115low population (blue 
circles, Figure 4-16) had upregulated CD115 expression by 12 hours and by 48 hours in 
culture the whole population was CD115+, and importantly remained NR4A1bright 
throughout the experiment (Figure 4-16).  
 
Figure 4-16 in vitro culture of CD115low NR4A1GFP populations.  
Geometric mean fluorescence intensity of CD115 and NR4A1GFP of sorted Ly6Clow MHC II- 
CD11b+ CD115low NR4A1int (black) and NR4A1birght (blue) populations after in vitro culture for 
1, 12, 24 or 48 hours. Representative of two independent experiments, n=3 mice per 
experiment. Symbols represent average of duplicate wells; error bars represent SD. Statistical 
significance analysed using unpaired t-test. 
 
 
This in vitro culture experiment provides evidence that Ly6Clow CD11b+ NR4A1bright 
CD115low cells have the capacity to upregulate CD115 to the cell surface in vitro 
whereas the NR4A1int CD115low population do not.  
Altogether, these data indicate that the development of Ly6Clow CD11b+ NR4A1int 
CD115low cells is not affected by Nr4a1-deficiency nor can it upregulate NR4A1 or 
CD115 expression in this in vitro system. Thus making it unlikely that this population 
contributes to Ly6Clow MHC II- monocyte development. On the contrary, the 
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as Ly6Clow MHC II- monocytes and upregulates CD115 expression, thus becoming 
phenotypically identical to a bona fide Ly6Clow MHC II- monocyte in this in vitro 
system. 
Collectively, the in vitro data combined with the in vivo genetic dependency of this 
population on NR4A1, establish Ly6Clow CD11b+ NR4A1bright CD115low cells as a novel 
BM intermediate in the Ly6Clow MHC II- monocyte development pathway.  
  The effects of Ccr2- and Irf8- deficiency on Ly6Clow 4.7
monocytes 
4.7.1 Ccr2-deficency and Ly6Clow MHC II- monocytes 
4.7.1.1 Phenotypic analysis of CCR2-/- mice 
The requirement of Ly6C+ monocytes on CCR2 receptor signalling for their BM egress 
has been well documented (Serbina et al., 2008; Serbina and Pamer, 2006), whereas the 
effect of Ccr2-deficiency on Ly6Clow monocytes is less well defined. Thus, Ccr2-/- 
animals and littermate controls were analysed to evaluate the effect of Ccr2-deficiency 
on both Ly6Clow MHC II- and Ly6Cint MHC II+ monocyte subsets. 
As expected, Ly6C+ monocytes were dramatically reduced in the blood of Ccr2-/- mice 
by 73% (Figure 4-17a). Interestingly, Ly6Cint MHC II+ monocytes were also reduced, 
by 51%, in the blood of Ccr2-/- mice and this may indicate that they also require CCR2 
signalling to egress from the BM. In contrast, blood Ly6Clow MHC II- monocytes were 




Figure 4-17 CCR2-deficiency in blood and BM monocyte subsets.  
(A) Effect of CCR2-deficiency on blood monocyte subsets, closed diamond represent 
Ccr2+/+(n=5); open diamonds represent Ccr2-/- (n=8) littermates. (B-D) BM analysis from 
Ccr2+/+ (closed diamonds, n=4) and Ccr2-/- (open diamonds, n=4) littermates showing MDP and 
cMoP (B); BM monocyte subsets (C); and BM Ly6Clow MHC II- CD11b+ CD115low (blue) and 
BM Ly6Clow MHC II- monocytes (red) (D). Symbols represent individual animals. Statistical 
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Additionally, MDP and cMoP populations were unaffected by Ccr2-deficiency (Figure 
4-17b). Moreover, BM Ly6C+ monocytes were only slightly, and not significantly, 
increased in Ccr2-deficient animals as expected for steady state conditions (Tsou et al., 
2007). Interestingly, the Ly6Cint MHC II+ BM monocyte subset showed significant 
accumulation under steady state conditions in the BM (Figure 4-17b), suggesting that 
Ly6Cint MHC II+ also require CCR2 signalling for their BM egress and that this 
population could represent a differentiation/maturation of Ly6C+ monocytes. Consistent 
with their blood phenotype, BM Ly6Clow MHC II- monocytes were also unaltered in 
Ccr2-deficient animals (Figure 4-17c). 
4.7.1.2 BrdU incorporation by Ccr2-deficient mice and littermates 
Blocking of CCR2 with the antibody MC21, ablates blood Ly6C+ monocytes (Bruhl et 
al., 2007) but not BM Ly6C+ monocytes (Yona et al., 2013).  It was demonstrated that 
administration of MC21 reduces BrdU labelling of blood Ly6Clow monocytes, thought 
to be due to the ablation of blood BrdU-labelled, Ccr2-expressing Ly6C+ monocytes 
(Yona et al., 2013). BM Ly6C+ monocytes are unaffected by MC21 and it was observed 
that BrdU labelling in the BM compartment was unaffected by MC21 treatment in 
either Ly6C+ or Ly6Clow monocyte subsets (Yona et al., 2013). However, the 
identification of a third monocyte subset with similar a requirement for CCR2-
signalling to mediate it’s BM egress as classical Ly6C+ monocytes prompted the 
reassessment of precursor-product relationships using BrdU incorporation in the context 
of CCR2 deficiency. As a consequence of the variability of Ly6C expression with the 
MHC II+ monocyte population, a proportion of these cells will fall into the gating of 
Ly6Clow monocytes when MHC II is not used as a marker, and be included in the 
analysis of Ly6Clow monocytes. Thus, the separation out of the MHC II+ cells can 
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provide new insights into the precursor-product relationships between monocyte 
subsets. 
It was hypothesised that analysis of BrdU incorporation into monocyte subsets from 
Ccr2-/- animals and littermate controls should demonstrate whether Ly6C+ blood 
monocytes are the obligate precursor of Nr4a1-dependent Ly6Clow MHC II- monocytes. 
If blood Ly6Clow MHC II- monocytes arise from blood Ly6C+ monocytes, it was 
hypothesised that there would be a delay in blood Ly6Clow MHC II- monocyte BrdU 
labelling to reflect considerably reduced Ly6C+ blood monocyte population. In contrast, 




Figure 4-18 BrdU incorporation in Ccr2-/- animals and littermate controls.  
(A-D) Frequency of BrdU+ monocytes and progenitors from Ccr2+/+ animals (closed diamonds) 
and Ccr2-/- (open diamonds) littermates in (A) MDP and cMoP; (B) BM (left) and blood (right) 
Ly6C+ monocytes; (C) BM (left) and blood (right) Ly6Cint MHC II+ monocytes; (D) BM (left) 
and blood (right) Ly6Clow MHC II- monocytes, n=3 mice per time point, error bars represent 
SD. Statistical significance assessed by unpaired t-test.  
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There were no differences observed in BrdU labelling between Ccr2+/+ and Ccr2-/- 
littermates in the MDP and cMoP (Figure 4-18a), BM and blood Ly6C+ monocytes 
(Figure 4-18b), BM and blood Ly6Cint MHC II+ monocytes (Figure 4-18c) or BM and 
blood Ly6Clow MHC II- monocytes. Indeed, Figure 4-18 demonstrates that, despite the 
reduction of Ly6C+ and Ly6Cint MHC II+ monocytes in the blood of Ccr2-deficient 
mice, the same proportion of each population is BrdU-labelled in Ccr2-/- animals as in 
wild type animals. These data fit with the notion that Ccr2-deficiency is an impairment 
of Ly6C+ monocyte mobilisation rather than an inherent developmental impairment.  
Furthermore, Ly6Clow MHC II- monocyte BrdU incorporation in the blood and BM was 
unaffected by Ccr2-deficiency and the predicted delay in Ly6Clow MHC II- blood 
monocyte labelling was not observed. These data further support the contention that 
Ly6Clow MHC II- monocytes develop in the BM and that their development is 
independent of blood Ly6C+ monocytes. However, as is demonstrated in Figure 4-17a, a 
small proportion of Ly6C+ monocytes do egress from the BM to the blood in Ccr2-
deficient mice, thus an alternative interpretation of these results could be that these 
Ccr2-independent Ly6C+ monocytes give rise to blood Ly6Clow MHC II- monocytes. To 
investigate these two possibilities further, characterisation of blood and BM monocyte 
subsets in Irf8-deficient animals was carried out. 
4.7.2 Irf8-deficiency and Ly6Clow MHC II- monocytes 
It has been reported that Irf8-/- animals lack Ly6C+ monocytes while Ly6Clow MHC II- 
monocytes remain, albeit at a lower frequency (Kurotaki et al., 2013). In light of the 
increased heterogeneity within the monocyte compartment established in this thesis, it 
was hypothesised that the reported reduction in Ly6Clow MHC II- monocytes was due to 
a reduction in Ly6Cint MHC II+ monocytes. 
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Analysis of blood monocyte subsets from Irf8-deficient mice and wild type controls 
revealed that blood Ly6Clow MHC II- monocytes were found at normal frequencies, 
unaffected by this deficiency (Figure 4-19a). In contrast, Ly6C+ were almost completely 
absent in the blood of Irf8-/- animals. Furthermore, Ly6Cint MHC II+ monocytes were 
also significantly decreased (Figure 4-19a). 
Interestingly, the BM CD115+ KIT+ compartment, containing the MDP and the cMoP 
populations was greatly expanded (Figure 4-19b). This was in stark contrast to the BM 
CD115+ KIT- compartment containing BM monocytes, which was dramatically reduced. 
This reduction was attributable to Ly6C+ BM monocytes, which were reduced by 95%. 
This suggests a differentiation block in the monocyte development pathway at the point 
of MDP/cMoP. Whilst it has previously been described that Irf8 is critical for monocyte 
development (Kurotaki et al., 2013), these data identify the point at which Irf8 is critical 





Figure 4-19 Irf8-deficiency in blood and BM monocytes and BM progenitors.  
(A) Representative dot plots and quantification of blood monocyte frequency from C57BL/6 
(closed circles, n=6) and Irf8-/- (open circles, n=6) animals. (B-C) Representative dot plots and 
quantification of BM cells per hind limb from C57BL/6 (closed circles, n=6) and Irf8-/- (open 
circles, n=6) animals of MDP and cMoP (B) and BM monocyte subsets (C). Statistical 















































































































In contrast, Ly6Clow MHC II- BM monocytes were unaffected by Irf8 deficiency (Figure 
4-19c and Figure 4-20), nor were CD11b+ CD115low cells (Figure 4-20). Thus, 
confirming Ly6Clow MHC II- monocytes and their proposed intermediate, the CD11b+ 
CD115low population, develop independently of IRF8. 
 
 
Figure 4-20 Irf8 deficiency does not affect Ly6Clow MHC II- BM monocytes or CD11b+ 
CD115low cells.  
Representative dot plots and quantification of Ly6Clow MHC II- CD11b+ compartment (number 
of cells per hind limb) from Irf8-/- animals (open circles, n=6) and C57BL/6 controls (closed 















































Collectively, these analyses of three separate genetic models indicate a shared 
dependency on Irf8 and Ccr2 for Ly6C+ and Ly6Cint MHC II+ monocyte populations for 
their development into blood circulating cells. Conversely, Ly6Clow MHC II- monocytes 
develop normally in Irf8- and Ccr2-deficient animals but are selectively and completely 
dependent upon Nr4a1. 
Interestingly, the Ly6C+ BM monocyte dependency upon Irf8 is not absolute and 
approximately 5% of BM Ly6C+ monocytes can develop independently of Irf8 whereas 
blood Ly6C+ monocytes are almost completely absent (reduced by 99%) (Figure 4-19a 
and c). This raises the question of what happens to this remaining Ly6C+ BM monocyte 
fraction that appears to be Irf8-independent?  
  Relative compartment size 4.8
To enable side-by-side comparison of the divergent genetic requirements of monocyte 
subsets in the BM and blood, the relative compartment size of each population of wild 
type, Irf8-/-, Ccr2-/- and Nr4a1∆/∆ mice was represented graphically. The absolute cell 
numbers in each population were measured by flow cytometry (method for obtaining 
absolute cell counts described in Chapter 2, Materials and Methods). For BM 
populations, the BM from two hind limbs (femur and tibia, no iliac crest) was counted, 
analysed and considered to represent 20% of total BM cellularity (Colvin et al., 2004; 
Colvin et al., 2000; Lambert et al., 2000).  
For blood populations, the total number of white blood cells per µl was obtained using a 
haemocytometer and the number of monocytes per µl was calculated from the flow 
cytometry data (as described in Chapter 2). Total blood volume was estimated at 80µl/g 
body weight, which for a 25g C57BL/6 mouse is 2ml total blood volume (Harkness and 
Wagner, 1995; Mitruka and Rawnsley, 1981). Using these calculations, it was possible 
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to extrapolate the average total number of cells within each compartment per animal. 
Each population was then represented as an area using the following formula 
(http://www.1728.org/diam.htm): 
Area of a circle = πr2 where r=1 is equivalent to 1x106 cells 
Figure 4-19 shows the graphical representation of the size of each population using the 
calculations outlined above where surface area is proportional to cell numbers in 
C57BL/6 wild type mice, Irf8-/-, Nr4a1Δ/Δ and Ccr2-/- mice. This graphical 
representation provides an interesting insight into the compartment sizes.  
 
Figure 4-21 Relative compartment size of monocyte populations and their progenitors in 



















































Visualising compartment size in this manner highlights that the BM Ly6Clow MHC II- 
population is considerably smaller than its blood counterpart in wild type animals, Irf8-
deficient and Ccr2-deficient mice. This is in line with the long half-life calculated for 
Ly6Clow MHC II- monocytes (see Figure 3-7d) (Yona et al., 2013). Thus, if blood 
Ly6Clow MHC II- monocytes are replenished by BM Ly6Clow MHC II- monocytes, it 
would logically follow that only a small number of cells is required for this 
replenishment.  
Furthermore, this analysis reveals that the BM Ly6C+ population is disproportionately 
large in wild type animals, significantly larger than their blood counterpart. This 
potentially suggests that the BM Ly6C+ population may be a more complicated, as yet 
uncharacterised, heterogeneous population rather than simply the mature Ly6C+ BM 
monocyte counterpart but may be a precursor population in its own right. This 
observation led to the hypothesis that the possibility that the 5% of BM Ly6C+ 
monocytes that remain in Irf8-deficient mice could potentially be a precursor population 
for Ly6Clow MHC II- monocytes. In turn, this raises the question of where the 
NR4A1bright CD11b+ CD115low population fits into the development pathway of Ly6Clow 
MHC II- monocytes. 
 
  Adoptive transfer 4.9
In order to assess the potential of Ly6C+ BM and blood monocytes to generate Ly6Clow 
MHC II- NR4A1bright monocytes, BM and blood Ly6C+ monocytes from Nr4a1GFP 
Nr4a1+/+ and from Nr4a1GFP Nr4a1-/- were adoptively transferred into non-irradiated, 
CD45.1 congenic animals. BM Ly6C+ monocytes transferred from Nr4a1GFP Nr4a1+/+ 
animals were found to give rise to CD115+ NR4A1bright Ly6Clow MHC II- monocytes in 
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the blood and spleen of CD45.1 congenic mice 3.5 days post transfer (Figure 4-22a). In 
addition, in the spleen a proportion of the NR4A1bright cells had low expression levels of 
CD115. These data to demonstrate the maturation process of Ly6Clow MHC II- 
monocytes from BM Ly6C+ monocytes via a CD115low intermediate in vivo, although 
one consideration in interpreting these data must be that the CD115low NR4A1bright 
population have not been observed in the spleens of wild type mice. However, these 
experiments involved the artificial transfer of BM cells directly into the blood stream, 
thus it is feasible that immature cells home to the spleen in order to complete their 
maturation process.  
In contrast, Ly6C+ BM monocytes from Nr4a1GFP Nr4a1-/- were unable to generate 
Ly6Clow MHC II- NR4A1bright cells (Figure 4-22a). In addition, neither Nr4a1GFP 
Nr4a1+/+ nor Nr4a1GFP Nr4a1-/- Ly6C+ blood monocytes were capable of giving rise to 
“true” NR4A1bright Ly6Clow MHC II- monocytes (Figure 4-22b). 
Whilst adoptive transfer is an inefficient system, these data clearly demonstrate in the 
absence of ionising radiation, Ly6C+ BM monocytes are capable of giving rise to 





Figure 4-22 Adoptive transfer of BM and blood Ly6C+ monocytes from Nr4a1GFP Nr4a1+/+ 
and Nr4a1GFP Nr4a1-/- littermates.  
(A) Analysis of blood and spleen from CD45.1 mice 3.5 days after adoptive transfer of BM 
Ly6C+ monocytes from Nr4a1GFP Nr4a1+/+ and Nr4a1GFP Nr4a1-/- littermates. (B) Analysis of 
blood and spleen from CD45.1 mice 3.5 days after adoptive transfer of blood Ly6C+ monocytes 





































































Interestingly, some donor CD45.2+ Ly6Clow MHC II- cells that could be seen in the 
blood and spleen of animals transferred with blood Ly6C+ monocytes from both 
Nr4a1GFP Nr4a1+/+ and Nr4a1GFP Nr4a1-/-. However, these cells were very few and did 
not express the characteristically high levels of NR4A1GFP expected of true Ly6Clow 
MHC II- monocytes and therefore could not be considered as such.  
 Overview and Discussion 4.10
4.10.1 Nr4a1 as a genetic tool for understanding Ly6Clow MHC II- 
monocytes 
The data presented in this chapter confirm and extend the previously published data that 
Ly6Clow MHC II- monocytes are selectively dependent upon the transcription factor 
Nr4a1 for their development (Hanna et al., 2011). Furthermore, Ly6Clow MHC II- 
monocytes express Nr4a1GFP at an appreciably higher level than other monocyte 
subsets, lymphocytes, dendritic cells, or tissue macrophages. Thus, Nr4a1GFP is a 
marker that enables clearer identification of bona fide Ly6Clow MHC II- patrolling 
monocytes separate from Ly6C+ or Ly6Cint MHC II+ monocytes better than was 
possible with Cx3cr1GFP transgenic animals. Furthermore, the double mutant Nr4a1GFP 
Nr4a1-/- animals provide a critical tool for analysing the genetic dependency of Ly6Clow 
MHC II- monocytes on Nr4a1 for their development in conjunction with a specific 
reporter signal for this subset. 
Using Nr4a1 transgenic and knockout animals as tools for understanding Ly6Clow MHC 
II- monocytes has provided evidence of a population of NR4A1bright CD115low cells 
within the Ly6Clow CD11b+ BM compartment that shares the same dependency for 
development on Nr4a1. Further more the data presented here indicate that this 
population is a developmental intermediate of BM Ly6Clow MHC II- monocytes.  
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4.10.2 Genetic evidence for increased monocyte heterogeneity  
The data presented here have provided genetic evidence for a third, previously 
uncharacterised MHC II+ monocyte subset. Using Ccr2- and Irf8-deficient in alongside 
Nr4a1∆/∆ animals has demonstrated that this Ly6Cint MHC II+ develops independently of 
Nr4a1 expression. As the expression of Ly6C in this subset is variable, ranging from 
Ly6C+ to Ly6Clow, it has been previously included in the analysis of both the classical 
and patrolling monocyte subsets, which is likely to account for the conflicting theories 
of Ly6Clow monocyte development. Analysis of the genetic models here clearly 
demonstrates that Ly6Cint MHC II+ monocytes are dependent upon Irf8 for their 
development and Ccr2 for their BM egress, whereas they develop normally in the 
absence of Nr4a1. These genetic requirements mirror those of Ly6C+ monocytes, which 
indicate that Ly6C+ and Ly6Cint MHC II+ monocytes are part of a single development 
pathway. In contrast, Ly6Clow MHC II- are absolutely dependent upon Nr4a1 for their 
development but independent of Irf8 and do not require Ccr2 to mediate their BM 
egress, demonstrating a distinct developmental lineage. Furthermore, this study has 
demonstrated that the point at which Ly6Clow MHC II- monocytes diverge from Ly6C+ 
and Ly6Cint MHC II+ is at the point of BM Ly6C+ monocytes.  
4.10.3 A new proposal for Ly6Clow MHC II- monocyte development 
The data presented here show that the BM Ly6C+ monocyte population is actively 
proliferating and can give rise to all three blood monocyte subsets, demonstrating that 
these cells represent a bona fide BM precursor population, and not equivalent to mature 
blood Ly6C+ monocytes. Thus, based on these data the model of monocyte 
development can be updated, and this study demonstrates that all three monocyte 
subsets are generated in the BM, arising from the BM Ly6C+ monocyte subset before 
egress to the periphery. Thus, we propose that BM Ly6C+ monocytes be renamed 
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“common pro-monocyte” to reflect their precursor potential to give rise to at least three 
separate blood monocyte subsets. 
Furthermore, this study demonstrates the presence of a slowly proliferating, BM KIT- 
Ly6Clow CD11b+ CD115low NR4A1bright population and establishes it as the transitional 















  Introduction, aims and objectives 5.1
5.1.1  Ly6Clow monocytes as a potential steady state precursor for tissue 
macrophages 
Over the last few years, there has been an enormous paradigm shift in our understanding 
of the development of tissue resident macrophage (TRM) populations. The basis of the 
MPS was data from inflammatory and irradiation chimera models, demonstrating that 
monocytes give rise to tissue resident macrophages (Ebert and Florey, 1939; van Furth 
et al., 1972). However, it is now understood that macrophages arise in the steady state 
from yolk sac derived precursors (Schulz et al., 2012; Yona et al., 2013). However, this 
understanding raised questions of replenishment by HSC-derived cells or self-
maintenance TRM populations by proliferation in the steady state.  
Ly6Clow monocytes have often been considered the blood-circulating precursor for 
tissue resident “M2” type macrophages (Auffray et al., 2009b; Geissmann et al., 2003). 
Early work into monocyte heterogeneity described the different migratory behaviours of 
monocyte subsets and suggested that Ly6Clow monocytes may be the precursors to 
certain TRM populations (Geissmann et al., 2003). However, with more recent 
appreciation of the yolk sac origin of macrophages, this hypothesis has not been borne 
out. An additional layer of confusion has been the use Ly6C as a marker for 
distinguishing macrophage subsets, with the assumption that Ly6C+ macrophages 
arising from Ly6C+ monocytes and likewise Ly6C- macrophages arising from Ly6C- 
monocytes. Several studies have shown this assumption does not stand up to 
experimental scrutiny (Hilgendorf et al., 2014; Varga et al., 2013). However, it remains 
to be confirmed whether Ly6Clow monocytes contribute to adult tissue resident 
macrophage populations in the steady state. As mounting evidence demonstrates, the 
maintenance of TRM populations is varied (Bain et al., 2014; Chorro et al., 2009; 
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Davies et al., 2011). It has been reported previously that Ly6Clow monocytes contribute 
to tissue macrophages/ DCs in tissues such as the lung and gut (Jakubzick et al., 2008; 
Landsman et al., 2007; Yrlid et al., 2006). 
5.1.1.1 Hypothesis and aims 
Chapter 5 objective: to address whether Ly6Clow monocytes represent a blood-
circulating progenitor for tissue myeloid populations. It was hypothesised that using the 
conditional Nr4a1-deletion model that selectively lacks Ly6Clow monocytes would 
enable assessment of their contribution to tissue myeloid conditions in steady state. 
Furthermore, this model would avoid the inflammatory phenotype associated with 
stromal deletion of Nr4a1 (Chao et al., 2013; Hanna et al., 2011).  
The aims of this chapter are as follows 
1. To systematically analyse the contribution of Nr4a1-dependent Ly6Clow MHC II- 
monocytes to tissue resident macrophage populations in adult mice under steady 
state conditions;  
2. To investigate the contribution of yolk sac derived macrophages and HSC 
derived macrophages in the thymic and peritoneal macrophage populations 
 Ly6Clow MHC II- monocytes do not contribute to tissue 5.2
macrophage homeostasis 
To systematically assess the contribution of Nr4a1-dependent Ly6Clow MHC II- 
monocytes to extravascular pools of myeloid cells in the steady state, the lung, liver, 
brain and skin from hematopoietic-specific Csf1riCre Nr4a1Δ/Δ mice and their wild-type 
Csf1riCre Nr4a1+/+ littermates were analysed (all gating strategies can be found in 
Appendix 1). It was hypothesised that any macrophage populations to which Ly6Clow 
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MHC II- monocytes contributed would be reduced in an animal model that selectively 
lacked circulating Ly6Clow MHC II- monocytes. 
 
Figure 5-1 Tissue resident myeloid populations in brain, lung, liver and skin.  
(A-D) Frequencies of myeloid and macrophage populations in the brain (A), lung (B), liver (C) 
and dermal macrophages (D) amongst CD45+ cells and (E) Epidermal Langerhans cells and 
CD3+ T cells from Nr4a1fl/fl (closed circles) and Nr4a1∆/∆ (open circles) littermates.  
 
 
There were no significant differences were detected in frequencies of macrophages and 
myeloid populations amongst CD45+ (haematopoietic) cells in the brain, lung, liver or 
skin (Figure 5-1). This included alveolar macrophages a population to which it has been 
suggested that Ly6Clow MHC II- monocytes may contribute (Landsman et al., 2007) 
(Figure 5-1).  
It has been shown in the gut, that circulating monocytes constantly replenish the gut 
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whether Ly6Clow MHC II- monocytes contribute to this replenishment. Furthermore, it 
has been suggested that Ly6Clow monocytes contribute to a proportion of intestinal 
lymph DCs (Yrlid et al., 2006). Consequently, the myeloid populations from the small 
intestine and the colon lamina propria were analysed (Figure 5-2). 
 
Figure 5-2 Gut myeloid populations from Nr4a1 Δ/Δ mice and littermates 
(A-B) Small intestine frequencies of macrophages, granulocytic and monocytic populations (A) 
and dendritic cell subsets (B); Colon frequencies of macrophages, granulocytic and monocytic 
populations (C) and dendritic cell subsets (D) from Nr4a1fl/fl (closed circles) and Nr4a1∆/∆ (open 




Gut myeloid cells, including macrophages, granulocytic populations, monocytic cells 
and DCs are not affected by a lack of circulating Ly6Clow MHC II- monocytes or 














































































































populations do not require Nr4a1 for their development nor do they rely on 
contributions from Ly6Clow MHC II- monocytes in the steady state confirming that the 
continual replenishment of gut macrophages is a result of differentiation of Ly6C+ 
monocytes and with no contribution from Ly6Clow MHC II- monocyte subset (Bain et 
al., 2014). 
5.2.1  Secondary lymphoid tissue macrophage populations 
5.2.1.1 Splenic macrophage populations 
Secondary lymphoid structures have highly defined organised structures. The spleen is 
the largest secondary lymphoid organ structurally similar to lymph nodes except the 
spleen lacks high endothelial venules. The spleen structured around the branches of the 
splenic artery, which open out into venous sinusoids, surrounded by a layer of lymphoid 
tissue consisting of B cell follicles and T cell zones (den Haan and Kraal, 2012). The 
highly structured organisation of the spleen enables functionally discrete niches within 
one organ and different macrophage subpopulations can be identified associated with 
specific anatomical niches (den Haan and Kraal, 2012; MacLennan, 1994; Mebius and 
Kraal, 2005; Taylor et al., 2005). 
In order to assess whether Nr4a1-deficiency affected tissue resident macrophage 
populations found in the spleen two complimentary methods of analysis were utilised. 
Red pulp macrophages (RPM) defined as F4/80bright CD11blow, were analysed by flow 
cytometry (Figure 5-3a and b). This population is established prenatally (Schulz et al., 
2012; Yona et al., 2013), their principal function is to phagocytose aged erythrocytes as 
they move through the red pulp (den Haan and Kraal, 2012), was found to be unaffected 
by Nr4a1-deficiency (Figure 5-3a).  
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To assess marginal zone macrophages and metallophilic macrophages in addition to 
checking that the splenic microarchitecture was also unaffected by Nr4a1-deficiency, in 
situ immunofluorescent staining was carried out.  
Marginal zone macrophages were defined by their expression of macrophage receptor 
with collagenous structure (MARCO) and metallophilic macrophages, defined by their 
expression of MOMA1 (CD169). Both marginal zone and metallophilic macrophages 
function to capture blood borne antigens passing through the spleen (Davies et al., 
2013a; den Haan and Kraal, 2012; Mebius and Kraal, 2005). Immunofluorescent 
staining demonstrated that the splenic microarchitecture remained intact and that neither 
marginal zone nor metallophilic macrophage populations were altered in Nr4a1-




Figure 5-3 Splenic macrophage populations in Nr4a1fl/fl and Nr4a1∆/∆ littermates 
(A and B) Flow cytometry analysis of F4/80bright CD11blow splenic macrophages from Nr4a1fl/fl 
(closed circles, n=7) and Nr4a1∆/∆ (open circles, n=7). (C) Immunofluorescence staining of 
splenic cryosections shows splenic microarchitecture. (D) MARCO+ and MOMA1+ populations 
quantified by integrated density. Scale bar = 50µm. Symbols represent individual animals, 
closed circles represent Nr4a1fl/fl mice (n=4), open circles represent Nr4a1∆/∆ mice (n=4). 
Statistical significance as assessed using unpaired t-test. 
 
 
5.2.1.2 Lymph node macrophage populations 
As mentioned above, lymph nodes (LN) are highly organised structures and studies 
using both in situ staining and flow cytometry have revealed several different 
macrophage subsets (Gray and Cyster, 2012; Phan et al., 2009; Phan et al., 2007). These 
macrophage subpopulations can be divided into medullary (CD169+ F4/80+) 















































macrophages were analysed by flow cytometry from Nr4a1∆/∆ animals and littermate 
controls as were LN dendritic cell populations (Figure 5-4). 
 
Figure 5-4 LN macrophage and dendritic cell populations  
(A) Medullary (CD169+ F4/80+) and subcapsular (CD169+ F4/80-) macrophages from Nr4a1fl/fl 
(closed circles, n=5) and Nr4a1∆/∆ (open circles, n=6) littermates were analysed and quantified 
by flow cytometry. (B) LN DC populations from Nr4a1fl/fl (closed circles, n=6) and Nr4a1∆/∆ 
(open circles, n=6) littermates were analysed and quantified by flow cytometry. Symbols 
represent individual animals. Statistical significance was tested using unpaired t-test. 
 
Thus it can be seen that neither medullary CD169+ F4/80+ nor subcapsular CD169+ 
F4/80- macrophages were affected by Nr4a1-deficiency. LN DCs were similarly 
unaffected by the mutation. These data further demonstrate that Ly6Clow MHC II- 














































  Thymic macrophage populations 5.3
5.3.1  A novel macrophage population is reduced in the thymus of 
Nr4a1Δ/Δ animals 
Nr4a1 has been widely investigated in terms of progenitor thymocytes and T cell 
antigen receptor (TCR) engagement in the thymus (Cheng et al., 1997; Lee et al., 1995; 
Sekiya et al., 2013). Indeed, Nr4a family members have been shown to have essential 
roles in regulatory T cell development (Sekiya et al., 2013). , Thymic macrophages have 
a vital role in the phagocytosis of apoptotic thymocytes during positive and negative T 
cell selection in the thymus (Esashi et al., 2003; Odaka and Mizuochi, 2002; Surh and 
Sprent, 1994). Although some level of functional redundancy between Nr4a family 
members during this process of T cell education has been reported (Sekiya et al., 2013), 
it is not known whether Nr4a1-deficiency would impact the phenotype of specific 
macrophage populations. Thus, it was important to investigate whether a lack Ly6Clow 
monocytes, or lack of haematopoietic Nr4a1, altered any of the thymic myeloid 
populations.  
Within the F4/80+ TIM4+ CD64+ macrophage compartment of the thymus, two separate 
populations could be isolated: classical F4/80bright CD11b+ thymic macrophage 
populations and a novel F4/80+ CD11b- population (Figure 5-5a). This novel population 
was reduced by 45% in Nr4a1Δ/Δ animals compared with wild type littermate controls 
(Figure 5-5b). Thymic dendritic cell subsets were also analysed and found to be 




Figure 5-5 Thymic macrophage and dendritic cell populations  
(A-B) Representative dot plots (A) of thymic macrophages from Nr4a1fl/fl (closed circles) and 
Nr4a1∆/∆ (open circles) mice: (1) F4/80bright CD11b+ classical macrophages and (2) F4/80+ 
CD11b- macrophages and quantification (B). (C) Thymic dendritic cells from Nr4a1fl/fl (closed 
circles) and Nr4a1∆/∆ (open circles) mice. 
 
The role of this novel macrophage population was investigated thoroughly by 
collaborators (Tacke et al., 2015), thus this project focused on investigating the origin of 
this population.  
5.3.1.1 Are thymic macrophages yolk sac or bone marrow derived? 
As the reduction of the F4/80+ CD11b- thymic population was 45% compared with 
littermates, it seemed unlikely that Ly6Clow monocytes act as progenitor cells for this 












































































this model uses Csf1riCre to delete Nr4a1, which is expressed by both YS- and HSC-
derived macrophages (Gomez Perdiguero et al., 2015; Schulz et al., 2012), it does not 
rule out either yolk sac or BM origins for this population.  
First, it was assessed whether this population expressed Nr4a1 using NR4A1GFP reporter 
mice. As can be seen in the top panel of Figure 5-6a, F4/80bright macrophages did not 
express NR4A1GFP and the F4/80+ CD11b- population only expressed very low levels of 
NR4A1GFP. In addition, Csf1riCre Rosa26YFP reporter mice were analysed as a proxy for 
analysing deletion. It was confirmed that Csf1riCre expression is sufficient to mediate 
recombination at the Rosa26 locus in both of these macrophage populations (Figure 5-
6a). Whilst it cannot be assumed that recombination by Csf1riCre at the Nr4a1 locus is 
equal to that at the Rosa26 locus, this data demonstrates that Csf1riCre is expressed and 




Figure 5-6 Fate mapping thymic macrophage populations  
(A) Expression of Nr4a1GFP (top) and Csf1riCre RosaYFP (bottom) by thymic macrophage 
populations. (B) Frequency of Flt3Cre RosaYFP+ cells in thymic macrophage populations over 
time from weaning to 40 weeks of age. (C) Frequency of Flt3Cre RosaYFP+ HSCs at 40 weeks; 
n=3-6 in each age group, error bars represent SD. 
 
In order to the ascertain whether thymic macrophage populations are the progeny of YS 
or HSC progenitors, thymic macrophage populations from Flt3Cre Rosa26YFP reporter 
mice were assessed.  Flt3Cre Rosa26YFP reporter mice labels foetal liver and adult HSC 
derived MPPs (Christensen and Weissman, 2001; Gomez Perdiguero et al., 2015; 
Schulz et al., 2012) and their progeny. (Full Flt3Cre Rosa26YFP fate mapping of HSCs is 




















































This facilitates lineage tracing of BM derived populations therefore thymic macrophage 
populations were analysed from this reporter strain at 3, 8, 12, 16, 24 and 40 weeks of 
age. In dark grey bars of Figure 5-6b show the percentage of Flt3YFP+ in F4/80bright 
CD11b+ macrophages. At three weeks of age, 27% (±3% SD) of this population 
expresses YFP, indicating that only 27% of this population is HSC derived and the 
remaining 70% of the population develops independently of Flt3. The most likely 
interpretation of this data is that the majority of F4/80bright CD11b+ macrophages are 
yolk sac derived. Over time, the frequency of YFP+ cells in this population gradually 
increases over time, reaching around 64% (±2% SD) at 40 weeks suggesting 
contribution from HSCs over time. However, the frequency of YFP+ cells in the 
F4/80bright CD11b+ macrophage population has not quite equilibrated with MPPs (74% 
(±6% SD) YFP+, Figure 5-6c) 40 weeks of age. In contrast, the F4/80+ CD11b- thymic 
macrophage population does equilibrate with the MPPs by 12 weeks, suggesting that in 
adulthood, this population is principally made up of BM derived cells.  
Collectively, these data demonstrate the presence of a novel macrophage subset within 
the thymus that is partially dependent up Nr4a1 for its development. Furthermore, these 
data indicate the dual origins of macrophage populations within the thymus. The Flt3 
labelling allows lineage tracing of populations that are of HSC origin and demonstrates 
that by 12 weeks of age, this novel F4/80+ CD11b- population consists mainly of HSC 




 Peritoneal macrophages 5.4
5.4.1 Characterisation of peritoneal macrophage populations 
The peritoneal cavity is used extensively to study macrophage populations due to the 
abundance of macrophages in this compartment, their relative ease of isolation and the 
large influx of inflammatory cells when this compartment is challenged. Furthermore, it 
has been demonstrated that there are two distinct macrophage populations within the 
peritoneal cavity: large peritoneal macrophages (LPM) and small peritoneal 
macrophages (SPM) (Ghosn et al., 2010). LPM are defined as F4/80bright CD11b+ MHC 
IIlow cells whereas SPM are defined as F4/80+ CD11b+ MHC II+ (Ghosn et al., 2010). 
Additionally, it is thought that the in the context of inflammation, the SPM is monocyte-
derived pool of cells, making it an interesting macrophage pool to check for Ly6Clow 
MHC II- monocyte contribution.  
Initially to ensure that these peritoneal populations are indeed macrophages, they were 
isolated using CD115 (Csf1r), F4/80, and TIM4 staining. TIM4 is a member of T-cell 
immunoglobin mucin protein family that binds phosphatidylserine on the surface of 
apoptotic cells (Kobayashi et al., 2007; Miyanishi et al., 2007), which is reportedly 




Figure 5-7 Peritoneal macrophage populations 
(A) Gating strategy to isolate peritoneal macrophage populations: F4/80+ MHC II+ SPM, 
F4/80bright MHC IIlow TIM4+ LPM and F4/80bright MHC IIlow TIM4- LPM. (B) NR4A1GFP and 
CX3CR1GFP expression of LPM populations and SPM, grey histograms represent GFP-, white 
histograms represent GFP+ mice. (C) Quantification of peritoneal macrophage populations from 
Nr4a1fl/fl (closed circles, n=8) and Nr4a1∆/∆ (open circles, n=8) animals. Statistical significance 
was assessed using unpaired t-test. 
 
Analysis of peritoneal macrophage populations including the marker TIM4 revealed the 
presence of two separate LPM populations (Figure 5-7a). The TIM4- population is a 
minor population that, to our knowledge, has not previously been described. Figure 5-
7b shows that NR4A1GFP expression in all three subsets is low. Conversely, SPM 
expressed high levels of CX3CR1GFP (Figure 5-7b), which prompted investigation into 
whether SPM relied on Ly6Clow monocyte contribution. 
In order to assess whether any of the peritoneal macrophage populations had some 
contribution from Ly6Clow monocytes, the peritoneal lavage from Nr4a1Δ/Δ animals and 
























































nor the SPM population were significantly reduced by lack of circulating Ly6Clow 
monocytes.  
It can be seen that the size of the TIM4- varies dramatically between littermates, 
although the distribution is comparable between iCre- and iCre+ littermates. This vast 
variation between mice raised the possibility that the TIM4+ and TIM4- are the same 
population but the TIM4- fraction represents a portion of the population that is 
undergoing receptor internalisation due to activation. To address this question, the 
origins of the different populations were investigated using the Flt3Cre RosaYFP mice. 
 
Figure 5-8 Fate mapping of peritoneal macrophage populations 
Frequency of Flt3YFP+ cells in the peritoneal TIM4+ LPM (light grey bars), TIM4- LPM (dark 
grey bars) and SPM (white bars) at 3, 8, 12, 16, 24 and 40 weeks of age, n=3-6 mice per age 
group; error bars represent standard deviation. 
 
Figure 5-8 demonstrates that, at 3 weeks of age, the TIM4+ macrophage population is 
only around 35% comes from an Flt3+ progenitor, indicating that ~65% of the 
population are Flt3-independent and therefore do not come from HSCs. However, by 24 
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derived cells replenish this population. An alternative interpretation of these results 
could be that TIM4+ macrophages upregulate Flt3 over time.  
In contrast, the TIM4- LPM and the SPM both exhibited high level of excision of the 
LSL cassette and subsequent expression of YFP. Thus, both of these populations are 
mostly derived from HSC-derived progenitors. These data demonstrate two independent 
development pathways between LPM subpopulations, with the TIM4+ population 
having dual origin in adulthood whereas the TIM4- population is dependent upon HSC 
progenitors. This makes it unlikely that the TIM4- population represents an activation 
state of the TIM4+ population. Rather, this data shows that there is heterogeneity with 
the LPM compartment. In addition, these data show that whilst SPM are HSC-derived, 
they have no contribution from Ly6Clow MHC II- monocytes in the steady state. 
  Overview and discussion 5.5
5.5.1  Ly6Clow MHC II- monocytes do not contribute tissue resident 
macrophages under steady state conditions 
This chapter demonstrates that Ly6Clow MHC II- monocytes do not contribute to tissue 
macrophage populations in the steady state. Systematic analysis of macrophage 
populations from the brain, liver, lung, skin, gut, spleen, LN and peritoneum reveals 
that, even in the total absence of Ly6Clow MHC II- monocytes in Nr4a1∆/∆ animals, 
tissue resident macrophage populations in these organs are found at similar frequencies 
to Nr4a1fl/fl littermate controls. In addition, the splenic microarchitecture was 
unchanged between Nr4a1∆/∆ and littermates. 
Interestingly, a novel population of thymic macrophages was found to be reduced by a 
half in Nr4a1∆/∆ animals compared to littermates. This finding was confirmed and 
validated by collaborators in an independent genetic model (Nr4a1-/-) and demonstrated 
 
191 
that this population is important for the effective clearance of apoptotic thymocytes 
(Tacke et al., 2015). As this population is halved in Nr4a1∆/∆ animals, it was reasoned 
that it was unlikely that the reduction was due to lack of Ly6Clow MHC II- monocytes, 
rather that this population is partially dependent on Nr4a1 for its development.  
Furthermore, the data presented here indicate that this novel thymic macrophage 
population in adult mice is HSC-derived, whereas classical tissue resident thymic 
macrophages are a mixture of YS- and HSC-derived cells. However, the interpretation 
of the Flt3Cre RosaYFP data must be considered with caution. As yet, we do not have a 
specific, positive marker for YS-derived macrophages and in this model we infer the 
absence of labelling indicates YS-origin but to be certain of this, it would be necessary 
to investigate using a reporter strain that was specific for YS-derived macrophages. In 
addition, the increase of YFP labelling over time is interpreted as being a reflection of 
HSC-derived cells infiltrating macrophage populations. However the possibility cannot 
be excluded that YS-derived macrophages upregulate Flt3 over time sufficiently to 
enable recombination of the Lox-STOP-Lox motif and subsequent expression of YFP. 
Finally, this chapter investigates the macrophages of the peritoneal cavity and 
demonstrates that large peritoneal macrophages consist of two subsets with distinct 
origins. The TIM4+ LPM population in young mice is a mixed population of YS- and 
HSC-derived macrophages whereas the TIM4- LPM population were entirely HSC-
derived, interpreting the Flt3Cre RosaYFP data with the same caveats as discussed above. 
Thus, the data presented in this chapter demonstrate that Ly6Clow MHC II- monocytes 
do not contribute to tissue macrophage populations in the steady state of the organs that 
were investigated here. It cannot be excluded that Ly6Clow MHC II- monocytes do not 
contribute to any macrophage populations, as these examinations were by no means 
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exhaustive. Furthermore, this chapter characterises the origin of macrophage subsets 
from the thymus and peritoneum, highlighting the complexity of macrophage origins 















  Summary of findings 6.1
Firstly, this thesis describes the phenotypic and genetic validation of a third, MHC II+ 
monocyte subset that can be found in the blood, spleen and BM of adult mice.  
Secondly, the data presented in this thesis suggest an updated maturation pathway of 
monocyte subsets that takes into account previously published reports and the findings 
here of a third, distinct subset. 
Thirdly, this study demonstrates that Ly6Clow MHC II- monocytes do not contribute to 
the tissue macrophage pool in the steady state, which suggests that the fate of this 
population is to remain in the vasculature in order to carry out their effector functions. 
The next section will discuss the value of studying murine monocyte development and 
discuss the interpretation of each of the principal findings, considering alternative 
interpretations and discussing the limitations of the experiments presented in the present 
study. 
  Murine model for understanding monocyte development 6.2
6.2.1  Conserved function between human and murine monocytes 
Our understanding of the origin and function of human patrolling monocytes is even 
more limited than our understanding of murine patrolling monocytes. However, human 
CD14dim CD16+ monocytes are considered to be analogous to murine Ly6Clow 
monocytes on account of some phenotypic characteristics including high CX3CR1 
expression (Geissmann et al., 2003) but also conserved patrolling behaviour (Auffray et 
al., 2007). Furthermore, it has been demonstrated that CD14dim CD16+ monocytes 
express higher levels of NR4A1 by RT-qPCR than the other two subsets: CD14+ CD16- 
and CD14+ CD16+ monocytes (Hanna et al., 2012). Thus, it seems that high Nr4a1 
 
195 
expression is conserved between species in patrolling monocytes which may indicate 
Nr4a1 could be a candidate gene for involved in susceptibility to infectious disease, 
inflammatory diseases and autoimmunity via it’s control of monocyte differentiation. 
Accordingly, understanding Ly6Clow monocyte ontogeny and the molecular 
mechanisms that control murine monocyte development and survival can provide in 
vivo clues for ex vivo research human monocyte development and survival. Given the 
incompletely elucidated roles of monocyte subsets in inflammatory diseases, infection 
and cancer understanding the mechanisms that control functional heterogeneity are 
essential to identify potential future therapeutic targets. Several studies directly 
comparing gene and/or protein expression profiles from human and murine monocytes 
(Cros et al., 2010; Ingersoll et al., 2010; Schmidl et al., 2014) show that there is 
significant homology but also important differences which serves as a reminder that 
findings from one species cannot be directly translated to another. Furthermore, 
CD14dim CD16+ monocytes, like their murine Ly6Clow counterpart appear to carry out 
their effector functions from within the vasculature, patrolling the luminal side of blood 
vessels and scavenging microparticles (Auffray et al., 2007; Carlin et al., 2013; Cros et 
al., 2010).  
Thus, understanding murine monocyte development can act as tool for identifying 
potential avenues of interest in addition to aiding our understanding of basic biology. 
  Monocyte heterogeneity 6.3
6.3.1  Two distinct genetic lineages within the monocyte compartment 
Monocyte heterogeneity has been appreciated for many years now (Geissmann et al., 
2003; Passlick et al., 1989). In mice it is generally considered that there are two 
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monocyte subsets, the Ly6C+ “classical” or “inflammatory” subset and the Ly6Clow 
“patrolling” subset but their relationship to each other has remained a topic of debate. 
This thesis establishes, in wild type mice that the monocyte compartment can be divided 
into three distinct subsets based the cell surface expression of Ly6C and MHC II, which 
is underscored by differing genetic requirements for development. As a consequence, 
the data presented here can be used to understand the seemingly conflicting reports of 
distinct genetic dependencies (Alder et al., 2008; Debien et al., 2013; Hanna et al., 
2011; Kurotaki et al., 2013) and the current model of monocyte conversion in the blood 
(Hettinger et al., 2013; Sunderkotter et al., 2004; Varol et al., 2007; Yona et al., 2013; 
Yrlid et al., 2006). 
As described in previous studies, we found that Ly6C+ monocytes depend upon Irf8 for 
their development (Alder et al., 2008; Kurotaki et al., 2013) and Ccr2 for their 
migration from the BM to the periphery (Serbina and Pamer, 2006). Interestingly, it was 
found that Ly6Cint MHC II+ monocytes also have the same genetic requirements for 
their development and BM egress. In contrast, Ly6Clow MHC II- monocytes were found 
to develop independently of Irf8 and did not require Ccr2 to exit the BM (Figures 4-17 
and 4-19). Moreover, as previously described by Hanna et al., Ly6Clow MHC II- 
monocytes were completely dependent upon Nr4a1 for successful BM development 
(Hanna et al., 2011). Taken together, these genetic dependencies reveal two separate 
developmental lineages of mature monocyte subsets: one which is dependent upon Irf8 
and Ccr2 and generates Ly6C+ and Ly6Cint MHC II+ monocytes and a second which is 
dependent upon Nr4a1 and gives rise to Ly6Clow MHC II- monocytes. Seemingly 
contradictory previously published reports regarding Ly6Clow monocyte development 
pathways can be explained by the overlap within the Ly6Clow monocyte compartment 
between Ly6Clow MHC II- and Ly6Cint MHC II+ subsets.  Thus, the observation that 
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Ly6Clow monocytes can still develop in the absence of Ly6C+ monocytes in Irf8-/- 
animals (Kurotaki et al., 2013) can be accounted for by the Nr4a1-dependent, Irf8-
independent Ly6Clow MHC II- monocyte subset. Furthermore, the residual Ly6Clow 
monocytes observed in Nr4a1-/- animals in the paper by Hanna et al., are Nr4a1-
independent Ly6Cint MHC II+ monocytes (Hanna et al., 2011) (See Figure 4-5).  
The genetic confirmation of monocyte heterogeneity supports the notion that there are 
at least two distinct monocyte lineages in the blood, away from relying only on cell 
surface markers (Figure 6-1). 
 
Figure 6-1 Murine monocyte heterogeneity  
The murine monocyte compartment consists of at least two genetically distinct lineages. One, 
which is dependent upon Irf8 for monocyte development and Ccr2 for BM egress and the 
second, which depends on Nr4a1 for development and S1pr5 for BM egress 
 
Furthermore, these differing genetic requirements have important consequences for our 
understanding of the molecular control of monocyte functional heterogeneity. The 
























speculate that, as they express MHC II+, CD11c and Flt3, it would be very interesting to 
investigate whether this subset has DC-like functions in vivo. 
6.3.2 Nr4a1GFP as a positive marker for Ly6Clow MHC II- monocytes 
In this study we utilise the high level of NR4A1GFP expression that is selectively 
observed in Ly6Clow monocytes. Whilst CX3CR1GFP has been critical for the progress of 
understanding myeloid biology, the difference in CX3CR1GFP MFI between Ly6C+ and 
Ly6Clow MHC II- monocytes is a 4-fold increase and the difference between Ly6Cint 
MHC II+ and Ly6Clow MHC II- monocytes is a 2-fold increase (Figure 3-2). Ly6C+ 
monocytes are often referred to in the literature as having intermediate Cx3cr1 
expression levels whereas Ly6Clow MHC II- monocytes are described as CX3CR1bright. In 
reality, this marked difference in expression levels does not allow clear distinction 
between subsets in flow cytometry.  
In contrast, the NR4A1GFP MFI of the blood Ly6Clow MHC II- subset is 25-fold higher 
than Ly6C+ monocytes and 10-fold higher than Ly6Cint MHC II+ subsets (Figure 3-2). 
Thus, whilst many different cell populations express Nr4a1, the selective high level of 
expression observed on Ly6Clow MHC II- proved very useful in separating monocyte 
populations from each other and using NR4A1GFP as positive marker for Nr4a1-
dependent monocytes.  
The increase in GFP of both Cx3cr1 and Nr4a1 as Ly6C expression decreases. GFP 
reporter lines should be a direct reflection of cellular expression of protein of interest. 
However, as was already noted, GFP protein has a long half-life and the increase in 
GFP MFI could be interpreted as an accumulation of protein within the cells as they 
convert from Ly6C+ through to Ly6Cint MHC II+ until finally maturing into Ly6Clow 
MHC II- monocytes. However, in light of the differing genetic dependencies of Ly6C+ 
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and Ly6Cint MHC II+ subsets compared to Ly6Clow MHC II- monocytes evidenced here, 
it would seem unlikely. However, one possibility that hasn’t been excluded is that 
Nr4a1-dependent Ly6Clow MHC II- monocytes can upregulate MHC II+, contributing to 
this compartment. In addition, the possibility cannot be excluded that investigations 
with further genetic models and with additional cell surface markers that the 
heterogeneity within the monocyte compartment will increase still further. 
 Monocyte dynamics 6.4
In the present study monocyte dynamics in the blood and BM were characterised using 
two different techniques: cell cycle analysis using Ki-67/DAPI staining and BrdU 
incorporation analysis. 
Cell cycle analysis using Ki-67/DAPI staining provided information regarding the 
proportion of each population actively cycling at any one time, however, as discussed in 
chapter 3, cell cycle analysis in this manner provides a snapshot of proliferation activity 
at that particular time and does not provide information regarding the rate at which a 
population turns over. Thus the combination with BrdU pulse-chase analysis provided 
information about the length of time it takes for a population to be completely replaced 
with unlabelled cells. 
The half-lives on monocyte subsets in the blood and BM were analysed using 
exponential curve fitting to the rate of decay of BrdU signal over time. It was clear that 
as blood monocytes were not actively cycling themselves all BrdU signal must come 
from their progenitor population replenishing the blood monocyte compartment. In 
contrast, BM Ly6C+ monocytes were found to be actively cycling, with approximately 
15% of the population in S+G2M phase. Thus, the BrdU+ fraction of BM Ly6C+ 
monocytes will have a combination of cells that are BrdU-labelled because they 
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themselves incorporated BrdU and others that have come into the BM Ly6C+ monocyte 
compartment from upstream progenitors. Nevertheless, the BrdU incorporation by 
MDP, cMoP, Ly6C+ BM monocytes and Ly6Cint MHC II+ BM monocytes all have very 
related kinetics: rapid incorporation of BrdU and rapid dilution of BrdU labelling in the 
compartment. The previously characterised development sequence of MDP 
upregulating Ly6C to become the cMoP, which in turn down regulate KIT to 
differentiate into BM Ly6C+ monocyte which then enter the blood as mature Ly6C+ 
monocytes (Auffray et al., 2009a; Fogg et al., 2006; Hettinger et al., 2013) show an 
anticipated delay as BrdU labelling moves downstream away from earlier progenitors. 
Interestingly, the Ly6Cint MHC II+ monocyte subset also follows this pattern and BrdU 
is incorporated into this subset rapidly following Ly6C+ monocytes. Analysis of the role 
of the chemokine receptor Ccr2 is also consistent with this interpretation. Here, we 
demonstrate that Ccr2 deficiency does not affect egress of the Ly6Clow MHC II- 
monocytes: previously published data demonstrating a dramatic increase in the half-life 
of Ly6Clow monocytes after blocking of Ccr2 with the antibody MC21, was interpreted 
as a possible compensatory survival of Ly6Clow monocytes in the absence of their 
precursor (Yona et al., 2013). In light of the data presented here, it seems probable that 
this observation corresponded to the decrease of the short lived Ly6Cint MHC II+ 
monocytes in the blood, thus, allowing the analysis of long-lived Ly6Clow MHC II- 
monocytes without the influence of short lived Ly6Cint MHC II+ on half-life 
calculations. 
The genetic and kinetic analyses of Ly6Cint MHC II+ monocytes indicate that this subset 
is the progeny of Ly6C+ monocytes. However, it is not clear whether the upregulation of 
MHC II and downregulation of Ly6C only occurs in the BM or if Ly6C+ monocytes can 
also undergo this differentiation step in the blood as well.  
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BrdU labelling of Ly6Clow MHC II- monocytes in the blood begins after blood Ly6C+ 
monocytes have almost completely diluted out the BrdU labelling in that subset. In 
addition, BM Ly6Clow MHC II- BrdU labelling appears to precede the blood labelling in 
a related manner. This was interpreted here, in conjunction with genetic data and 
adoptive transfer experiments, that blood Ly6C+ monocytes do not give rise to Ly6Clow 
MHC II- monocytes in the blood. However, although not evidenced here, the possibility 
cannot be completely excluded that a small proportion of Ly6C+ monocytes do give rise 
to Ly6Clow MHC II- monocytes within the blood. This is, in part, due to the few 
remaining Ly6C+ monocytes that are observed in the blood of Irf8 and Ccr2 deficient 
animals.  
The identification of a cell surface marker specific for Ly6Clow MHC II- monocytes 
would be incredibly useful, particularly for the BrdU incorporation experiments. The 
protocol involves several fixation/ permeablisation steps, which can pose a problem for 
combining with GFP-reporter cells as it is well documented that fixation/ 
permeabilisation protocols can cause leakage of cytoplasmic GFP. Whilst the Nr4a1GFP 
transgene is fused to a Cre codon which in principal should ensure it’s nuclear 
localisation (Shimshek et al., 2002), BrdU protocols require DNA denaturation to 
expose the BrdU signal. In optimising the BrdU incorporation experiment, this 
denaturation step was found to greatly reduce GFP signal. Thus the identification of a 
specific marker for Ly6Clow MHC II- monocytes and their BM Ly6Clow CD11b+ 
intermediate would improve accuracy of analysis.  
One limitation of the kinetic analysis experiments presented in this study is that we 
cannot label a single cell and trace it through its life span to fully understand its fate 
from HSC to maturity. An interesting way to establish the exact fate of monocytes from 
their progenitors would be to make use genetic barcoding techniques that have been 
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utilised in haematopoietic lineage tracing (Lu et al., 2011; Naik et al., 2013; Naik et al., 
2014). 
 An updated model of the Ly6Clow monocyte development 6.5
pathway 
6.5.1 Bone marrow Ly6C+ monocytes – a progenitor population? 
The results in this study indicate that Ly6C+ BM monocytes are a precursor population 
in there own right, capable of giving rise to at least three different blood monocyte 
populations. Calculating the relative compartment size of monocytes and their 
progenitors demonstrated that the BM Ly6C+ monocyte population is disproportionately 
expanded compared with blood Ly6C+ monocytes suggesting that it may be a precursor 
population to more than just blood monocyte populations. An interesting postulation is 
that this population is the direct precursor to gut macrophage populations, which are 
constantly replenished by Ccr2-dependent Ly6C+ monocytes (Bain et al., 2014). To 
clearly distinguish BM Ly6C+ monocytes as a bona fide precursor population, capable 
of giving rise to a number of different subsets, we suggest that it could be referred to as 
“common pro-monocyte” (cProM), following Shand et al., who referred to BM 
monocytes as “pro-monocytes” (Shand et al., 2014) and with the prefix “common” to 
reflect the ability of this cell type to generate several distinct monocyte populations. 
Further investigations into the cProM could provide great insight into the precursor 
potential and also inform on the heterogeneity within this population. This study has 
demonstrated that there are cells within the cProM with at least two different genetic 
dependencies: the majority of the population is Irf8- and Ccr2-dependent but a fraction 
of the population develops independently of these genes. An interesting way of 
investigating this could be by utilising the technology of mass cytometry (CyTOF), 
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which combines the resolution capabilities of mass spectrometry at the single cell level 
with traditional flow cytometry techniques but without the limitations of spectral 
overlap. Mass cytometry can allow analysis of multiple different antigens; both internal 
such as phosphoproteins and external cell surface markers, facilitating multiparameter 
single-cell characterisation of complex populations (Bendall et al., 2011). 
6.5.2 A novel Ly6Clow CD11b+ NR4A1bright monocyte intermediate 
In the present study, it was possible to identify in the absence of irradiation and in vivo 
using two independent Nr4a1-deficient models, a novel BM Nr4a1-dependent Ly6Clow 
CD11b+ MHC II- NR4A1bright CX3CR1bright population. Systematic analysis of this 
population revealed that the differentiation block observed in the BM of Nr4a1-
deficient animals (Hanna et al., 2011) occurs at this step in the Ly6Clow MHC II- 
monocyte development pathway. Whilst this population is considerably reduced in 
Nr4a1-deficient animals, the few remaining cells were actively cycling yet were unable 
to fully mature, instead undergoing apoptosis, similarly to Ly6Clow MHC II- BM 
monocytes. Furthermore, this population was slowly proliferating, in line with being an 
intermediate of a long-lived cell population and was shown to be capable of 
upregulating CD115 in vitro. Altogether, these data demonstrate the presence of an 
intermediate BM population between the “cProM” and BM Ly6Clow MHC II- monocytes 
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 The fate of Ly6Clow MHC II- monocytes in steady state 6.6
This study further demonstrated that Ly6Clow MHC II- monocytes are distinct from 
Ly6C+ monocytes in fate in the periphery. Interestingly, Ly6Clow MHC II- monocytes 
were shown not contribute to tissue myeloid cells in a steady state, but apparently spend 
their lifespan within the vasculature, congruent with the reported ‘patrolling’ role of 
Nr4a1-dependent Ly6Clow monocytes as scavengers of the micro-vasculature (Auffray 
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2010). Ly6Clow MHC II- monocytes, and their human CD14dim CD16+ counterparts 
(Cros et al., 2010), have been shown to mediate intravascular inflammatory responses to 
viruses and nucleic acid signals, facilitate IgG-dependent effector functions and are 
implicated in diseases with nucleic acid aetiology, such as viral infections and Systemic 
Lupus Erythematosus (Amano et al., 2005; Biburger et al., 2011; Carlin et al., 2013; 
Cros et al., 2010; Daley-Bauer et al., 2014; Devi et al., 2013; Santiago-Raber et al., 
2009).  
This study investigated a number of different tissue myeloid populations including 
brain, spleen, liver and skin; it is by no means exhaustive analysis of all tissue 
macrophage populations, therefore it is impossible to conclude that Ly6Clow MHC II- 
monocytes do not contribute to any tissue macrophage populations in the steady state. 
However, we infer that it seems highly unlikely as the evidence presented here 
demonstrates that absence of Ly6Clow MHC II- monocytes did not directly affect any of 
the macrophage populations analysed. Thus, it can be inferred from the data presented 
here that Ly6Clow MHC II- monocytes remain in the circulation throughout their life 
span, and their effector functions in steady state are carried out from within blood 
vessels.   
 What genes does Nr4a1 regulate during monopoiesis?  6.7
Nr4a family members are known to regulate gene expression and are involved in a wide 
range of physiological processes (Bonta et al., 2006; Boudreaux et al., 2012; Liu et al., 
2003; Sekiya et al., 2013). The absolute requirement of Nr4a1 for Ly6Clow MHC II- 
monocytes is interesting as there is a level of functional redundancy within the Nr4a 
family, which is partly attributed to the ability of all three family members to trans-
activate the same Nur-response element (Chao et al., 2013; Cheng et al., 1997; Sekiya et 
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al., 2013). However, the data presented here demonstrate that for Ly6Clow MHC II- 
monocyte development, Nr4a1 is essential and that other Nr4a family members cannot 
compensate its absence. Furthermore, a strong haploinsufficiency was observed, a 
finding that is reminiscent of the gene dosage effect reported for other members of the 
Nr4a family during haematopoiesis (Ramirez-Herrick et al., 2011). The molecular 
mechanisms and control of gene expression that Nr4a1 exerts during Ly6Clow MHC II- 
monocyte development would be extremely interesting to investigate further.  
The transcriptional activity of Nr4a family members is thought to be regulated by their 
expression levels in combination with co-activators (Rambaud et al., 2009; Rosenfeld et 
al., 2006; Wansa et al., 2002; Wansa et al., 2003; Wansa and Muscat, 2005), co-
repressors (Sohn et al., 2001) and post translational modifications (Hermanson et al., 
2002; Kang et al., 2010; Katagiri et al., 1997). One such regulator of Nr4a1 activity is 
the member of the small interferon stimulated gene family, Isg12 (interferon stimulatory 
gene 12) (Papac-Milicevic et al., 2012). ISG12 is an interaction partner of NR4A1 and 
upon its upregulation, ISG12 has been shown to mediate the translocation of NR4A1 
from the nucleus to the cytoplasm, thus reducing the availability of NR4A1 to bind 
DNA thus activating transcription (Papac-Milicevic et al., 2012; Uhrin et al., 2013). It 
would be interesting to investigate whether Isg12-/- mice have a phenotype in the 
Ly6Clow MHC II- monocyte compartment.  
An unbiased approach would to be to use genome wide analysis to investigate the 
transcriptional and epigenetic networks of the differing monocyte subsets using high-
throughput genome-wide sequencing assays such as RNA-sequencing (RNA-seq), 
chromatin immunoprecipitation sequencing (ChIP-seq) and assay for trasnposase 
accessible chromatin sequencing (ATAC-seq). RNA-seq would information on the 
global gene expression profiles of monocyte subsets (RNA-seq), genome wide profiling 
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of histone modifications (ChIP-seq) and analysis of open (therefore accessible for 
protein binding) chromatin regions. Together, these data could shed interesting light 
into the cellular identity of monocyte subsets, which could potentially provide further 
information on their ontogeny.  
 General conclusion 6.8
To conclude; within the monocyte compartment, there are at least two genetically 
distinct monocyte lineages, one which requires Irf8 for development and Ccr2 for 
migration from the BM to the periphery and a second lineage which is completely 
dependent upon Nr4a1 for its development in the BM from the Ly6C+ common pro-
monocyte.  
The loss of Nr4a1 resulted in the absence of Ly6Clow MHC II- monocytes in the BM and 
periphery due to a differentiation block in the BM at the point of a newly identified BM 
Ly6Clow CD11b+ CD115low NR4A1bright intermediate. This intermediate population was 
also shown to be the transitional step between Ly6C+ common pro-monocyte population 
and Ly6Clow MHC II- monocytes.  
Finally, this thesis demonstrates that the fate of Ly6Clow MHC II- monocytes is to 
remain within the circulation and these cells do not contribute to tissue macrophage 
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Appendix 1- 1 Gating strategies used in flow cytometry analysis in this thesis 
Gating strategies used for analysing tissue myeloid populations in this thesis with the exception 
of blood, BM and peritoneal lavage, the gating strategies for these are included in the main body 






































































































9 Appendix 2 
 
Appendix 1- 2 Flt3Cre RosaYFP labelling of HSCs 
Frequency of YFP+ HSCs at 9 days, 4 weeks and 12 weeks of age, n=3-6 per age group, error 












LT-HSC ST-HSC MPP 
